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The development of fetal ovary is a complex process involving the communication 
between primordial germ cells (PGCs), Gonadal Ridge Epithelial-Like (GREL) cells and 
stroma. Many studies in ovarian development have focused on follicles, making other 
features, such as stroma and ovarian surface the least studied. Additionally, perturbation of 
ovarian development has been suggested to lead to many reproductive diseases, such as 
Polycystic Ovary Syndrome (PCOS) and ovarian cancer. Studies have shown that prenatally 
androgenised female mammals had ovaries with PCOS features, such as small follicles and 
increased ovarian stromal volume. Similarly, ovarian cancer has been suggested to be able to 
arise from non-ovarian tissue, such as fallopian tubes and endometrium. This thesis discussed 
the changes of ovarian stroma (chapter II) and linked the changes to PCOS (chapter III). 
Furthermore, this thesis quantitated changes of non-stromal areas containing GREL cells and 
follicles (chapter IV) as well as identified the changes in ovarian surface during fetal 
development (chapter V). 
Early in ovarian development, the surface epithelium of the mesonephros 
differentiates into GREL cells and proliferates, forming the ovarian primordium into which 
PGCs migrate. The stroma from the mesonephros penetrates the developing ovary and then 
branches. At this time, a true surface epithelium is located only at the base of the developing 
ovary. When the stroma reaches just underneath the surface of the developing ovary, it 
spreads laterally. The branching and spreading of the stroma encloses some GREL cells and 
PGCs into ovigerous cords. At this point, the ovigerous cords are still open to the ovarian 
surface. The stroma keeps on spreading, dividing the ovigerous cords into smaller units and 
eventually into primordial follicles. GREL cells located on the ovarian surface then start to 
differentiate into surface epithelium. At the last stage of development, a single layer of 
surface epithelium is formed and the stroma underneath the surface epithelium changes its 
phenotype into tunica albuginea, a collagen rich layer.  
In this thesis, I analysed the stromal and non-stromal areas morphometrically and 
linked ovarian development with expression of a number of extracellular matrix genes. My 
results show that the volume of the ovarian cortex and medulla increased throughout 
gestation. The stromal proportion and total volume in the cortex were significantly increased 
(p>0.05), whereas the proliferation index and numerical density of proliferating cells in the 
xi 
 
stroma decreased significantly (p>0.05). There was no change in numerical density of stromal 
cells in the cortex. Twelve extracellular matrix genes were highly expressed later in the 
development and positively correlated with each other and with gestational age. The total 
volume of non-stromal areas in the ovarian cortex significantly increased and then levelled 
off. The proportion of non-stromal areas in the cortex decreased significantly. The 
proliferation index of the non-stromal area peaked in early gestation and then decreased 
significantly and then remained low. The numerical density of the stromal area remained 
constant throughout ovarian development. My morphometric data of the stromal area as well 
as the gene expression have been published in Reproduction Fertility and Development. The 
data of the non-stromal area have been combined with other data and published in PLoS 
ONE. 
Since many reproductive diseases might have a fetal origin, we studied the linkage 
between fetal ovarian development and PCOS. Recent studies have recognised 18 PCOS 
candidate genes identified by genome wide associated study (GWAS) analyses. Using qRT-
PCR, I analysed the expression of these genes, as well as three other genes (androgen receptor 
(AR), Transforming Growth Factor Beta 1 induced transcript 1 (TGFB1I1), fibrillin3 (FBN3)) 
in the bovine fetal ovaries across gestation. To assess the regulation of these genes in the 
bovine fetal ovary, I analysed the expression of these genes in bovine fetal fibroblasts which 
had been treated with cAMP regulators, growth factors and hormones in vitro (24 treatments 
in total) during a previous honour project. FBN3, GATA4, HMGA2, TOX3, DENND1A and 
LHCGR were highly expressed in the early development, whereas INSR, FSHR and LHCGR, 
including 3 PCOS-related genes (AMH, AR and TGFB1I1) were highly expressed in the late 
development. These eleven genes were strongly correlated to each other, although some of 
them expressed in different cell types. Treatment of fetal stromal cells with TGFβ induced the 
expression of INSR, AR, C8H9orf3 and RAD50 and inhibited expression of TGFB1I1. The 
data have been submitted to Scientific Reports.  
In the attempt of investigating the changes of ovarian surface, I analysed Scanning 
Electron Microscope (SEM) images and compared them with immunohistochemistry images, 
as well as determined the proportions of different types of cells in the ovarian surface 
epithelium. Early in development, the cells at the base of the developing ovary were cuboidal 
whereas the remaining surface appeared more irregular. Around 10 weeks of gestation until 5 
months of gestation, the surface was covered by a stratified or simple epithelium of cuboidal 
cells. During mid-gestation clefts could be observed on the surface coinciding below with 
open ovigerous cords. Later in development, most of the ovary was covered by a simple 
surface epithelium. There appear to be two origins of ovarian surface epithelium – at the 
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base/hilum originating from the mesonephros and on the remainder from the GREL cells.. 
The data have been submitted to Journal of Histology and Cytochemistry.  
Together, this work has shown the behavioural and structural changes of stroma and 
ovarian surface during fetal development. Since some of the PCOS candidate genes are 
expressed during fetal ovarian development, any potential disruption during ovarian 
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Literature review / significance of the research 
Understanding fetal development is critical for discovering the developmental origins 
of poor health and non-communicable diseases. Perturbations of ovarian development may 
cause a permanent alteration in ovarian functions, leading to infertility or hormonal 
imbalances. It is imperative to recognise all the processes involved in ovarian development in 
order to mitigate these perturbations. This study advances our knowledge of key aspects of 
ovarian development.  
 
1.1.   The formation of the mammalian fetal ovary 
Observations by Hummitzsch et al. reveal that the formation of the bovine fetal ovary 
can be subdivided into six critical stages of development (Fig. 1): (1) Mesonephric stromal 
penetration; (2) Ovigerous cord formation; (3) Ovigerous cord breakdown; (4) Follicle 
formation; (5) Surface epithelium formation; and (6) Tunica albuginea formation. More recent 
findings in humans agree with these findings (Heeren et al. 2015).  
1.1.1. Mesonephric stromal penetration 
The formation of the ovary begins with the thickening of the surface epithelium on the 
ventromedial surface of the mesonephros (Sarraj & Drummond 2012, Hummitzsch et al. 
2013, Wilhelm et al. 2013), the location where the genital ridge will be established at around 
32 days of gestation (Ross et al. 2009). The mesonephros acts as a transient kidney in fetal 
mammals and starts to degenerate at around 40-47 days of gestation (Wrobel 2001) when the 
metanephros is fully functioning as a kidney. The surface epithelial cells of the mesonephric 
thickening will change their phenotype into Gonadal Ridge Epithelial Like (GREL) cells 
which start to proliferate and will form the somatic cell population of the ovary at the early 
stage of the ovarian primordium (Hummitzsch et al. 2013). After breakdown of the basal 
lamina underlying the mesonephric surface epithelium, the stroma from the mesonephros, 
which contains fibroblasts, fibres, and capillaries, commences to penetrate the ovarian 




1.1.2. Ovigerous cord formation 
As the stroma is penetrating the developing ovary, primordial germ cells (PGCs), 
which have emerged from the yolk sac, start to proliferate, while migrating through the 
hindgut along the dorsal mesentery and into the gonadal ridges. This migration occurs at 
approximately days 18-31 in cows (Wrobel & Süß 1998) and at 4-14 weeks post-conception 
in humans (Mamsen et al. 2012). Once resident in the ovary, PGCs are referred to as oogonia 
and continue proliferating. As the stroma spread towards the ovarian surface between the 
GREL cells and oogonia of the primordial ovary, the stroma branches and thus corrals the 
 
Fig. 1. Schematic diagram of the developmental stages of bovine fetal ovaries. Modified 
from (Hummitzsch et al. 2013). 
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oogonia and GREL into defined areas called ovigerous cords. This occurs at day 70 in cows 
(Hummitzsch et al. 2013) and from week 15 onwards in humans (Konishi et al. 1986) and it 
results in the compartmentalisation of the ovarian primordium into the cortex, which 
alternates between ovigerous cords and stromal areas, and medulla, which mainly contains the 
mesonephros stroma containing the extracellular matrix, fibroblasts and vasculature.  
The oogonia within the ovigerous cords begin to differentiate into oocytes, entering  
meiosis at around 75-80 days in bovines and at 11-12 weeks’ gestation in humans (Cohen & 
Holloway 2010). At this stage, there is no defined surface epithelium on the ovarian surface 
and the ovigerous cords are still ‘open’ to the surface (Hummitzsch et al. 2013, Heeren et al. 
2015). The ovigerous cords are separated from the surrounding stroma by a basal lamina 
(Hummitzsch et al. 2013, Heeren et al. 2015). The stromal strands between ovigerous cords 
also contain capillaries, each surrounded by a sub-endothelial basal lamina.  
1.1.3. Ovigerous cord breakdown 
Further penetration of stroma from the ovarian medulla into the cortex causes the 
breakdown of large ovigerous cords into smaller clusters of GREL cells and oogonia, 
commencing in the area closest to the medulla. The breakdown of ovigerous cords is observed 
at around 90 and 105 days in cattle (Garverick et al. 2010), and at around 112 days in humans 
(Motta et al. 1997), and 20.5-22.5 dpc in mice (Pepling & Spradling 2001). Apoptosis is 
observed during the breakdown of mice ovigerous cords suggesting that cell loss might have 
an important role in the breakdown of the ovigerous cords (Pepling & Spradling 2001, 
Juengel & Smith 2014). 
1.1.4. Follicle formation 
In bovine ovaries the breakdown of ovigerous cords by the stroma into ever smaller 
clusters of oogonia/oocytes and GREL cells finally results in the formation of primordial 
follicles, consisting of an oocyte surrounded by flattened pre-granulosa cells, which are 
separated from the adjacent tissue by a basal lamina (Hummitzsch et al. 2013). The first 
primordial follicles form close to the medulla at day 105 in cattle, while the more external 
areas of the cortex still contain ovigerous cords. Later in development, more primordial 
follicles are formed closer to the ovarian surface (Burkhart et al. 2010). Some primordial 
follicles are activated and develop further into primary follicles. The follicles continue to 
develop into preantral follicles, which contain two or more granulosa cell layers (Fortune et 
al. 2010) , and into antral follicles, which are composed of columnar-shaped granulosa cells, 
two theca cell layers (theca interna and externa) and the antrum (Burkhart et al. 2010, 




1.1.5. Surface epithelium formation 
In bovine ovaries in late in development, stromal cells branch laterally underneath the 
outermost layers of cells on the ovarian surface, separating them from the ovigerous cords 
below, thereby ‘closing’ the cords. A basal lamina is located at the border of the stroma and 
the cells on the surface. At this stage, the ovary has a surface epithelium as classically 
defined, with an epithelial layer with a sub-epithelial basal lamina at the stromal interface. 
The early multi-layered surface epithelium differentiates into a mature single-layered 
epithelium later on (Hummitzsch et al. 2013).  
1.1.6. Tunica albuginea formation 
In bovine ovaries at the final stage of bovine ovarian development, the stroma below 
the basal lamina, underlying the ovarian surface epithelium, differentiates into the tunica 
albuginea (Hummitzsch et al. 2013); an avascular collagen-rich layer (van Wezel & Rodgers 
1996).  
 
1.2.  Gene regulation during ovarian development 
During ovarian development, complex processes involving crosstalk between germ 
cells, somatic cells and stromal cells occur. A better understanding of these early factors that 
regulate the cell populations in the fetal ovary will enhance our knowledge about the 
formation of follicles and normal ovarian development. This subchapter reviews various 
genes and signals involved in germ and somatic cell development in the fetal ovary.   
1.2.1. The regulation of germ cells 
The positive regulatory domain I-binding factor 1 (PRDM1), PRDM13 and interferon-
induced transmembrane protein 3 (IFITM3/Fragilis) are expressed in PGC precursors at 
embryonic day (E) 6-6.5 in mice (Chuva de Sousa Lopes & Roelen 2010, Fortune et al. 2010, 
Matsui 2010). After the PGCs are located posterior to the primitive streak in the 
extraembryonic mesoderm, nonspecific alkaline phosphatase (TNAP) and developmental 
pluripotency associated 3 (DPPA3 or Stella) are expressed. During the migration process, 
PGCs continue to express TNAP and start to express POU Domain, Class 5, Transcription 
Factor 1 (POU5F1), the proto-oncogene cKIT and stage-specific embryonic antigen (SSEA) 1 
and 3 [reviewed in (Hummitzsch et al. 2015)]. 
POU5F1 encodes a transcription factor containing a POU (Pit-Oct-Unc) 
homeodomain that plays a key role in embryonic development and stem cell pluripotency 
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(Yeom et al. 1996). POU5F1 is also known as octamer-binding transcription factor 3/4 
(OCT3/4). The OCT3/4 protein is observed in bovine PGC and oogonia, as well as in the 
oocytes of primordial and primary follicles in cows (Hummitzsch et al. 2013) and women 
(Anderson et al. 2007). OCT3/4 protein is highly expressed in mouse and human oogonia that 
are mitotically active and it rapidly declines in the oocytes during folliculogenesis (Meyts et 
al. 2004, Stoop et al. 2005). 
Nanog1 encodes the Nanog transcription factor that maintains the self-renewal and 
pluripotency of embryonic stem cells (Chambers et al. 2003, Mitsui et al. 2003). Nanog is 
expressed in human fetal PGC and oogonia between 7-11 weeks of gestation. At 7 weeks of 
gestation, it is observed in the medullary and cortical regions, however by 8 weeks of 
gestation its expression can mostly be observed in the cortex. After week 11, the number of 
Nanog positive cells decreases and most are located in the outer cortex (Kerr et al. 2008).  
DAZL encodes an RNA binding protein and is detected in the cytoplasm of germ cells 
(Cooke et al. 1996). In the bovine fetal ovary, the DAZL protein is observed in germ cells at 
around 70-130 days of gestation (Hummitzsch et al. 2013), whereas in humans it is more 
commonly observed in the second trimester (Anderson et al. 2007). Furthermore, any 
knockout of DAZL in fetal mice results in infertility due to the loss of oocytes (McNeilly et 
al. 2000, Lin & Page 2005). 
DDX4 encodes DEAD box proteins, which is a homolog of VASA proteins in several 
other species, such as Drosophila, and is involved in germ cell development (Chen et al. 
2014). It is known as the late germ cell marker and it is detected in oogonia and oocytes in 
bovine and human fetal ovaries (Anderson et al. 2007, Albamonte et al. 2008, Kenngott et al. 
2014, Heeren et al. 2015). 
Figlα encodes factors in the germ line, a transcription factor. The expression of Figlα 
is detected from 13 dpc in mouse oocytes and this gene continues to be expressed in 
adulthood (Liang et al. 1997). It is believed that Figlα is critical for the survival of germ cells 
and the formation of primordial follicles (Soyal et al. 2000, Lei et al. 2006).  
Stra8 encodes stimulated by retinoic acid gene 8 protein. Stra8 is believed to be 
required for germ cell entry into meiosis [reviewed (Feng et al. 2014)]. Studies in mice have 
shown that a deficit of Stra8 causes impaired meiosis in fetal ovaries, leading to infertility 
(Baltus et al. 2006). Stra8-null mouse fetal ovaries showed hindered meiosis prior to prophase 
I entry (Baltus et al. 2006, Anderson et al. 2008).  
Besides germ cell markers, germ cells also express some bone morphogenic proteins 
(BMPs). The BMP family is a member of the Transforming growth factor (TGF) superfamily 
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and consists of 18 members [reviewed in (Juengel & McNatty 2005)]. BMPs are believed to 
regulate physiological processes related to the functions of ovarian follicles at different 
developmental stages [reviewed in (Rossi et al. 2016)]. BMP-4 and -8 have been shown to 
facilitate the differentiation of stem cells into PGCs in humans (West et al. 2010) as well as 
the proliferation of PGCs in rodents (Ross et al. 2003) and humans (Childs et al. 2010). Some 
BMPs have been found to be expressed in oocytes at different follicle stages, such as BMP-2, 
-4, -6, -7 and -15. These BMPs are observed in the adult and fetal ovaries of humans, cattle, 
sheep, goats and rodents (Fatehi et al 2005; Juengel et al 2006; Glister, Kemp & Knight 2004; 
Frota et al 2013; Silva et al 2005; Juengel & McNatty 2005; Childs et al 2010; Miyoshi et al 
2006; Erickson & Shimasaki 2003; Abir et al 2008).  
1.2.2. The regulation of somatic cells 
The GATA family and their co-factor FOG2 play a crucial role in the beginning of 
ovarian developmental processes [reviewed in (Morceau et al. 2004, Viger et al. 2008)]. 
GATA4 is expressed in human fetal granulosa cells at 23 weeks of gestation, then its 
expression decreases by week 33 (Vaskivuo et al. 2001a). In adult human and rat ovaries, the 
expression of GATA4 is observed in theca cells and in ovarian surface epithelium (Vaskivuo 
et al. 2001a, Anttonen et al. 2003, Capo-chichi et al. 2003).  
The sexual development of the ovary is dramatically affected by the loss of the 
interaction of Gata4-Fog in mice (Manuylov et al. 2008). The GATA4-FOG2 complex 
regulates the canonical Wnt/β-catenin pathway by activating the wingless-related MMTV 
integrated site 4 (WNT4), as well as repressing the Dickkopf-related protein 1 (DKK1) gene 
(Manuylov et al. 2008). WNT4 is important for activating this pathway in the granulosa cells 
of humans (Sanchez et al. 2014), cattle (Abedini et al. 2015), pigs (Kiewisz et al. 2011) and 
mice (Hsieh et al. 2002, Harwood et al. 2008), as well as activating bone morphogenetic 
protein 2 (BMP2) and follistatin (FST) (Yao et al. 2004). DKK1 is a potent inhibitor of Wnt 
signalling (Glinka et al. 1998).  
Follistatin (FST) and forkhead box L2 (FOXL2) are two of the first genes that can be 
detected early in ovarian development (Menke & Page 2002). Foxl2 is a granulosa cell 
marker and can be observed at embryonic day 11.5 in the developing XX gonad in mice 
(Wilhelm et al. 2009), in the human female genital ridge at around 6 weeks of gestation or 
before sex determination (Cocquet et al. 2002) and in cattle at 90 days of gestation 
(Hummitzsch et al. 2013). The cooperation of β-catenin, FOXL2, and BMP2 initiates the 
expression of FST, which supports female germ cell differentiation/development. 
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It has been shown that the members of the TGF- superfamily play important roles in 
regulating the function of the ovary (Knight & Glister 2006). TGF- ligands bind the TGF- 
type II receptor dimer, which is a serine/threonine receptor kinase, which both recruits and 
phosphorylates the type I receptor, forming a hetero-tetrameric complex with the ligand 
[reviewed in (Weiss & Attisano 2013)] . TGF- superfamily members include TGF-, activin, 
inhibin, BMPs and growth differentiation factor 9 (GDF9), anti-mullerian hormone (AMH), 
follicle stimulating hormone receptor (FSHR) and FST (Piek & Roberts 2001). The regulation 
of TGF- family signalling depends on the recruitment of the second messengers of the Smad 
family. These complexes have been shown to be expressed throughout folliculogenesis 
(Bristol & Woodruff 2004), suggesting the importance of these pathways in ovarian 
development.  
TGF-1-3 isoforms are detected in the oocytes, thecal cells and granulosa cells of 
adult rat ovaries (Benahmed et al. 1993). In adult human ovaries, TGF-1 is observed in 
granulosa cells and oocytes, TGF-2 is mostly found in the granulosa cells and none of the 
ovarian cells express TGF-3 (Schilling & Yeh 1999). In adult sheep ovaries, the mRNA 
expression of TGFB1-2 are detected in stromal and/or thecal cells of follicles with multilayers 
of granulosa cells, whereas TGFB3 is only expressed in the vascular system (Juengel 2004). 
In adult bovine ovaries, TGFB1-3 are expressed in granulosa cells, theca interna, surface 
epithelium and stroma (Matiler 2014, Nillson 2001).  
TGF-β 1-3 isoforms and the two TGF-β receptors are observed in human and bovine 
fetal ovaries (Schilling & Yeh 1999, Hatzirodos et al. 2011). Components that are involved in 
TGF- signalling, such as receptors and Smads, have been identified in oocytes and granulosa 
cells (Schilling & Yeh 1999, Ӧsterlund & Fried 2000, Pangas et al. 2002). It is believed that 
TGF- is involved in the proliferation of granulosa cells (Mondschein et al. 1988), 
steroidogenesis (McAllister et al. 1994) and the maturation of oocytes during follicular 
development (Feng et al. 1988), as well as facilitating the synthesis of FSHR in granulosa 
cells (Dunkel et al. 1994). 
Activin A or B subunit mRNA and proteins have been shown to be expressed in the 
human oogonia during fetal life starting at 14 weeks of gestation (da Silva et al. 2004). 
Activin A increases oogonia proliferation in vitro in 14-21 week old human fetal ovaries, 
suggesting that activin might be involved in the regulation of germ cell proliferation (da Silva 
et al. 2004). Inhibin A mRNA and protein have been shown to be expressed in stromal and 
granulosa cells of fetal mice ovaries at around E13 (Weng et al. 2006).  
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BMP-1, -2, -4, -5, -6, -7 and -15 have been shown to be expressed in granulosa and/or 
thecal cells of primordial to antral follicles in cattle, sheep, mice, goats and humans [reviewed 
in (Rossi et al. 2016). BMP-1 has been found to regulate the formation of the extracellular 
matrix (ECM) during folliculogenesis in sheep (Canty-Laird et al. 2010). Furthermore, the 
changes in the composition of ECM in thecal and granulosa cells have been shown to be 
related to the growth of ovine ovarian follicles (Berkholtz et al. 2006). BMP-2, -4, -6 and -7 
have been found to be involved in steroidogenesis in mice (Erickson & Shimasaki 2003), 
sheep (Juengel et al. 2006b), humans (Miyoshi et al. 2006), cattle (Glister et al. 2004), and 
goats (Frota et al. 2013) by regulating the expression StAR, P450 aromatase (CYP19A1), 
P450 side chain cleavage enzyme (CYP11A1), and cytochrome P450 family 17 subfamily A 
member 1 (CYP17A1), as well as the production of oestradiol and progesterone. BMP-5, -6 
and -15 are also found to be involved in the proliferation of granulosa cells in cattle (Glister et 
al. 2004), sheep (Shimizu et al. 2004) and mice (Otsuka et al. 2000, Pierre et al. 2005). 
BMPs signalling involves its type I (ALK-2, 3 and 6) and II receptors (BMPRII, 
ActR-II) (Glister et al. 2004, Goto et al. 2007, Miyagi et al. 2012). The interaction of type I 
and II BMP receptors will induce the phosphorylation of Smads, which subsequently relocate 
to the nucleus and regulate the expression of specific genes (Lembong et al. 2008, Manuylov 
et al. 2008, Ohta et al. 2008). These receptors and Smads have been observed in granulosa 
cells from primordial/primary follicles onwards in humans [reviewed in (Juengel & McNatty 
2005), suggesting that BMP is critical for the development of follicles.  
GDF-9 can be found in oocytes and granulosa cells in humans (Yamamoto et al. 
2002), cattle (Bodensteiner et al. 1999), sheep (McNatty et al. 2001) and mice (Yan et al. 
2001, Hreinsson et al. 2002) during folliculogenesis. In cultured human granulosa cells, GDF-
9 has been shown to inhibit cAMP-induced steroid production and expression of StAR, 
CYP11A1 and CYP19A1, which are involved in steroidogenesis (Yamamoto et al. 2002). 
GDF-9 also enhances the development of primordial to secondary follicles in cultured human 
follicles (Hreinsson et al. 2002). Treatment of GDF-9 in rats progresses the development of 
follicles in vivo (Vitt et al. 2000) and in vitro (Nilsson & Skinner 2002). GDF-9 receptors, 
TGFBR1 (activin receptor-like kinase 5, ALK5) and BMPRII are expressed in ovine 
granulosa cells from primordial follicles onwards (Juengel & McNatty 2005). GDF-9 
upregulates Kit Ligand (KL) expression in bovine granulosa cells (Nilsson & Skinner 2002). 
KL has been shown in vitro to facilitate the activation of primordial into primary follicles and 
the growth of oocytes in rats (Nilsson & Skinner 2002). GDF-9 null mutation mice are 
infertile due to arrested follicle development at the primary stage (Dong et al. 1996, 
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Carabatsos et al. 1998). Taken together GDF-9 is essential for further follicle progression by 
regulating factors that are involved in the further development of primordial follicles.  
AMH is a member of the TGFβ superfamily involved in the regulation of 
folliculogenesis (Baarends et al. 1995). The AMH protein is expressed in granulosa cells after 
32 weeks of gestation in humans (Meyts et al. 1999), as well as in granulosa cells of human 
(Weenen 2004), cow (Monniaux 2008), sheep (Bezard 1987) and rodent (Visser et al. 2006) 
adult ovaries. Deletion of amh in mice results in an increased rate of recruitment of primordial 
follicles (Durlinger et al. 1999) leading to the rapid depletion of follicle reserves. In humans 
(Visser 2006) and mice (Keveenar 2006), AMH is believed to be the marker of the ovarian 
follicular reserve, whereas in cattle AMH is shown to be a marker of the population of small 
antral gonadotrophin-responsive follicles (Rico 2009). 
Follistatin is believed to act as an important regulatory factor in fetal ovarian 
development (Kashimada et al. 2011). Follistatin acts in the Wnt4 pathway to suppress the 
male pathway in XX gonads (Yao et al. 2004). Later in ovarian development, follistatin 
facilitates the survival of meiotic germ cells (Yao et al. 2004). Excessive follistatin in mice 
results in an increase in the number of germ cells within the ovigerous cords, due to a delay in 
ovigerous cord breakdown, as well as a decrease in the apoptosis of germ cells (Kimura et al. 
2011), suggesting a critical role of follistatin is in regulating the breakdown of ovigerous 
cords. 
 
1.3.  Ovarian Surface Epithelium 
The surface epithelium of the ovary has been described as an altered pelvic 
mesothelium composed of a single layered flat to cuboidal epithelium (Fig. 2) (Nicosia et al. 
1991, Murdoch 1994). It expresses keratin types 7, 8, 18 and 19, as well as the mucin antigen 
(MUC1), 17β-hydroxysteroid dehydrogenase, and has cilia (Blaustein & Lee 1979, Auersperg 
et al. 1994, Zhang et al. 1998, Dubeau 1999). Simple desmosomes, tight junctions (Siemens 
& Auersperg 1988, Sawyer et al. 2002), integrins (Kruk et al. 1994, Cruet et al. 1999) and 
cadherins (Sundfeldt et al. 1997, Davies et al. 1998) maintain the intercellular contact and 




In early development, the future ovarian surface epithelium does not cover the 
presumptive gonad, except at the base (Hummitzsch et al. 2013, Kenngott et al. 2013). At 
around 10 weeks until 5 months of gestation, the human fetal ovarian surface epithelium 
changes from a flat to a cuboidal epithelium [reviewed in (Auersperg et al. 2001)]. The GREL 
cell population eventually differentiates into a surface epithelium when the stroma has 
penetrated to just below the superficial GREL cells (Hummitzsch et al. 2013). Taken together, 
there are two regions of ovarian surface, an established surface epithelium at the base of the 
ovary, derived directly from the mesonephros; and the GREL cell originated surface 
epithelium, covering the rest of the ovarian surface (Fig. 3). 
The functions of ovarian surface epithelium are to transport material to and from the 
peritoneal cavity, as well as to take part in the ruptures and repair of ovulatory cycles (Nicosia 
et al. 1991, Murdoch 1994).  Epidermal growth factor (EGF), collagen, ascorbate, TGF- 
modulate epithelia-mesenchymal initiates epithelio-mesenchymal conversion in many 
epithelial cell types (Toda et al. 1997, Auersperg et al. 2001). This ability is beneficial for 
supporting postovulatory repair of ovarian surfaces because it enhances motility, modifies 
proliferative responses and capacities to alter ECM, and provides the contraction of the cells 
[review in (Auersperg et al. 2001). Aldehyde dehydrogenase (ALDH), Leucine Rich Repeat 
Containing G Protein-Coupled Receptor 5 (LGR5), lymphoid enhancer-binding factor 1 (Lef-
1), cluster of differentiation 133 (CD133), cytokeratin 6B (CK6B) are known to be the 
markers of stem/progenitor cells. These genes are detected in the hilum of adult mice ovaries 
and believed to be responsible for the postovulatory repair of the ovarian surface epithelium 
 
Fig. 2. Representative image of single layered cuboidal cell on  
the adult human ovarian surface. Modified from (Auersperg et al. 2001). 
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(Flesken-Nikitin et al. 2013). Another study of murine ovaries has shown that LGR5 is 
observed close to ovulating follicles and on the apical side of corpora lutea (Ng et al. 2014). 
 
1.4.  Polycystic Ovary Syndrome and its impact on reproduction 
Polycystic ovary syndrome is one of the most common endocrine and metabolic 
disorders, affecting around 10% of women of reproductive age (Ehrmann et al. 2006, Bozdag 
et al. 2016). The exact underlying aetiology of PCOS is complex and still unclear. It is 
believed that PCOS is a multifactorial system disorder, involving abnormal steroidogenesis 
and regulation of ovarian function, as well as metabolic syndrome, such as insulin resistance 
and increased type 2 diabetes mellitus and cardiovascular disease risk factors (Teede et al. 
2011). Dysregulation of steroidogenesis and ovarian function in PCOS is characterised by 
dysfunction of intrinsic thecal and granulosa cells, leading to hyperandrogenism and 
perturbation of folliculogenesis.  
1.4.1. Dysfunction of thecal cells 
The defect of steroidogenesis in PCOS thecal cells has been well studied. It has been 
shown that the activities of three important enzymes in androgen synthesis, CYP17A1, 3-
beta-hydroxysteroid dehydrogenase type II (HSD3B2) and CYP11A1, are increased in PCOS 
thecal cells (Nelson et al. 1999, Wood et al. 2004). CYP11A1 converts cholesterol to 
pregnenolone, which is the first and rate-limiting step of the steroid biosynthesis. CYP17A1 
catalyses the 17α-hydroxylation of both pregnenolone and progesterone, as well as cleaves the 
C17–C20 bond of 17α-hydroxypregnenolone and 17α-hydroxyprogesterone to form 
dehydroepiandrosterone (DHEA) and androstenedione, respectively. HSD3B2 transforms Δ5-
 
 
Fig. 3. The origin of the bovine ovarian surface epithelium. Modified from (Hummitzsch 
et al. 2015) 
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steroids (pregnenolone, 17α-hydroxypregnenolone and DHEA) into their Δ4-congenors. On 
the transcription level, it has been shown that nuclear factor 1C (NF1C) will bind to the 
CYP17A1 gene promoter, leading to the repression of the CYP17A1 promoter function. The 
expression levels of NF1C are decreased in PCOS thecal cells, suggesting its contribution to 
hyperandrogenemia caused by increased activity of the CYP17A1 promoter (Wickenheisser et 
al. 2006). 
The defect of thecal cell steroidogenesis in PCOS has an effect on extra-ovarian 
factors, such as the luteinising hormone (LH), follicle-stimulating hormone (FSH) and insulin, 
, as well as intra-ovarian factors, such as AMH and inhibins [reviewed in (Diamanti-
Kandarakis 2008)]. Increased LH leads to the decrease of mitogen-activated protein kinase 
kinase 1 (MAP2K1), which is associated with increased thecal androgen biosynthesis. In the 
intracellular signalling of insulin, phosphoinositide 3-kinase (PI3K) and phosphoinositol 
glycan (IPG) activities are increased, leading to the stimulation of androgen production in 
thecal cells. At the same time, increased LH interacts with increased insulin and subsequently 
amplifies the intrinsic steroidogenic defect. In relation to increased levels of LH, FSH levels 
are decreased, reducing the activity of aromatase in alliance with AMH. The increase in AMH 
levels may have a direct effect in stimulating thecal cell androgen synthesis, leading to the 
inhibition of aromatase activity.   
Hyperandrogenism has been linked to anovulation in PCOS women. The excessive 
androgen levels stimulate the growth of preantral to antral follicles as well as hinder the 
maturation of follicles towards the dominant stage, leading to impaired folliculogenesis 
(Jonard & Dewailly 2004, Maciel et al. 2004). Androgen receptors are required during early 
development of follicles, thus androgen may have an effect on the initial follicular recruitment 
that results in growth impairment of early follicular growth in PCOS (Vendola et al. 1999, 
Rice et al. 2007). 
1.4.2. Details of PCOS candidate genes. 
Recent genome-wide association studies (GWAS) have discovered PCOS candidate 
genes, such as the luteinising hormone/choriogonadotrophin receptor (LHCGR), FSHR, 
thyroid adenoma associated (THADA), erb-b2 receptor tyrosine kinase 4 (ERBB4), RAD50 
double strand break repair protein (RAD50), GATA4, DENN domain-containing protein 1A 
(DENND1A), chromosome 9 open reading frame 3 (C9orf3), follicle-stimulating hormone 
beta subunit (FSHB), yes-associated protein 1 (YAP1), High-mobility group AT-hook 2 
(HMGA2), Ras-related protein Rab-5B (RAB5B), Sulfite oxidase (SUOX), KRR1 small 
subunit processome component homolog (KRR1), TOX high mobility group box family 
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member 3 (TOX3), insulin receptor (INSR) and Small ubiquitin-related modifier 1 SUMO1 
pseudogene 1 (SUMO1P1) (Jones & Goodarzi 2016).  
The paragraphs below summarise briefly information about the roles of PCOS 
candidate genes and any knowledge of their existence in ovaries. Additionally, 4 other PCOS 
related genes, fibrillin (FBN3), anti Mullerian hormone (AMH), androgen receptor (AR) and 
Transforming Growth Factor Beta 1 Induced Transcript 1 (TGFB1I1) will be discussed 
below.  
A study in women has linked DENND1A with PCOS by showing that an 
overexpression of DENND1A isoforms in normal thecal cells resulted in a PCOS phenotype 
in thecal cells, such as augmented CYP17A1 and CYP11A1 expression and androgen 
biosynthesis (McAllister et al. 2014). Knock-down of DENND1A.V2 in PCOS thecal cells 
reduced androgen biosynthesis and expression of CYP17A1 and CYP11A1 (McAllister et al. 
2014).  
FBN3 has been shown before to be highly expressed at the early developmental stage 
of human and bovine fetal ovaries in vivo and in vitro and then to decline later in gestation 
(Hatzirodos et al. 2011, Hummitzsch et al. 2013). FBN3 is not expressed in the adult ovaries 
of women (Prodoehl et al. 2009a) and cows (Prodoehl et al. 2009b). FBN3 encodes fibrillin 3, 
which is an extracellular matrix protein expressed in the stromal compartment of the bovine 
fetal ovary (Hatzirodos et al. 2011) and thought to be involved in stromal penetration during 
early gestation (Hummitzsch et al. 2013). Little is known about the regulation and action of 
fibrillin 3, but it is thought to bind latent Transforming Growth Factor- (TGF-) binding 
proteins (LTBPs) due to its homologous structure to fibrillins 1 and 2 [reviewed in (Davis & 
Summers 2012)]. Therefore, fibrillins and LTBPs sequester TGF- in tissue and regulate its 
local bioavailability and action (Todorovic & Rifkin 2012). The PCOS ovary is characterised 
by increased thickness of the tunica albuginea, as well as increased collagen deposition and 
fibrous tissue of cortical and subcortical stroma (Hughesdon 1982b). It is believed that TGF- 
superfamily members contribute to the phenotype of PCOS ovaries due to their role in 
regulating the production and deposition of collagen in normal and fibrotic tissues (Govinden 
& Bhoola 2003, Hetzel et al. 2005, Khan & Sheppard 2006, Kisseleva & Brenner 2007, 
LeClair & Lindner 2007, Prud'homme 2007). Taken together, changes in fibrillin 3 during 
ovarian development and subsequent dysregulation of TGF- might contribute to the 
phenotype of the PCOS ovary.  
HMGA2 and TOX3 encode proteins which belong to the HMG-box superfamily and 
have a role in regulating gene expression, chromatin remodelling, genomic stability and DNA 
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repair [reviewed in (Cleynen & Van De Ven 2008)]. Hmga2 is highly expressed in mouse 
undifferentiated cells during embryogenesis, neural stem cells and tumor cells (Nishino et al. 
2008), as well as in human fetal tissues, including the ovary (Gattas et al. 1999). In adult 
human tissues, it is only expressed in lungs and kidneys (Gattas et al. 1999) and it is barely 
detectable in adult rat kidneys, lungs, hearts, brains, livers and intestines (Fedele et al. 2010). 
It is believed that HMGA2 is involved in the Epithelial-Mesenchymal Transition (EMT) 
occurring during embryogenesis, as well as in carcinoma invasiveness and metastasis and can 
be provoked by TGF- signaling via Smad transducers (Thuault et al. 2006). TOX3 encodes a 
nuclear transcriptional factor and is a member of the thymocyte selection-associated HMG 
box protein (TOX) subfamily of HMG-box proteins. TOX family members share a DNA-
binding domain and are believed to interact with DNA in a structure-dependent way 
[reviewed in (Yu & Li 2015). TOX plays an important role in the development of the immune 
system (Aliahmad & Kaye 2008, Aliahmad et al. 2010). Little is known about the function of 
TOX3 in female reproduction, however, it is known to be overexpressed in breast tumors and 
has been linked to the fibrosis that causes an increase in mammographic density (Han et al. 
2016). Increased breast density is related to increased epithelial and stromal tissue and 
fibrillary collagen deposition (Guo et al. 2001, Li et al. 2005, Hawes et al. 2006). In addition, 
TOX3 has also been linked to bladder (Demtroder 2013), lung (Tessema et al. 2012) and 
gastric (Zhang et al. 2013) cancers. Collectively, TOX3 may play an important role in 
regulating collagen deposition in tumors as well as other fibrotic disorders such as PCOS. 
Recent studies have discovered that levels of HMGA2 mRNA were higher in PCOS (Li et al. 
2018), whereas the TOX3 protein level was significantly lower in PCOS serum and granulosa 
cells, compared with normal ones (Ning et al. 2017). 
GATA4 encodes a transcription factor regulating gonadal development and belongs to 
the GATA family of zinc finger proteins, having an important role in cell differentiation and 
organ development (Viger et al. 1998). Deletion of Gata4 leads to an abnormal response of 
the exogenous gonadotrophins and diminished fertility in mice (Lavoie et al. 2004). During 
mouse fetal ovarian development, GATA4 protein is expressed mostly in the granulosa cells 
and to a lesser extent in the stroma and is detected in male and female gonads as early as 11.5 
days of gestation in mice (Viger et al. 1998), 19 days post coitum (dpc) in pigs (McCoard et 
al. 2001), and 13-14 weeks of gestation in humans (Vaskivuo et al. 2001b). It is thought that 
Gata4 is required for the breakdown of the mesonephric surface epithelium basal lamina 
below the surface before genital ridge formation in mice (Hu et al. 2013). The expression 
level of GATA4 protein is heavily decreased after the differentiation of the ovary at 13.5 days 
of gestation in mice (Viger et al. 1998). However, in human and porcine fetal ovaries, GATA4 
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is greatly expressed in the early stages, then decreases until the end of development (McCoard 
et al. 2001, Vaskivuo et al. 2001b), which is similar with our findings. In all four species, 
GATA4 protein is localised in the granulosa cells of the adult ovary, mainly during the time 
when the granulosa cells are actively proliferating and it is thought to be involved in 
protecting the granulosa cells from apoptosis (McCoard et al. 2001, Vaskivuo et al. 2001b, 
Anttonen et al. 2003, Lavoie et al. 2004). Taken together, GATA4 might be involved in the 
breaking of the mesonephric surface epithelium basal lamina, which allows the penetration of 
mesonephric stroma during early stages of ovarian development. 
LHCGR encodes the LH/CG receptor and belongs to the G protein-coupled receptor 
superfamily (Nogueira et al. 2010). It is the target receptor for the pituitary-derived 
luteinising hormone (LH) and the placental chorionic gonadotrophin (CG). The function of 
LHCGR has been well studied in many species, such as humans (Reshef et al. 1990), cattle 
(Nogueira et al. 2010), pigs (Derecka et al. 1995), rabbits (Jensen & Odell 1988), rats 
(Bonnamy et al. 1993) and mice (Zheng et al. 2001). The LHCGR is expressed in the thecal 
cells, granulosa cells, stromal cells and luteal cells. The activation of LHCGR by LH in the 
thecal cells triggers androgen production, providing the substrate for oestradiol conversion by 
the follicle-stimulating hormone (FSH) induced aromatase in granulosa cells [reviewed in 
(Richards 1994)]. In early rat ovarian development, only a truncated mRNA Lhcgr receptor 
was detected at around 13.5 days post gestation, without evidence of translation (Sokka et al. 
1996). The full-length functional mRNA Lhcgr only appeared when the rat thecal layers are 
formed in the later stages (Sokka et al. 1996).  
AMH has been well studied for its role in regulating male sex differentiation during 
gonad development. Fetal Sertoli cells produce the AMH protein to induce the regression of 
the Mullerian duct to avoid the default female pathway [reviewed in (Visser et al. 2006)]. In  
females, however, the AMH protein is first expressed in the granulosa cells of primary 
follicles and the expression is increased in pre-antral and small antral follicles but diminished 
in larger follicles (Durlinger et al. 1990). Additionally, AMH protein has a role in inhibiting 
the recruitment of primordial follicles and the responsiveness of developing follicles to FSH 
in mice ovaries (Durlinger et al. 1990).  
FSHR, which is member of the Rhodopsin receptor family of G protein-coupled 
receptors (GPCRs), has an extended N-terminal extracellular domain with leucine–rich 
repeats (Lagerstrom & Schioth 2008). The extracellular domain of FSHR is first detected in 
embryonic rat ovaries at day 20 and the full length mRNA is observed in the granulosa cells 
at day 3 post partum (Rannikki et al. 1995). In sheep fetal ovaries, FSHR mRNA is first 
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detected in the granulosa cells in follicles with two or more layers of granulosa cells in 100 
day old sheep fetuses (Tisdall et al. 1995).  
INSR encodes a member of the ligand-activated receptor and the receptor tyrosine 
kinase family. Although this receptor is involved in regulating cell differentiation, growth and 
metabolism, the main function of INSR appears to be metabolic regulation (Lee & Pilch 
1994). During ovarian development, INSR protein is expressed in developing oocytes of 
mice, rats and humans (Pitetti et al. 2009). In addition, a human study showed that the INSR 
protein is only expressed in the stroma at the beginning of follicle development, and then in 
the granulosa and thecal cells in the later stages. (Samoto et al. 1993). 
The AR is a member of the nuclear hormone receptor (NHR) superfamily and located 
on the X chromosome at Xq11-12 and Xq26 in humans and cattle, respectively (Grosse et al. 
2012). The AR signalling pathway is modulated by coregulatory proteins: enhancing 
(coactivators), such as Hic-5/TGFB1I1, androgen receptor-interacting protein 4 (ARIP4), and 
steroid receptor coactivator 1 (SRC1), or reducing (corepressors) AR transactivation, such as 
nuclear receptor co-repressor 2 (NCoR) and the silencing mediator for retinoid or thyroid-
hormone receptors (SMRT) (van de Wijngaart et al. 2012). In the sheep fetal ovary, AR 
mRNA and protein were first detected in the penetrating mesonephric stroma but not in the 
ovigerous cords (Juengel et al. 2006a). It was then observed in the membrana granulosa of 
larger follicles, as well as in the stroma at the later stages. In adult mice and sheep ovaries, AR 
mRNA and protein are expressed in all cells of the follicles (oocyte, granulosa and thecal 
cells) and in stromal compartments, such as the cortical stroma (Juengel et al. 2006a, Sen & 
Hammes 2010). In developing human ovaries, the AR is expressed in the stroma (Fowler et 
al. 2011). In the current study, AR was elevated in the medulla compared with the cortex, in 
agreement with its expression in the stroma. Our previous study has shown that treatment of 
human fetal fibroblasts with TGF-1 caused a significant reduction in the expression level of 
AR (Bastian et al. 2016) and this could be mediated by regulating Smad3, one of the TGF-1 
effector proteins. It is known that the interaction of Smad3 with AR supresses AR-mediated 
transcription (Chipuk et al. 2002). Thus, AR may be critical for regulating stromal cell 
functions at the later stages of gestation. This could be critical for the development of PCOS, 
and in particular for the animal models of PCOS, which are induced by androgens or 
alterations of AR expression (Walters et al. 2018). 
TGFB1I1, a coregulatory protein of the AR, is a member of the LIM protein 
superfamily and also known as Hic-5, as well as AR-associated protein 55 (ARA55) 
(Shibanuma et al. 1994, Wang et al. 2005). As an AR coactivator, TGFB1I1 will activate the 
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AR promoter by binding to the Ligand Binding Domain (LBD) of the AR via the conserved 
LxxLL motif (Kato et al. 2011, Jehle et al. 2014). TGFB1I1 has been identified as a negative 
regulator of TGF-β1 via the inhibition of Smad3, which is one of the TGF-β intracellular 
effectors, in the rat and human prostate cell lines (Wang et al. 2005). The role of TGF-β in 
modulating the proliferation of fibroblasts, the major cell type of the stromal compartment, 
has been well established (Fine & Goldstein 1987, Xiao et al. 2012, Gao et al. 2016, Liu et al. 
2016). In addition, there is an increased level of TGF-β in fibrotic diseases, such as PCOS 
(Raja-Khan et al. 2014), fibrotic lung disease (Willis & Zea Borok 2007) and hepatic fibrosis 
(Gressner et al. 2002). Since TGF-β is one of the target genes of the AR (Kanda et al. 2014), 
the increased expression of TGFB1I1 mRNA and the elevated levels in the medulla, 
suggesting stromal expression, in this study suggest that TGFB1I1 might be involved in 
regulating the stromal cell function at the later stage of ovarian development via the TGF-β 
and AR signalling pathways.  
THADA, RAB5B and SOUX have been linked to type 2 diabetes (Bai et al. 2015, 
Saxena et al. 2015). THADA encodes thyroid adenoma-associated protein and was originally 
detected in thyroid adenomas (Rippe et al. 2003). RAB5B encodes the Ras-related proteins 
involved in early endosome formation (Hirota et al. 2007). SUOX encodes a sulfite oxidase 
enzyme located in the intermembrane space of mitochondria (Oshino & Chance 1975). SUOX 
mRNA is expressed strongly in the human and rat adult liver, kidney, skeletal muscle, heart, 
placenta and brain (Woo et al. 2003). RAD50, C8H9orf3, YAP1 and FSHB are thought to be 
associated with follicular and oocyte development (McGee & Hsueh 2000, Franceschini et al. 
2013, Dunaif 2016, Ji et al. 2017). RAD50 encodes the Double Strand Break Repair Protein 
that is involved in DNA double-strand break repair (Day et al. 2015). Interestingly, TGF- 
was observed to have a role in DNA repair by reducing the expression of genes involved in 
DNA repair, such as RAD50, and caused a reduction of the cells’ capacity to repair the DNA 
double strain break (Wiegman et al. 2007, Liu et al. 2014, Pal et al. 2017). C8H9orf3 
(chromosome 8 open reading frame, human C9orf3) is a homolog of the human C9orf3 gene 
that encodes a zinc-dependent metallopeptidase (Diaz-Perales et al. 2005) and has been linked 
to erectile dysfunction in a GWAS cohort of prostate cancer patients (Kerns et al. 2010). 
C9orf3 is upregulated in the TGF-1 treated human bone marrow stromal cells (Elsafadi et al. 
2017), suggesting that TGF signalling has an effect on the expression of C9orf3. It is known 
that C9orf3 is one of the target genes of the Smad4 transcription factor, which is a TGF 
inducible DNA binding protein (Yingling et al. 1997). YAP1 encodes a transcriptional 
coactivator of the Hippo signalling pathway (Ji et al. 2017), which regulates the tissue growth 
and cell fate [reviewed in (Harvey et al. 2013)]. FSHB encodes the beta subunit of FSH, a 
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pituitary-secreted glycoprotein (Meduri et al. 2008). A study in Han Chinese women found 
that variants in the FSHB gene are related with PCOS and LH levels (Tian et al. 2016). 
ERBB4 encodes Erb-Be Receptor Tyrosine Kinase 4 protein and belongs to the type I growth 
factor receptor family (Ma et al. 1999). A human study showed that ERBB4 protein is weakly 
detected in the adult ovarian surface epithelium,  (Srinivasan et al. 1998), suggesting the 
ERBB4 might be involved in the formation of surface epithelium during fetal ovarian 
development. KRR1 encodes KRR1, a small subunit processome component homolog protein 




Table 1. PCOS-related genes 
 
Gene name Gene 
symbol 





LHCGR Triggers androgen 
production 
Adult thecal, granulosa, 
stromal and luteal cells. 
Humans, 
cattle(Nogueira 
et al. 2010), 
pigs, rabbits, 
























GATA4 Cell differentiation and 
organ development 
Fetal granulosa cells and 
stroma 



























HMGA2 Regulating gene 
expression, chromatin 
remodelling, genomic 
stability and DNA repair 
Fetal ovary  Human 
Ras-related 
protein Rab-5B 
RAB5B Unknown Unknown Unknown 















TOX3 Regulating gene 
expression, chromatin 
remodelling, genomic 
stability and DNA repair 
Unknown Unknown 
Insulin receptor INSR Regulating cell 
differentiation, growth 
and metabolism 
Fetal oocytes, adult 
stroma at the beginning 
of follicle development, 
granulosa and thecal 
cells in the later stages 






SUMO1P1 Unknown Unknown Unknown 




AMH Regulating male sex 
differentiation during 
gonad development 





AR Activate the AR 
promoter  
Adult all cells of the 
follicles (oocyte, 
granulosa and thecal 
cells) and in stromal 
compartments, such as 





Beta 1 Induced 
Transcript 1 






1.4.3. Dysfunction of granulosa cells 
Granulosa cells have been shown to modulate the thecal cell function. Transforming 
growth factor beta receptor III (TGFBR3) is produced by granulosa cells of preantral and 
antral follicles (Jaatinen et al. 1994, Roberts et al. 1994). TGFBR3 has been linked to thecal 
androgen production (Hirshfeld-Cytron et al. 2009). TGFBR3 has been shown to be hyper-
responsive to FSH in ovarian hyperandrogenism, which occurs in two thirds of PCOS cases.  
In addition, the expression of TGFBR3 is upregulated in the PCOS ovary. Other granulosa 
cell peptides, such as the Indian hedgehog (IHH) and Desert hedgehog (DHH), have been 
shown to be involved in facilitating the expression of LH receptors and steroidogenic 
enzymes during early thecal cell development (Magarelli et al. 1996, Liu et al. 2015), 





1.4.4. Metabolic features in PCOS women 
PCOS has been associated with metabolic syndromes with features such as insulin 
resistance, dyslipidaemia and higher cardiovascular risk (Teede et al. 2010). In vitro studies 
have described the significant role of insulin in the production of androgen in thecal cells. 
This stimulation is mediated via the pathway of PI3K/proteinase kinase B (PKB), which is 
upregulated in PCOS thecal cells (Munir et al. 2004). Dyslipidaemia in PCOS is characterised 
by higher triglycerides and lower high-density lipoprotein cholesterol (Clark et al. 2014, 
Ladron de Guevara et al. 2014, Christ et al. 2015, Romualdi et al. 2016). It is believed that 
there are multifactorial causes of dyslipidaemia, however insulin resistance seems to be 
critical in mediating the stimulation of lipolysis and altering the expression of lipoprotein 
lipase and hepatic lipase (Ladron de Guevara et al. 2014). Factors of cardiovascular risk are 
inflammation, oxidative stress and impaired fibrinolysis (Barbieri et al. 1986). Moreover, 
higher levels of atherosclerosis markers have been observed in PCOS women, such as 
endothelial dysfunction, impaired pulse wave velocity, increased thickness of  carotid tunica 
intima and media walls, the presence of carotid plaque and increased coronary artery 
calcification (Fauser et al. 2012, Clark et al. 2014).  
 
1.5.  Genetic linkage between ovarian development and PCOS 
Recent studies indicate that there might be a fetal origin of PCOS (Abbott et al. 2006, 
Li & Huang 2008, Hatzirodos et al. 2011, Tata et al. 2018). A study in rats has found that 
higher levels of testosterone (T) early in intrauterine life are associated with anovulatory 
sterility and the polycystic ovary phenotype in offspring (Foecking et al. 2005). Another 
study in mice showed that prenatal treatment of mice with dihydrotestosterone (DHT) induced 
PCOS ovarian features, including irregular oestrous cycles, oligo-ovulation, reduced preantral 
follicle numbers, hepatic steatosis and adipocyte hypertrophy (Caldwell et al. 2014). 
Studies in rhesus monkeys have shown that prenatally androgenised rhesus monkeys 
showed characteristics of the PCOS phenotype, such as irregular ovulatory menstrual cycles, 
ovarian hyperandrogenism, enlarged poly-follicular ovaries and LH hypersecretion, insulin 
resistance, diminished insulin secretion, increased incidence of type 2 diabetes, visceral 
adiposity, and hyperlipidaemia in adult life (Abbott et al. 2005). These monkeys also showed 
an impaired glucose-mediated -cell secretion of insulin (Eisner et al. 2000) and a gluco-
regulatory deficit (Abbott 2002). Additionally, an exposure carried out in early gestation 
resulted in female primates with enhanced male-type behaviour, diminished female-like 
behaviour, as well as genital masculinisation (Goy et al. 1988). In later gestation (100-110 
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days of gestation), exposure to excess androgens in female fetuses results in an adult PCOS-
like phenotype, such as high blood levels of androstenedione at birth, increased numbers of 
primary, preantral and small antral follicles, and increased proliferation of granulosa cells 
(Abbott et al. 2005). Furthermore, mRNA expression levels of genes that are involved in the 
growth of primordial follicles onwards, such as FSHR, insulin-like growth factor 1 (IGF-1) 
and IGF-I receptors in granulosa cells were increased (Abbott et al. 2005). Impaired insulin 
action was also observed in these late exposed androgenised monkeys, but not impaired 
insulin secretion (Eisner et al. 2000). Moreover, all female offspring showed increased 5α-
reductase and decreased aromatase activities, suggesting impaired follicular maturation, 
similar to a PCOS ovary (Dumesic et al. 2003). 
 Recently, a study of prenatally AMH treated mice (Tata et al. 2018) showed similar 
results to the rhesus monkey studies. The exposed mice showed maternal neuroendocrine-
driven testosterone excess and diminished placental metabolism of testosterone to oestradiol, 
resulting in masculinisation of female fetuses and a PCOS-like phenotype in adulthood (Tata 
et al. 2018). This study suggests the important role of excess prenatal AMH exposure in 
developing the PCOS phenotype in adulthood.  
In the bovine fetal ovary, fibrillin-3 (FBN-3) is expressed in the stromal compartment 
at an early stage of ovarian development (Hatzirodos et al. 2011). Fibrillin-3 is an 
extracellular matrix protein, which controls the bioactivity of TGF-β in the tissue by binding 
latent TGF-β binding proteins. In the ovaries of PCOS women, increased TGF-β activity has 
been observed [reviewed in (Raja-Khan et al. 2014)]. Additionally, increased amounts of 
fibrous tissue and collagens have been found in several parts of PCOS ovaries, such as the 
ovarian capsule and tunica albuginea, as well as the stroma (Hughesdon 1982a). Thus, an 
altered expression of fibrillin-3 might be a predisposition of having a PCOS phenotype in 
adulthood.  
 
1.6.   Aims of this research 
Previous studies in cows and women showed the important involvement of the stroma 
originating from the mesonephros in the formation of ovigerous cords, follicles, surface 
epithelium and tunica albuginea. To date, there are limited studies dedicated to the action of 
the stroma, including its cells and matrices, in ovarian development (Hummitzsch et al. 2013, 
Heeren et al. 2015).  
The first aim of my research project therefore focuses on the expansion of ovarian 
stroma during development and relates this to the expression of the stroma-related genes. 
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Additionally, non-stromal analysis is also conducted to investigate the behaviour of germ 
cells, GREL cells and granulosa cells during ovarian development.  
Dysregulation of ovarian stromal activity has been linked to many reproductive 
diseases, such as PCOS (Hughesdon 1982a) and premature ovarian failure (Chen et al. 2014). 
Although a recent GWAS study about PCOS candidate genes has opened a new chance of 
understanding PCOS, little is known about their expression, functions and mechanisms in 
adult and fetal ovaries.  
The second aim of my thesis is to investigate the links between PCOS-related genes 
and the development of bovine fetal ovaries.  
The dynamics of stroma behaviour during bovine fetal development appears to be 
critical for the formation of surface epithelium. Microscopic studies in cows and women 
showed that the surface of fetal ovaries undergoes dramatic changes throughout the 
development of the ovary (Hummitzsch et al. 2013, Heeren et al. 2015). Firstly, the surface is 
covered by cells [called gonadal-ridge epithelial like cells (GREL) (Hummitzsch et al. 2013), 
which originate from the surface epithelium of the mesonephros and which change their 
phenotype to form the somatic cell population of the developing ovary. These GREL cells 
appear more tightly connected in the outermost layer of the developing surface. With the 
involvement of the penetrating stroma, multiple GREL cell layers become separated from the 
remaining underlying ovarian structures, with a basal lamina below these layers. The GREL 
cells on the surface change their phenotype and, at the final stage, they differentiate into a 
mature ovarian surface epithelium. However, no specific studies dedicated to the development 
of the ovarian surface have been conducted to date. It is important to understand the cellular 
changes in the ovarian surface during fetal development and its relationship with stromal 
development because their alteration might be the cause of some disorders in adult life. A 
Scanning Electron Microscope (SEM) has been used to describe the structure of adult and 
fetal human ovaries, however, these studies were carried out around 40 years ago.  
The last aim of my research use a scanning electron microscopic approach to study 
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Abstract. During ovarian development stroma from the mesonephros penetrates and expands into the ovarian 
primordium and thus appears to be involved, at least physically, in the formation of ovigerous cords, follicles and surface 
epithelium. Cortical stromal development during gestation in bovine fetal ovaries (n ¼ 27) was characterised by 
immunohistochemistry and by mRNA analyses. Stroma was identified by immunostaining of stromal matrix collagen 
type I and proliferating cells were identified by Ki67 expression. The cortical and medullar volume expanded across 
gestation, with the rate of cortical expansion slowing over time. During gestation, the proportion of stroma in the cortex 
and total volume in the cortex significantly increased (P , 0.05). The proliferation index and numerical density of 
proliferating cells in the stroma significantly decreased (P , 0.05), whereas the numerical density of cells in the stroma did 
not change (P . 0.05). The expression levels of 12 genes out of 18 examined, including osteoglycin (OGN) and lumican 
(LUM), were significantly increased later in development (P , 0.05) and the expression of many genes was positively 
correlated with other genes and with gestational age. Thus, the rate of cortical stromal expansion peaked in early gestation 
due to cell proliferation, whilst late in development expression of extracellular matrix genes increased.
Additional keywords: extracellular matrix, proliferation, stroma.
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Introduction
Connective tissue or stroma plays an important role in the for-
mation of the ovary and during folliculogenesis as shown in
mouse (Weng et al. 2006), cow (Wandji et al. 1996) and human
(Heeren et al. 2015). Ovarian stroma contains fibroblasts and
extracellular matrix. The matrix contains reticular fibres (Ban-
deira et al. 2015), fibrillar collagens (Iwahashi et al. 2000;
Hummitzsch et al. 2013, 2015), decorin (Hummitzsch et al.
2013, 2015), fibronectin (Hummitzsch et al. 2013, 2015), ver-
sican (McArthur et al. 2000; Hummitzsch et al. 2013, 2015),
fribillins (Prodoehl et al. 2009; Hatzirodos et al. 2011; Hum-
mitzsch et al. 2013, 2015; Bastian et al. 2016), latent trans-
forming growth factor b (TGFb)-binding proteins (Prodoehl
et al. 2009; Hatzirodos et al. 2011; Bastian et al. 2016) and
hyaluronan (Kobayashi et al. 1999; Irving-Rodgers and Rodgers
2007). Stromal extracellular matrix components have been
linked to the growth and maturation of follicles in sheep (Huet
et al. 2001) by maintaining the shape of granulosa cells as well
as their survival and proliferation in vitro.
The ovarian stroma is initially derived from the underlying
mesonephros and infiltrates the genital ridge composed of the
somatic gonadal ridge epithelial-like (GREL) cells and primor-
dial germ cells–oogonia (Hummitzsch et al. 2013). When
stroma first penetrates the ovaries, it is vascularised with
capillaries. As it penetrates towards the surface of the ovary
primordium the stroma branches and thus corrals the germ cells
and somatic GREL cells into forming the ovigerous cords. This
region containing the ovigerous cords and the branches of
stroma becomes the cortex of the ovary, while the medullary
area is substantially mesonephric stroma containing the rete
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derived from mesonephric ducts. Later, commencing at the
medullary–cortical interface, primordial follicles are formed
and some become activated and develop further into primary
and preantral follicles (Sarraj and Drummond 2012; Smith et al.
2014). As the stroma reaches to below the ovarian surface, it
expands laterally below the surface sequestering a population of
GREL cells underlain by a basal lamina at the interface
(Hummitzsch et al. 2013); the hallmark of an epithelium. At
the final stage of ovarian development, the stroma just below the
surface develops into the avascular, collagen-rich tunica
albuginea.
Many changes in gene expression occur during fetal ovarian
development, such as expression of the pluripotency marker
POU class 5 homeobox 1 (POU5F1 or Oct4), deleted in
azoospermia-like (DAZL), forkhead box L2 (FOXL2), as well
as members of the TGF family including TGFB1, 2 and 3,
activins, inhibins and bone morphogenetic proteins (BMPs;
reviewed in Sarraj and Drummond 2012). The ovarian stroma
is potentially influenced by several factors, including members
of the TGFb pathway (Roy and Kole 1998; Bastian et al. 2016)
and androgens and oestrogens (Abbott et al. 2006; Loverro et al.
2010). Abnormal development of ovarian stroma could poten-
tially lead to an altered stromal volume in adulthood, as
observed in polycystic ovary syndrome (PCOS; Hughesdon
1982; Fulghesu et al. 2001; Abbott et al. 2006; Li and Huang
2008). Despite the importance of stroma, it is probably the least
studied compartment of the ovary. Using the bovine ovary,
which is similar to the human ovary (Adams and Pierson 1995;
Kagawa et al. 2009), including fetal ovarian development
(Hatzirodos et al. 2011), stereometric and gene expression
analyses were undertaken to evaluate stromal development
and the expression of several genes respectively, in relation to
major histological changes during the development of the ovary.
Materials and methods
Abattoir ovary collection
Bovine fetal ovarian pairs (n¼ 27) from different stages of
development were collected from pregnant Bos taurus cows
from a local abattoir (Thomas Foods International) and crown–
rump length (CRL)wasmeasured to estimate the gestational age
(Russe 1983). All samples were transported to the laboratory on
ice in Hank’s balanced-salt solution containing Mg2þ and Ca2þ
(HBSSþ/þ; Sigma-Aldrich Pty Ltd, Australia). To determine the
sex of fetuseswith CRL,10 cm in order to excludemales in this
study, a tail sample was taken, the DNA was extracted and a
polymerase chain reaction (PCR) for sex-determining region Y
(SRY) was performed as previously described (Hummitzsch
et al. 2013). For histology and immunohistochemistry, one
ovary from each pair was weighed and processed for further
analysis, whereas for RNA analysis, the corresponding ovary
was snap-frozen on dry ice and stored at 808C for subsequent
RNA extraction.
Ovaries of known gestational age
An additional group of fetal ovaries was derived from another
study inwhich the age of the fetus was known. The experimental
design of the cattle trial from which these fetal ovaries were
obtained has been described previously (Copping et al. 2014).
Briefly, the influence of diet on development in utero was
assessed on Santa Gertrudis (Bos taurusBos indicus) heifers
divided into four groups according to different dietary protocols
based on a two-by-two factorial crossover design. The heifers
were randomly assigned to either a high (H¼ 14% crude pro-
tein, (CP)) or low (L¼ 7% CP) protein diet 60 days before
conception to 23 days postconception (dpc; periconception
treatment). This diet was individually fed in stalls and straw (5%
crude protein) was available ad libitum. The ration was as iso-
caloric as possible in the ruminant and supplemented with a
commercial vitamin and mineral preparation (Ridley Agripro-
ducts). The heifers were synchronously artificially inseminated
to a single bull. At 23 dpc, half of each nutritional treatment
group was swapped to the alternative postconception treatment,
high or low. At the end of the first trimester (98 dpc), heifers
were culled and the fetuses and placentae were collected. The
fetuses were sexed and the fetal gonads were excised and
weighed. One gonad from each fetus was processed for histol-
ogy and two ovaries from each of the four groups were analysed
by morphometry.
Histology
Fetal ovaries from the abattoir (n¼ 27) and the ovaries of known
gestational age (n¼ 8) were fixed in 4% paraformaldehyde
(Merck Pty Ltd) in 0.1M phosphate buffer (pH 7.4) and
embedded in paraffin using a Leica EG 1140H (Leica Micro-
systems). Serial sections of 6mmwere prepared using aCM1850
V2.2 Leica microtome (Leica Microsystems), mounted on
Superfrost glass slides (HD Scientific Supplies) and stored at
room temperature until used for haematoxylin–eosin staining
and immunohistochemistry.
Sample grouping
Abattoir samples were sorted into five groups based on histo-
logical morphology, as follows: Stage I, ovigerous cord for-
mation (the period when the ovigerous cords are formed
(n¼ 7)); Stage II, ovigerous cord breakdown (the period when
most of the ovigerous cords have broken down (n¼ 4)); Stage
III, follicle formation (the period when most of primordial and
primary follicles have formed but the cords are still open to the
ovarian surface (n¼ 3)); Stage IV, ovarian surface epithelium
formation (the time point when the ovarian surface epithelium is
completely formed (n¼ 8)) and Stage V, tunica albuginea for-
mation (the time point when tunica albuginea is formed (n¼ 5)).
Additionally, the age of each fetus was estimated from the CRL
(y¼0.0103x2þ 3.4332xþ 36.08, where y is age in days and x
is CRL in cm and calculated from the method of Russe (1983)).
Immunohistochemistry
An indirect immunofluorescence method was used for dual
localisation of Ki67 and collagen type I (Irving-Rodgers et al.
2002). Paraffin-embedded sections from different ovaries
(n¼ 35 animals) were dewaxed then subjected to a pressure-
cooker antigen retrieval method for 20min (2100 retriever;
Prestige Medical Ltd) in 10mM Tris–ethylenediamine tetra-
acetic acid (EDTA) buffer (pH 9.0). The primary antibodies
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used were mouse anti-human Ki67 (1 : 800; M7240/MIB-1;
DAKO Australia Pty Ltd) to identify proliferating cells in
combination with rabbit anti-human collagen type I (1 : 400;
20 mg mL1; ab34710; Abcam) to mark the stroma. Secondary
antibodies were donkey anti-mouse IgG conjugated to Cy3
(1 : 100; 715 166 151) and Biotin–(SP)-conjugated AffiniPure
donkey anti-rabbit IgG (1 : 100; 711 066 152) followed by
dichlorotriazinylamino fluorescein (DTAF)-conjugated strep-
tavidin (1 : 100; 016 010 084). All secondary antibodies and
conjugated streptavidin were from Jackson ImmunoResearch
Laboratories Inc. Cell nuclei were counterstained with 4’,6’-
diamidino-2-phenylindole dihydrochloride (DAPI) solution
(Molecular Probes). The bovine adult ovary was used as a
positive control whereas nonimmune mouse and rabbit sera
(Sigma-Aldrich) were used as negative controls. All sections
were photographed with an Olympus BX51 microscope with an
epifluorescence attachment and a Spot RT digital camera
(Diagnostic Instruments) at a magnification of 40.
Morphometric analyses
The largest cross-section from each ovary, determined by hae-
matoxylin–eosin staining for every 10th section, was examined
using NPD.view2 software (Hamamatsu Photon). Using the
ImageJ software (Schindelin et al. 2012), images of the cortex at
40 magnification were taken randomly with a single image
dimension set at 1600 1200 pixels (0.06mm2). Each image
represented a field of view that was used for morphometric
analysis in this study. The total number of fields of view to be
examined for each analysis was first determined by examining
the coefficient of variation (CV) of 3–40 fields of view. For
measuring the stromal area, the following steps were performed
(Fig. 1). First, the total cortical area was identified, saved as a
region of interest (tissue area) and its area measured. Next, the
stromal area in the cortex was identified based on positive col-
lagen type I staining (Fig. 2). To calculate the proportion of
stroma in the cortex (volume density) and total stromal volume,
the following calculationswere applied and all calculations used
equations that are listed in Table 1. The ovarian volume (Vovary)
was estimated using the ovarian weight, assuming a density of
1 g cm3. Then, the proportion of stroma in the cortex (Vv[stroma])
and the total stromal volume (Vstroma) were calculated using the
equations shown in Table 1. The number of proliferating stromal
cells (Ki67 positive) and all stromal cells (DAPI positive) in a
field of viewwere counted using themultipoint and findmaxima
tool with adjusted noise tolerance (ImageJ). Nuclei, which were
not detected by the threshold, were added manually using the
multipoint tool. Results of proliferating cells are presented as a
proliferation index (PI) and as a numerical density (Ndp/Nd) in
the stromal area using the equations shown in Table 1.
RNA extraction and cDNA synthesis
RNA was extracted from the whole fetal ovary using 1mL
Trizol (Thermo Fisher Scientific) with 0.5 g of ceramic beads
in homogenisation tubes using the Mo Bio Powerlyser 24 (Mo
Bio Laboratories Inc.) and 200mL chloroform (RNase-free)
according to the manufacturer’s instructions. The RNA con-
centration was determined using a Nanodrop spectrophotometer
(NanoDrop 1000 3.7.1; Nanodrop Technologies) based on the
260l (wavelength) absorbance. All samples which had a
260 : 280l absorbance ratio .1.8 were used and subsequently
treated with DNase I (Promega/Life Technologies Australia Pty
Ltd). ComplementaryDNAwas then synthesised from 200 ng of
DNase-treated RNA using 250 ng mL1 random hexamers
(Geneworks) and 200U Superscript Reverse Transcriptase III
(Thermo Fisher Scientific) as previously described (Matti et al.
2010). For a negative control, diethyl pyrocarbonate (DEPC)-
treated water instead of the Superscript Reverse Transcriptase
III was added.
Quantitative real-time PCR
To conduct quantitative real-time PCR (qPCR), primers were
designed against the published reference RNA sequences
(Table 2) using Primer3 plus (Rozen and Skaletsky 2000) and
Net primer (PREMIER Biosoft) software. To test the combi-
nation of primers, the cDNA was diluted to five different con-
centrations from 1 : 4 to 1 : 1000 to generate a standard curve of
cycle threshold (Ct) versus concentrations. Primer combinations
that showed a single sharp peak and achieved an amplification
efficiency of 0.9–1.1 and an R2 value $ 0.98 were used for
further analysis.
Quantitative PCR was carried out using a Rotor-Gene 6000










Fig. 1. Schematic diagram of the procedure for determining the stromal
areas and proliferating cells in fetal ovarian tissues. For immunohistochem-
istry and subsequent analysis by ImageJ, the largest cross-section of each
fetal ovary was used and 20–40 fields of view (each 0.06mm2) were
randomly chosen from each section. Fluorescence staining for collagen type
I was used to distinguish between stromal and non-stromal areas and Ki67
was used to mark any proliferating cells in the ovarian tissue. In each
photograph the total ovarian tissue was marked as region of interest (ROI)
tissue and measured. The stromal area, marked by collagen type I fibres
(shaded areas), was identified as ROI stroma and measured. Ki67-positive
cells (black dots) and DAPI-positive cells (white dots) were counted in
stromal areas.
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for 15 s then 608C for 60 s for 40 cycles. Amplification of cDNA
dilutions were prepared in 10 mL reactions containing 2mL of
the 1 : 20 cDNA dilution, 5mL Power SYBRGreen PCRMaster
Mix (Applied Biosystems), 0.2 mL each of forward and reserve
primers (Geneworks; Table 2) for the target genes and 2.6mL of
DEPC-treated water. Ct values were determined using the
Rotor-Gene 6000 software (Q series; Qiagen GmbH) at a
threshold of 0.05 normalised fluorescence units. Gene expres-
sionwas determined by themean of 2DCt, whereDCt represents
the target gene Ct – glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) Ct. GAPDH was used as a housekeeping gene





Fig. 2. Stromal distribution and proliferation in fetal ovaries from different developmental stages. Representative photographs from
(a) Stage I (ovigerous cord formation), (b) Stage II (ovigerous cord breakdown), (c) Stage III (follicle formation), (d) Stage IV (ovarian
surface epithelium formation) and (e) StageV (tunica albuginea formation) of fetal ovarian development showing stroma (S), ovigerous
cords–primordial follicles (markedwith asterisks), surface epithelium (SE), tunica albuginea (TA) and a preantral follicle (markedwith
diamond). The stroma was identified based on the expression of collagen type I, which is a stromal marker. Collagen type I (green) is
combined with the proliferation marker Ki67 (red, marked with arrows). Nuclei are counterstained with DAPI. Scale bar¼ 25 mm.
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Table 2. List of genes and primers used for quantitative real-time PCR
Gene name Gene symbol Primers (50-30) Genebank accession number Size (bp)
Glyceraldehyde-3-phosphate dehydrogenase GAPDH F: ACCACTTTGGCATCGTGGAG NM_001034034.2 76
R: GGGCCATCCACAGTCTTCTG
Osteoglycin OGN F: TGCAAGGCTAATGACACCAG NM_173946.2 85
R: GATGTTTTCCCAGGATGACG
Lumican LUM F: TTCAAAGCATTCGCCAAAATG NM_173934.1 62
R: CCGCCAATTAATGCCAAGAG
Asporin ASPN F: AAGGACATGGAAGACGAAGG NM_001034309.2 80
R: GGGAAGAAGGGGTTAATTGG
Fibromodulin FMOD F: AGGTGGGCAAGAAGGTTTTC NM_174058.2 129
R: TCTGGTTGTGGTCAAGATGG
Biglycan BGN F: CACCTTGGTGATGTTGTTGG NM_178318.4 202
R: TCTCGTCCGCTACTCCAAGT
Collagen type VI a1 chain COL6A1 F: CAAGGATGTCTTTGGCTTGG NM_001143865.1 120
R: AGAAGCTCGGCGTAGTTTTC
Collagen type VI a2 chain COL6A2 F: TCAAAGAGGCCGTCAAGAAC NM_001075126.1 84
R: TGAGCTTGTTGTAGGCGAAC
Collagen type VI a3 chain COL6A3 F: TCAATACCTACCCCAGCAAGA XM_005197965.3 200
R: GACCGCATCTAGGGACTTACC
Collagen type I a2 chain COL1A2 F: TTGAAGGAGTAACCACCAAGG NM_174520.2 321
R: TGTCCAAAGGTGCAATATCAA
Fibronectin FN1 F: CGACGGCATCACTTACAATG NM_001163778.1 118
R: CGACGGCATCACTTACAATG
Fibronectin extra domain A FN1-EDA F: CCTGTTACTGGTTACAGAGTG AF 260303 550
R: AGTGAGCTGAACATTGGG
Fibronectin extra domain B FN1-EDB F: GCCGATCAGAGTTCCTGCACC AF 260304 456
R: GAGCCCAGGTGACACGCATAG
Fibronectin V region FN1-V F: CTGAAGAACAATCAGAAGAG AF 260305 600
R: CCACTATGATGTTGTAGGTG
Lectin, galactoside-binding soluble 1 (galectin 1) LGALS1 F: AATCATGGCTTGTGGTCTGG NM_175782.1 129
R: AGGTTGTTGTCGTCTTTGCC
Regulator of G-protein signalling 5 RGS5 F: GCCATTGACCTTGTCATTCC NM_001034707.2 119
R: TTGTTCTGCAGGAGCTTGTC
Fibulin-1 FBLN1 F: GCAGCGCAGCCAAGTCAT NM_001098029.1 66
R: AGATATGTCTGGGTGCTACAAACG
Fibulin-2 FBLN2 F: TGGCACTCACGATTGTAACC XM_589271.8 130
R: GTTGATGTCCACGCATTTCC
Fibulin-5 FBLN5 F: TGCAACTGAGAATCCCTGTG NM_001014946 121
R: GCATTCGTCCATATCACTGC
Table 1. List of equations for morphometric analyses
Acortex, cortical area in each image; Aovary, ovarian area in each image; Astroma, stromal area in each image; Atotalstroma, total analysed stromal area;
Npstroma, total number of proliferating cells in all analysed images of the stroma;Nstroma, total number of cells in all analysed images of the stroma;Vovary,
ovarian volume
Parameter Equation Units
Proportion of cortex in the ovary or cortical volume density (Vv[cortical]) Vv[cortical]¼Acortex /Aovary %
Cortical volume (Vcortex) Vcortex¼Vv[cortical]Vovary mm3
Proportion of stroma in cortex or volume density of stroma in the ovarian cortex (Vv[stroma]) Vv[stroma]¼Astroma /Acortex %
Cortical stromal volume (Vstroma) Vstroma¼Vv[stroma]Vcortex mm3
Proliferation index in the cortical stroma (PI) PI¼Npstroma / Nstroma %
Numerical density of proliferating cells in the stroma (Ndp) Ndp ¼ Npstroma / Atotalstroma Nmm
2
Numerical density of all cells in the stroma (Nd) Nd¼Nstroma / Atotalstroma Nmm2
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(Berisha et al. 2002) and showed stable expression in our
samples.
Statistical analyses
All statistical analyses were carried out using Microsoft Office
Excel 2010 and GraphPad Prism Version 6.00 (GraphPad
Software Inc.). All data that were not normally distributed or
showed significantly different standard deviations between
groups were first log-transformed. The morphometric and 2DCt
data for each fetal ovarian sample were compared using
ANOVA with Tukey’s post-hoc test. A value of P, 0.05 was
considered to be significant. For testing the association between
expression levels of each gene throughout development, corre-
lation coefficients were determined using the Spearman corre-
lation coefficient. After correlation values between genes were
identified, a network graph was plotted using the qgraph R




Aswe have observed previously (Hummitzsch et al. 2013), there
was variation in the developmental stage of ovaries from fetuses
of the same crown–rump length, particularly at early stages. We
therefore devised a classification system based upon five iden-
tifiable stages of development of the cortex commencing with
ovigerous cord formation (Stage I), ovigerous cord breakdown
(Stage II), follicle formation (Stage III), surface epithelium
formation (Stage IV) and tunica albuginea formation (Stage V)
as illustrated in Fig. 2 and subsequently analysed data from the
abattoir collection using this classification system.
Determination of total number of fields of view
Using the ovaries from our abattoir collections we first deter-
mined the optimum number of total fields of view required for
the morphometric measurements of the proportion of stroma in
the cortex and the proportion of proliferating stromal cells in the
ovarian cortex. A CV analysis was conducted from 3 up to 40
fields of view photographed at 40 magnification accounting
for 0.06mm2 (Fig. S1, available as Supplementary Material to
this paper). For fetuses with a CRL ,30 cm, the CV of the
volume density of stroma (Fig. S1a–c) and the proportion of
proliferating stromal cells in the ovarian cortex (Fig. S1g–i) was
relatively variable until nine fields of view and then remained
similar until 20 fields of view. However, for fetuses with CRL of
39 cm the CV of the proportion of stroma in the cortex (Fig. S1d)
and the proportion of proliferating stromal cells in the ovarian
cortex (Fig. S1j) were similar for almost all numbers of fields of
view. For fetuses with CRL.50 cm, the parameters were highly
variable from 3 to 20 fields of view (Fig. S1e, f, k, l) and then
stabilised from 20 to 40 fields of view. Thus, for morphometric
quantitation of fetuses with a CRL of ,50 cm we assessed
10 fields of view and for fetuses with a CRL of .50 cm we
assessed 20 fields of view.
Ovary changes in Stages I to V
Details of the ovaries and fetuses of each stage from our abattoir
collection are presented in Table 3. With advancing stages the
fetuses were older and the ovaries became significantly heavier
and they had more cortex and medulla, but proportionally less
cortex relative to medulla in the last two stages of development
(Table 3).We calculated the time to transit from one stage to the
next and fold changes between each stage in weight, cortical
volume and medullary volume (Table 3). The transition time
between Stages I and II, II and III, III and IV and IV and V were
48, 46, 61 and 30 days respectively (Table 3); thus, the duration
of development before Stage III was 94 (48þ 46) days and after
Stage III was 91 (61þ 30) days. From Stages I to III versus
Stages III to V the fold changes in weight were 6.2 and 4.2, the
fold changes in cortical volume were 6.7 and 2.0 and the fold
changes in medullary volume were 6.3 and 7.6 respectively
Table 3. Characteristics of developmental stages (I to V) of bovine fetal ovaries from the abattoir collection
Data are mean s.e.m. One-wayANOVAwith post hoc Tuckey’s tests were used to analyse data. a,b,c,dValues within a rowwith different superscripts indicate
significant differences (P, 0.05)
Parameter Developmental stage
I II III IV V
Gestational age (days)A,B 79 6a 127 6b 173 12c 234 9d 264 6d
Time from previous stage (days) 48 46 61 30
Weight (mg)B 17.9 5.1a 49.2 7.9b 113.5 33.6bc 245.8 62.9cd 475.3 22.6c
Fold change in weight from previous stage 2.7 2.3 2.2 1.9
Total cortical volume (mm3)B 10.3 3.0a 30.1 4.8b 70.7 27.4bc 65.5 9.0bcd 142.1 37.5cd
Fold change in cortical volume from previous stage 2.9 2.3 0.9 2.2
Cortical volume density (%) 56.9 3.0a 61.7 6.7a 59.7 9.1ab 33.2 5.5bc 29.5 7.0c
Total medullar volume (mm3)B,C 7.7 2.1a 19.0 4.5ab 42.8 9.5bc 180.3 57.9cd 333.1 34.8d
Fold change in medullar volume from previous stage 2.5 2.5 4.2 1.8
Total cortical stromal volume (mm3)B 3.3 0.8a 12.9 1.9b 43.4 20.1bc 49.6 7.3cd 112.7 28.1cd
Fold change in cortical stroma from previous stage 3.9 3.4 1.1 2.3
AEstimated from the CRL (Russe 1983).
BStatistical analysis was conducted using log-transformed data.
CCalculated from total cortical volume and percentage of medullar area.
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(calculated from Table 3). Thus, after Stage III when follicles
formed, the expansion of the cortex slowed but the medulla
continued to expand at its previous rate, leading to proportion-
ally more medulla. From 79 to 264 days of gestation the ovarian
volume increased 26.5 fold (17.9 to 475.3mm3), the cortex
increased 13.8 fold in volume (10.3 to 142.1mm3) and the
medulla increased 34.1 fold in volume (3.3 to 112.7 mm3).
Morphometric characteristics of fetal ovarian stroma
During ovigerous cord formation at Stage I (Fig. 2a), the stroma
containing many Ki67-positive cells formed branches between
ovigerous cords (Fig. 3c, d). At this stage the ovigerous cords
contained oogonia, undergoing mitosis as shown by colocali-
sation with the proliferation marker Ki67 (Fig. 2a). The pro-
portion of stroma in the ovarian cortex increased during
ovigerous cord breakdown at Stage II (Fig. 3a, b), although it
was not statistically significant. Ki67-positive cells were
observed in the stromal area and in the partitioned ovigerous
cords (Fig. 2b). In the stromal area, the total number of Ki67-
positive cells was lower than during Stage I (Fig. 3c, d); how-
ever, the difference was not statistically significant. During
follicle formation at Stage III (Fig. 2c), the proportion of stroma
in the ovarian cortex had increased further (Fig. 3a, b). The
stroma now surrounded the primordial follicles, whichwere first
formed at the inner cortex adjacent to the medulla. Proliferating
cells were observed in the stroma but not in primordial follicles
(Fig. 2c); however, the total number of Ki67-positive cells in
stroma were lower than during Stage II (Fig. 3c, d), although the
difference was not statistically significant. During the formation
of surface epithelium at Stage IV (Fig. 2d), the ovary had more
stroma underneath the ovarian surface. At this stage Ki67-pos-
itive cells localised in the stroma as well as the ovarian surface.
Tunica albuginea formation at Stage V was characterised by
bundles of thick collagen type I fibres underneath the ovarian
surface epithelium (Fig. 2e). At this stage stromal cells and some
granulosa cells in growing follicles were positive for Ki67.
We quantitatively measured the proportion of stroma in the
cortex and the total volume of the stroma in the cortex (Fig. 3)
and both were significantly increased during ovarian develop-
ment (P, 0.05; Fig. 3a, b). Interestingly, the cell proliferation
index of the stroma in the ovarian cortex significantly declined
during ovarian development (Fig. 3c). The numerical density of
proliferating cells also significantly declined in the cortical
stroma throughout gestation (Fig. 3d). However, the numerical
density of cortical stromal cells was stable during ovarian
development (Fig. 3e), suggesting that the increase in stromal
volume during gestation was not affected by an increase in


































Volume density Total volume
















(c) (d ) (e)
(b)
I Ovigerous cord formation
II Ovigerous cord breakdown
III Follicle formation
IV OSE formation

















































































Fig. 3. Morphometric analyses of the stroma during bovine fetal ovarian development. Data are presented asmean s.e.m. Sampleswere
grouped into five stages of ovarian development based on their histological morphology: ovigerous cord formation (n¼ 7, Stage I),
ovigerous cord breakdown (n¼ 4, Stage II), follicle formation (n¼ 3, Stage III), ovarian surface epithelium (OSE) formation (n¼ 8, Stage
IV) and tunica albuginea formation (n¼ 5, Stage V). (a) Volume density represents the proportion of stroma in the cortex, (b) total volume
represents the total stromal volume in the ovarian cortex, (c) proliferation index represents the ratio between total proliferating and all cells
in the cortical stroma, (d) proliferating cells represents the numerical density of proliferating cells in the cortical stroma and (e) all cells
represents the numerical density of all cells in the cortical stroma. One-way ANOVAwith post hoc Tuckey’s tests were used to analyse the
data. *P, 0.05, **P, 0.01, ***P, 0.001, ****P, 0.0001.
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To assess if our morphometric analyses used for the abattoir
collection were adequate, we analysed fetal ovarian samples
from the trial collected on Day 98 of gestation. Using the CRL,
age was estimated by the method of Russe (1983) to be
95.3 1.2 days, which is in very good agreement with the
known age of 98 days. During this time of gestation, the stroma
occupied 26.1 0.1% of the cortex and was 3.9 0.2mm3 in
total volume. The proliferation index of the cortical stroma was
7.3 0.5%, the numerical density of the proliferating stromal
cells in the cortex was 1340 77 cells mm2 and the numerical
density of all the stromal cells was 18 737 607 cells mm2
(Table 4).
Gene expression
Weanalysed themRNAexpression of genes that are specifically
expressed in the stroma of many adult tissues, including the
ovary. The mRNA expression of osteoglycin (OGN), lumican
(LUM), asporin (ASPN), collagen type VI A1 (COL6A1),
COL6A2, COL6A3, fibronectin (FN1), regulator of G-protein
signalling 5 (RGS5) and fibulin 5 (FBLN5) in fetal ovaries sig-
nificantly increased in Stages IV and V of development
(Fig. 4a–c, g–j, o, r) relative to earlier stages. We also analysed
the mRNA expression of another threeFN1 splice variants (FN1
extra domain A (FN1-EDA), FN1 extra domain B (FN1-EDB)
and FN1 variable (FN1-V)), which have three different addi-
tional domains. Our results showed that FN1-EDA, FN1-EDB
andFN1-Vwere also significantly increased late in development
(Fig. 4k–m). The expression of fibromodulin (FMOD), biglycan
(BGN), COL1A2, FBLN1, FBLN2 and Lectin galactoside-
binding soluble 1 (galectin 1) (LGALS1) did not show any sig-
nificant differences across stages of ovarian development
(Fig. 4d–f, n, p, q).
Correlation analyses
To analyse the correlations between the 18 genes of interest and
additionally with gestational age (Table 5), we generated the
Spearman correlation matrix from the Ct values of all genes.
After correlation values between genes were identified, a net-
work graph was plotted using the qgraph R package (Epskamp
et al. 2012) to plot an adjacent matrix (Fig. 5) and some
examples of these are correlations as shown in Fig. 6. OGN,
LUM,ASPN,BGN,COL6A1,COL6A2,COLA3,COL1A2,FN1,
FN1-EDA, FN1-EDB, FN1-V, RGS5, FBLN1 and FBLN5 were
all strongly positively associated with each other (r .0.6). In
addition, FMOD had strong positive correlations (r. 0.6) with
BGN, COL6A1, COL6A2, COLA3, COL1A2, FN1, FN1-EDA,
FN1-EDB, FN1-V and LGALS1. FBLN2 and LGALS1 showed
weaker positive relationships to other genes (r ,0.6). Gesta-
tional age had strong positive correlations (r.0.6) withFBLN5,
LUM, RGS5, ASPN, OGN, FN1-EDB, COL6A3, COL6A2,
COLA1, FN1-V, FN1-EDA, COL1A2 and FBLN1, but had
weaker positive correlations (r,0.6) with FN1, BGN, LGALS1
andFMOD (Table 5). Interestingly,FBLN2 had aweak negative
correlation with gestational age (Table 5).
Discussion
In this study we conducted morphometric analyses of the
developing bovine fetal ovary, focusing on cortical stroma. We
were able to identify the stroma by immunostaining of the
stromal extracellular matrix collagen type I. We optimised our
morphometric sampling regime and also examined ovaries of a
known stage of gestation. Across gestation we measured the
total volume and relative proportions of cortex and medulla, the
proportion and total volume of stroma in the cortex and the
numerical and proliferation index of cells in the stroma of the
cortex. We also examined the expression of 18 genes that had
previously been reported as relevant to stroma in other organs.
We believe this is one of the first critical studies of the devel-
opment of ovarian stroma.
Collagen type I is an extracellular matrix of stroma that has
been localised in the stroma of fetal bovine (Hummitzsch et al.
2013) and rat ovaries (Paranko 1987), as well as adult bovine
(Figueiredo et al. 1995), mouse (Berkholtz et al. 2006) and
human (Lind et al. 2006) ovaries. Collagen type I was observed
at all stages of fetal bovine ovary development by immunostain-
ing but the intensity of immunostaining increased qualitatively
throughout development. This suggests that greater deposition
of collagen type I occurs during fetal development, leading to a
stiffer stromal matrix.
An earlier morphometric study examining the bovine fetal
ovary has been conducted but over a shorter period of time than
our study. From their results we calculated that the ovary volume
increased 4.2 fold in volume (35 to 148mm3), the cortex
increased 2.8 fold in volume (21.9 to 62.4mm3) and the medulla
increased 6.5 fold (13.1 to 85.6mm3) from 3 to 7 months of
gestation (Santos et al. 2013). Our measurements are in agree-
ment with theirs where, during Stages I to III (taking 94 days)
versus Stages III to V (taking 91 days) the changes in ovarian
weight were 6.2 and 4.2 fold, in medullary volume were 6.3 and
7.6 fold and in cortical volume were 6.7 and 2.0 fold respec-
tively. Our values are higher than theirs as our study was over a
longer time frame. Our results also show that throughout
gestation the medulla expanded substantially more (34.1 fold)
than the cortex (13.8 fold) did and that the rate of expansion of
the cortex declined past Stage III when follicles were formed.
What drives the continued expansion of the medulla is not
known, nor why this would continue.
The numerical density (cells per area or volume) of cells in
the cortical stroma, however, did not change across gestation.
Assuming that the sizes of the stromal cells did not change, and
there was no observable evidence that they did, then the
Table 4. Morphometric analyses of the cortical stroma in bovine fetal
ovaries from the trial at Day 98 of gestation
Data are mean s.e.m. (n¼ 8)
Characteristic Value
Weight (mg) 26.5 1.1
Total volume cortical stroma (mm3) 3.9 0.2
Proportion of stroma in the cortex (%) 26.1 0.1
Proliferation index of cortical stroma (%) 7.3 0.5
Numerical density of proliferating cells in cortical
stroma (Nmm2)
1340 77
Numerical density of cortical stromal cells (Nmm2) 18 737 607
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proportion of extracellular space in the cortical stroma was
constant across gestation. This is different from what is known
to happen in the tunica albuginea, which has a significantly
lower cell numerical density than cortical stroma and has
proportionally more extracellular space rich in extracellular
matrix containing at least collagens, versican, fibronectin,
decorin (Hummitzsch et al. 2013), latent transforming growth
factor b-binding protein 2 and fibrillin 1 (Prodoehl et al. 2009).
Thus, as also observed in the human fetal ovary from 20 to 25
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Fig. 4. Differential mRNA expression levels of genes in whole bovine fetal ovaries. One ovary from each pair was used for mRNA analysis (n¼ 27
pairs). Data are presented as mean s.e.m. (normalised to GAPDH). Samples were grouped into five stages of ovarian development based on their
histological morphology: ovigerous cord formation (n¼ 7, Stage I), ovigerous cord breakdown (n¼ 4, Stage II), follicle formation (n¼ 3, Stage III),
surface epithelium formation (n¼ 8, Stage IV) and tunica albuginea formation (n¼ 5, Stage V). One-way ANOVA with post hoc Tuckey’s tests were
used to analyse the data. *P, 0.05, **P, 0.01, ***P, 0.001, ****P, 0.0001.
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increase in stroma expansion across gestation but this rate of
expansion slowed after Stage III. These rates of expansion are
mirrored by the proliferation of stromal cells, but not the
proportion of extracellular space, suggesting that stromal cell
proliferation is largely responsible for stromal expansion during
ovarian development.
Since stroma has been shown to expand significantly during
ovarian development, genes that encode extracellular matrix
proteins that might be involved in the expansion of the ovarian
stroma were examined. Small leucine-rich proteoglycans
(SLRPs) have a role in regulating collagen type I fibrillogenesis,
which has been shown to be expressed during ovarian develop-
ment in the rat (Paranko 1987) and cow (Hummitzsch et al.
2013). There are three classes of SLRP, Class I, Class II and
Class III, which consist of extracellular matrix proteins, includ-







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fig. 5. Scatter plots showing related mRNA expression levels of (a) LUM
versus FBLN5, (b) FN1-EDB versus COL1A2 and (c) FN1-EDA versus
COL6A2 in whole bovine fetal ovaries. One ovary from each pair was used
for mRNA analysis (n¼ 27 pairs). Data are presented as normalised gene
expression toGAPDH. Spearman’s correlation coefficient (R) test was used
to analyse the data.
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fibromodulin (FMOD) and osteoglycin (OGN; Ameye and
Young 2002). ASPN and BGN have been shown to be involved
in collagen type I fibrillogenesis in human embryonic kidney
cells and adult mouse ovary respectively (Oksjoki et al. 1999;
Kalamajski et al. 2009). Another study showed that LUM and
FMOD bind to collagen type I in an antagonistic manner during
tendon development, which might be related to the formation of
progressively thicker collagen fibrils (Kalamajski and Oldberg
2009). Additionally, OGN is involved in regulating collagen
type I fibrillogenesis in mouse embryo fibroblasts (Ge et al.
2004). Since collagen type I also increases as the stroma expands
during ovarian development, our findings indicate that ASPN,
LUM and OGN might be involved in the deposition and assem-
bly of extracellular matrix in stroma in bovine fetal ovary.
The establishment and the remodelling of the ovarian vascu-
lar system is required for development of the ovary (Robinson
et al. 2009). Initially the penetration and expansion of the
mesonephric stroma into the developing ovary brings with it
capillaries contained therein (Hummitzsch et al. 2013; Smith
et al. 2014). It has been shown that RGS5 and FBLN5, which
encode regulator of G-protein signalling 5 and fibulin 5 protein
respectively, are involved in vascular remodelling (Berger et al.
2005; Spencer et al. 2005). RGS5 protein is a pericyte marker
observed in the vasculature of mouse ovarian follicles (Berger
et al. 2005), rat cerebral capillaries (Kirsch et al. 2001) and
mouse embryonic pericytes (Bondjers et al. 2003). Pericytes
have been observed in 23–24week human fetal ovary as a part of
a vascular network in the stroma (Niculescu et al. 2011).
Additionally, a study using FBLN5 knockout mice suggests
the important role of FBLN5 in neointima formation and
vascular remodelling after an induced vascular injury (Spencer
et al. 2005). Since the interaction between endothelial cells,
pericytes and smoothmuscle cells is critical for the development
of the vasculature (Niculescu et al. 2011), the increased
expression of RGS5 and FBLN5 suggests that these genes may
play a role in expansion of the vasculature in the cortical stroma.
COL6A1, COL6A2 and COL6A3 encode the extracellular
matrix component collagen typeVI,which is predicted to help in
anchoring tissues and cells to the connective tissue extracellular
matrix (Cescon et al. 2015). In human adult ovary, collagen type
VI is observed in the thecal layer, especially in the theca externa,
and has a role in the interactions between the thecal cell and
extracellular matrix during folliculogenesis (Iwahashi et al.
2000). A study using a yeast two-hybrid system showed an
interaction between collagen type VI and collagen type IV (Kuo
et al. 1997), which is localised in follicular basal lamina during
ovarian development (Hummitzsch et al. 2013). Additionally,
collagen type VI also interacts with other extracellular matrix
components, such as collagen type I (Bonaldo et al. 1990) and
fibronectin (Sabatelli et al. 2001). A study in the bovine fetal
ovary showed that collagen type I and fibronectin were specifi-
cally expressed in the ovarian stroma (Hummitzsch et al. 2013),
suggesting that collagen type VI might have an important role in
anchoring vasculature in the stroma during the late stage of
ovarian development.
FN1 encodes fibronectin, which modulates cell–cell and
cell–matrix interactions (Goldberg et al. 2006). Fibronectin is
composed of three structurally homologous types of repeated
domains: Type I, II and III. Three different alternative splicing
regions are located in Type III fibronectin: extra domain A
(ED-A), B (ED-B) and the variable (V) region, encoded byFN1-
EDA, FN1-EDB and FN1-V, respectively, (the variable region
can have three to five alternative splicing events). The ED-A,
ED-B and V regions are located between the 11th and 12th,
between the 7th and 8th and between the 14th and 15th Type III
repeats respectively (De Candia and Rodgers 1999). Collec-
tively, these alternative splicing events potentially produce
multiple different isoforms in humans, cows, mice and rats:
ED-Aþ, ED-A–, ED-Bþ, ED-B–, Vþ and V–. These have been
shown to be expressed in bovine antral follicles of 0.5–9mm
diameter, in corpora lutea and in fetal bovine liver, lung and
kidney but fetal ovaries were not examined in that study
(De Candia and Rodgers 1999). The ED-Aþ isoform has been
identified in ovarian follicles and is predicted to be associated
with the replication of granulosa cells (Colman-Lerner et al.
1999), whereas the ED-Bþ and Vþ isoforms have been shown
to be involved in angiogenesis (Castellani et al. 1994; DeCandia
and Rodgers 1999). It is possible that the isoforms of FN1 might
be involved in follicle formation and angiogenesis during
ovarian development.
Many of the genes examined in the present study were highly
positively correlated with gestational age and also with each
other. This is not surprising as many of these genes were
extracellular matrix genes associated with stroma, which also
expanded during fetal development. Comparisons with earlier
studies of bovine fetal ovaries (Hatzirodos et al. 2011) showed
that fibrillin 3, another extracellular matrix gene that is famil-
iarly linked to PCOS, is highly expressed only in the first
trimester and declines in expression thereafter. This is interest-
ing as fibrillin 3 is thus expressed in the fetal cortical stroma
when it is proportionally expanding the most during fetal


























Fig. 6. An adjacent matrix network graph using correlation coefficients
from Table 5. The closeness of the genes and the thickness of the
interconnecting lines indicate stronger correlations between genes. Age is
age of gestation.
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behaviour and not other stromal extracellular matrix genes is not
known, but it does suggest that fibrillin 3may have a unique role
during ovarian cortical stroma expansion.
In summary we have shown quantitatively that the rate of
expansion of cortical stroma is greatest early in development
when the stroma penetrates the ovarian primordium from the
mesonephros. The expansion of the cortical stroma occurs due to
cell proliferation and not a change in cell size or a change in the
amount of extracellular space. The mRNA expression levels of
many extracellular matrix genes increased in the later stages of
ovarian development and were highly correlated with each
other, suggesting that theymight be co-regulated. In conclusion,
the behaviour of stroma changes during ovarian development
and this might have consequences for its roles.
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Fig. S1. Hartanti et al. 
Fig. S1. Variation of morphometric analysis. Data are presented as percentage 
of 3 – 40 fields of view and was counted by dividing standard deviation by the 
mean from each total number of fields of view to calculate the coefficient of 
variation (CV). The CV of the percentage of stromal area (A-F) and the 
proportion of stromal cells that are proliferating (G-L) in the ovarian cortex are 
presented. CRL 13.5 cm or 80 days (A and G), CRL 15.5 cm or 87 days (B and 
H), CRL 24 cm or 112 days (C and I), CRL 39 cm of 154 days (D and J), CRL 58 
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Polycystic ovary syndrome (PCOS) affects around 10% of young women, with adverse 
consequences on fertility and cardiometabolic outcomes. The polycystic ovary has numerous 
small follicles and an expanded fibrous, collagen-rich stroma. PCOS appears to result from a 
sgenetic predisposition interacting with developmental events during fetal or perinatal life. 
We hypothesised that PCOS candidate genes might be expressed in the fetal ovary when the 
stroma develops; mechanistically linking the genetics, fetal origins and adult ovarian 
phenotype of PCOS. We examined human and bovine fetal ovaries. Of 18 PCOS candidate 
genes only one (SUMO1P1) was not expressed. Three patterns of expression were observed: 
early gestation (FBN3, GATA4, HMGA2, TOX3, DENND1A and LHCGR), late gestation 
(INSR, FSHR and LHCGR) and throughout gestation (THADA, ERBB4, RAD50, C8H9orf3, 
YAP1, RAB5B, SUOX and KRR1). Three other genes, likely to be related to the PCOS 
aetiology [AMH, AR and TGFB1I1 (a TGFβ-regulated coactivator of the androgen receptor)], 
were also expressed late in gestation. Significantly within each of the three groups, the mRNA 
levels of many genes were highly correlated with each other, despite, in some instances, being 
expressed in different cell types. TGFβ is a well-known stimulator of stromal cell replication 
and collagen synthesis. TGFβ treatment of cultured fetal ovarian stromal cells increased 
expression of INSR, AR, C8H9orf3 and RAD50 and inhibited expression of TGFB1I1.  
These results have enabled the formulation of a new hypothesis that the predisposition to 
PCOS in adult life arises by perturbation of the expression of PCOS candidate genes during 
development of the ovary. 
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Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder, affecting around 
10 % of women of reproductive age 1. It is characterized by the high level of androgens, 
ovulatory disturbances, infertility, hyperinsulinemia, insulin resistance and obesity 2, 3. The 
cause(s) and aetiology of PCOS are not completely understood. PCOS appears to have a 
genetic origin 4, 5, 6 and a predisposition arising in fetal or perinatal life 7, 8, 9.  
Recent genome-wide association cohort studies (GWAS) into PCOS discovered new 
susceptibility loci associated with 17 genes [reviewed by 10]: DENN domain-containing 1A 
(DENND1A), luteinizing hormone/chorionic gonadotropin receptor (LHCGR), follicle 
stimulating hormone beta subunit (FSHB), follicle stimulating hormone receptor (FSHR), yes 
associated protein 1 (YAP1), insulin receptor (INSR), ras-related protein RAB5B, TOX high 
mobility group box family member 3 (TOX3), high mobility group AT-hook 2 (HMGA2), 
chromosome 9 open reading frame 3 (C9orf3), GATA binding protein 4 (GATA4), Erb-B2 
receptor tyrosine kinase 4 (ERBB4), DNA repair protein (RAD50), thyroid adenoma 
associated (THADA), sulphite oxidase (SUOX), Ca2+/calmodulin-dependent protein kinase 
(KRR1) and the small ubiquitin-like modifier 1 pseudogene 1 (SUMO1P1) 11, 12, 13, 14. Many 
human studies have been conducted in an effort to investigate these PCOS candidate genes, 
particularly DENND1A and its variants 15, TOX3 16, FSHR 17, LHCGR 18 and INSR 19. Another 
PCOS susceptibility loci was identified earlier by case-cohort studies using microsatellite 
analyses and it is located in an intron of fibrillin 3 (FBN3) 20. However, the contribution of 
these and other candidate gene loci in the development of the PCOS phenotype are still 
unclear. This is not an uncommon situation for many polygenic diseases where identifying 
how a SNP or loci identified from genomic studies are related to the aetiology of the disease 
can take considerable research effort to succeed 21. 
Some of the cardinal features of the PCOS ovary are the increased production of 
androgens, the presence of many antral follicles (inaccurately referred to as cysts in the name 
PCOS) and substantially more fibrous collagen-rich stroma and tunica albuginea 22. How or 
why the stroma is different are not known. However, it is known that when the ovary 
develops, the stroma in the mesonephros underlying the gonadal ridge migrates or penetrates 
into the developing ovary; this is a consistent process observed in ovine 23 bovine 24, 25 and 
human 26, 27 ovarian development. The existence of a relationship between the genetics and 
fetal origins and the fibrous ovarian phenotype received impetus when it was discovered that 
FBN3 is expressed in human and bovine ovarian stroma only in the early stage of fetal 
development when the stroma penetrates the ovary 8. Fibrillins regulate TGFβ activity in 
tissues by their ability to bind latent TGFβ binding proteins 28 and TGFβ stimulates stromal 
growth and collagen deposition 29. Thus the concept was developed that increased TGFβ 
bioactivity during fetal development could contribute to the mechanism of the fetal origins of 
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a predisposition to developing PCOS in later life 8, 30. These developmental changes might be 
subject to environmental modification, during development or postnatally 31. 
 To date the potential expression of the other PCOS candidate genes in fetal ovaries has 
not been investigated. Access to human fetal ovaries is relatively limited especially at later 
gestational ages and so we additionally chose an animal model to investigate expression of 
PCOS candidate genes. The histology and development of the bovine fetal ovary is similar to 
the human fetal ovary, as is the length of gestation 32, 33. Therefore, we analysed the 
expression of PCOS candidate genes identified by GWAS and additional genes, including 
androgen receptor (AR), transforming growth factor beta 1 induced transcript 1 (TGFB1I1), 
FBN3 and anti-Mullerian hormone (AMH), in bovine fetal ovaries throughout gestation as 
well as in adult ovaries. We examined the cellular location of expression of these genes by 
laser capture micro-dissection and examined their expression in bovine fetal ovarian stromal 
cells in vitro. We also analysed the expression of some PCOS candidate genes in human fetal 
ovaries from the first half of gestation.  
 
 
Materials and Methods 
 
Ethics approvals 
The human study was approved by the Lothian Research Ethics Committee (ref 08/S1101/1). 
For our bovine study, there were no ethical issues regarding this project since fetal bovine 
ovaries were collected from the local abattoir which was processing animals for the food 
chain.  
 
Collection of human fetal ovaries 
Human fetal ovaries (n = 15, 8-20 weeks of gestation) were obtained following medical 
termination of pregnancy as previously described 34. Maternal informed consent was obtained 
and the study was approved by the Lothian Research Ethics Committee (ref 08/S1101/1). To 
determine the gestational age, an ultrasound scan was performed and the length of the fetal 
foot was measured 35.   
 
Collection of bovine fetal and adult ovaries 
Thirty-seven ovaries from fetuses of Bos taurus cows across gestation as well as five adult 
ovaries  taken from non-pregnant animals across the estrous cycle (early and mid-luteal 
phases and the follicular phases) were collected from local abattoirs (Thomas Foods 
International, Murray Bridge, SA, Australia and Midfield Meat International, Warrnambool, 
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Victoria, Australia) and were either transferred on ice in Hank’s Balanced-Salt solution 
containing Mg2+ and Ca2+ (HBSS+/+, Sigma-Aldrich Pty Ltd, Castle Hill, NSW, Australia) to 
the laboratory or dissected and processed on site. To estimate the gestational age of fetal 
samples, the crown-rump length (CRL) was measured 36.  
For laser capture micro-dissection (LCM), fetal ovaries from early (n = 5, 10 – 17 
weeks of gestation) and late (n = 5, 36 – 39 weeks of gestation) stage of development were 
embedded into cryomolds filled with optimal cutting temperature (OCT) compound 
(ProSciTech, Thuringowa central, QLD, Australia) with the hilum on the side of the mould, 
frozen on dry ice and stored at -80oC. For RNA extraction from the ovarian samples, 27 
whole fetal and 1-3 pieces of cortical area containing preantral follicles and stroma from 5 
adult ovaries were snap-frozen on dry ice and stored at -80°C freezer for further analysis, 
whereas for the laser capture micro-dissected samples the cortical and medullar area were 
dissected from the fetal ovary and subsequently used for qRT-PCR.   
 
Sex determination of bovine fetuses 
Genomic DNA was extracted from the tail of fetuses with a CRL less than 10 cm using the 
Wizard SV Genomic DNA Purification System (Promega Australia, Alexandria, NSW, 
Australia) according to the manufacturer’s instructions and subsequently amplified. Two pairs 
of primers specific for a region in the SRY-determining sequence (sense primer: 5’-
TCACTCCTGCAAAAGGAGCA-3’, antisense primer: 5’-TTATTGTGGCCCAGGCTTG-
3’) and for the 18S ribosomal RNA (18S) gene sequence was used for amplifying the 
genomic DNA in individual reactions. Sex determining region Y (SRY) product sequences 
were verified using a PCR as previously described 24. 
 
Classification of bovine fetal ovaries 
Non-laser capture micro-dissected fetal ovary samples were grouped into five groups based 
on their histological morphology; stage I: ovigerous cord formation (n = 7, 79 ± 6 days of 
gestation), stage II: ovigerous cord breakdown (n = 4, 127 ± 6 days), stage III: follicle 
formation (n = 3, 173 ± 12 days), stage IV: ovarian surface epithelium formation (n = 8, 234 ± 
9 days) and stage V: tunica albuginea formation (n = 5, 264 ± 6 days) 25.   
 
Laser capture micro-dissection of bovine fetal ovaries 
Serial frozen sections of 8 µm thickness were cut using a CM1800 cryostat (Leica 
Microsystems, Buffalo, IL). Cryosections were transferred onto room temperature PET 
(polyethylene terephthalate) membrane frame slides (Leica Microsystems, North Ryde, NSW, 
Australia) and stored in a RNase-free slide box. Slides were fixed in 70% ethanol in DEPC-
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treated water, stained in 1% cresyl violet acetate (pH 7.75) (ProSciTech) in 70% ethanol 37, 
washed for 30 sec with 70%, 90%, and 100% ethanol, followed by 1 min in 100% ethanol and 
either dissected directly or stored overnight at -80oC in a parafilm-sealed 50 ml tube with dry 
desiccant. Slides were transferred to the LCM room on dry ice, then incubated for 5 min at 
55°C immediately prior to LCM (LMD AS, Leica Microsystems, North Ryde, NSW, 
Australia). Excised cortical and medullar samples [Supplemental Fig. S1 38] were collected 
into 20 µl of Ambion lysis solution for RNA isolation (Invitrogen, Carlsbad, CA, USA). Ten 
sections per area collected from 5 animals for each early and late stage of development were 
used for RNA isolation and subsequent qRT-PCR analysis. 
 
RNA Extraction and cDNA synthesis for human and bovine fetal ovaries 
For human samples, RNA from fetal ovaries was extracted using the RNeasy Micro Kit 
(Qiagen, Crawley, UK) according to manufacturer’s instructions. 500ng of RNA was reverse 
transcribed to cDNA using concentrated random primers and Superscript III reverse 
transcriptase (Life Technologies) according to manufacturer’s instructions, and the cDNA 
synthesis reaction was diluted 1:20 before proceeding. 
Whole fetal and adult bovine ovaries, as well as bovine fetal fibroblasts, were 
homogenised in 1 ml Trizol® (Thermo Fisher Scientific, Waltham, MA, USA) using the Mo 
Bio Powerlyser 24 (Mo Bio Laboratories Inc., Carlsbad, CA, USA) and RNA extracted 
according to manufacturer’s instructions. The RNA concentration was then determined using 
a Nanodrop spectrophotometer (NanoDrop 1000 3.7.1, Nanodrop Technologies, Wilmington, 
DE, USA) based on the 260 (wavelength) absorbance. Only samples which had a 260/280 
absorbance ratio > 1.8 were used and subsequently treated with DNase I (Promega/Life 
Technologies Australia Pty Ltd, Tullmarine, Vic, Australia) for 20 min at 37°C. 
For the laser capture micro-dissected samples, total RNA from 2 tissue sections was 
extracted and DNase treated using the RNAqueous®-Micro Kit (Cat# AM1931, Thermo 
Fisher Scientific, Waltham, MA, USA) procedure for LCM according to the manufacturer’s 
protocol. The integrity of RNA was assessed using the ExperionTM automated electrophoresis 
system with the Experion RNA HighSens Analysis Kit (Cat# 7007105, Biorad, Hercules, 
California, USA). Only samples which had a RNA Quality Index (RQI) more than 4 were 
concentrated using 3M sodium acetate and 100% ethanol. Concentrated RNA samples were 
then reassessed using the ExperionTM automated electrophoresis system and only those which 
had RQI more than 5 were used for qRT-PCR analysis.  
Complementary DNA was then synthesised from 9-200 ng of DNase-treated RNA 
using 250 ng/µl random hexamers (Sigma, Adelaide, SA, Australia) and 200 U Superscript 
Reverse Transcriptase III (Thermo Fisher Scientific, Waltham, MA, USA) as previously 
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described 39. To exclude genomic contamination, negative control was generated by adding 
DEPC-water instead of the Superscript Reverse Transcriptase III. 
 
Quantitative real-time PCR 
For each gene a standard curve of Cycle threshold (Ct) versus cDNA concentrations was then 
generated to test the combination of primers. The reactions were performed in duplicate using 
the following steps. cDNA dilutions were prepared in 10 l reactions containing 1-2 l of the 
0.5 ng/ul cDNA dilution, 5 l of Power SYBRTM Green PCR Master Mix (Applied 
Biosystems, Foster City, CA, USA), 0.1-0.3 l each of forward and reserve primers [Sigma; 
Supplemental Table 1 38] for the target genes, and 2.6-3.6 l of DEPC-treated water. The 
amplification conditions were a 95°C for 15 s, then by 60°C for 60 s for 40 cycles using a 
Rotor-Gene 6000 series 1.7 thermal cycler (Qiagen GmbH, Hilden, Germany). Ct values were 
then determined using the Rotor-Gene 6000 software (Q series, Qiagen GmbH, Hilden, 
Germany) at a threshold of 0.05 normalised fluorescence units. Gene expression was 
determined by the mean of 2-ΔCt, where ΔCt represents the target gene Ct – average of 
ribosomal protein L32 (RPL32) and peptidylprolyl isomerase A (PPIA) Ct for fetal samples 
and RPL19 and RPL32 for comparison of fetal and adult samples. These combinations of 
housekeeping genes were used because they were the most stable across all samples out of 
RPL32, RPL19, PPIA, actin beta (ACTB) and glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH). 
 
Primers for quantitative real-time PCR 
For human fetal ovary samples, qRT-PCR primers were designed to amplify all transcript 
variants and to span exons [Supplemental Table 1 38]. Primer pair efficiencies were calculated 
with the LinReg PCR applet 40. Each reaction was performed in a final volume of 10 µL, with 
1x Brilliant III SYBR Green qPCR Master Mix (Agilent, Santa Clara, California), 20 pmol of 
each primer and 2 µL of diluted cDNA. Each cDNA sample was analysed in triplicate. For 
expression analyses in human fetal ovaries, target genes were normalised to the geometric 
mean expression of beta-2-microglobulin (B2M) and RPL32. Data analysis for relative 
quantification of gene expression and calculation of standard deviations was performed as 
outlined by 41. 
For bovine samples, qRT-PCR primers were designed based on the published 
reference RNA sequences available in NCBI [Supplemental Table 1 38] using Primer3 plus 42 
and Net primer (PREMIER Biosoft Palo Alto, CA, USA) software. DENND1A is 
alternatively spliced and variant 1 is the full length mRNA and shares a number of exons in 
common with other splice variants. Primers used in the human (exons 21 and 22) detected 
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DENND1A.V1 but could also possibly detect variants 3 and 4 (DENND1A.V3,4) 
[Supplemental Figs 2-4 38] and in bovine (exon 12), the primers could also possibly detect the 
predicted variants 1, 2, 3 and 4 (DENND1A.X1-4) [Supplemental Figs. 2-4 38]. To attempt to 
detect variant 2 in the bovine primers to exon 20, and to a what is listed as intronic but 
corresponding to exon 21 in the human, were used [Supplemental Fig 4 38]. The alignment of 
the human and bovine DENND1A sequences and the primer sequences was analysed with the 
T-coffee method for multiple sequences alignment 43. Gene C8H9orf3 is the bovine 
homologue of the human PCOS candidate gene C9orf3. 
 
Statistical analyses 
All statistical analyses were carried out using Microsoft Office Excel 2013 (Microsoft 
Redmond, WA, USA) and GraphPad Prism version 7.00 (GraphPad Software Inc., La Jolla, 
CA, USA). All 2-∆Ct data for each fetal ovarian sample were plotted in scatter plot and bar 
graphs to describe their levels of expression during ovarian development. To analyse the 
difference between the level of mRNA expression of each gene, one-way ANOVA with 
Holm-Sidak and Dunnet’s post-hoc test were used for the whole ovary samples and fetal 
fibroblasts, respectively. For laser capture micro-dissected samples, unpaired t-test was 
applied. Pearson correlation test was used for analysing the correlation between levels of each 
gene with gestational age. After correlation values between genes were identified, a network 
graph was plotted using the qgraph R package 44 and illustrated using an adjacent matrix plot.  
 
 
Screening for regulators of PCOS candidate genes 
For screening of possible regulators of PCOS candidate genes in fetal ovary, RNA extracted 
from cultured and treated bovine fetal fibroblasts from another study was used 45. All ovaries 
analysed in the current study were from the second trimester. Briefly, bovine fetal ovaries 
were collected, gestational ages of the fetuses were determined and all ovaries were 
transferred to the laboratory using the protocol previously mentioned. After removing the 
surrounded connective tissue, the ovaries were rinsed in 70% ethanol and HBSS+/+, dissected 
and minced with a scalpel. The samples were digested in 1mg/ml collagenase type I (GIBCO/ 
Life Technologies Australia Pty Ltd, Mulgrave, VIC, Australia) in HBSS+/+ at 37ºC shaking at 
150 rpm and after centrifugation at 1500 rpm for 5 min, the supernatant was removed. The 
samples were then digested in 2 ml of 0.025% trypsin/EDTA (GIBCO/Life Technologies) in 
Hank’s Balanced-Salt Solution without Mg2+ and Ca2+ (HBSS-/-; Sigma-Aldrich) for 5 min at 
37ºC at 150 rpm and centrifuged at 1500 rpm for 5 min. The pellet was then resuspended in 
DMEM/F12 medium containing 5% FCS, 1% penicillin and streptomycin sulphate, and 0.1% 
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fungizone (all GIBCO/Life Technologies). The cells were then dispersed and cultured in 6-
well plates or 10 cm petri dishes at 38.5ºC and 5% CO2 until confluent. The fetal fibroblast 
cultures were detached by treatment with 0.25% trypsin/EDTA, then the total number of 
viable cells was estimated with the trypan blue method and stored in liquid nitrogen for 
subsequent experiments. Bovine fetal fibroblasts (n = 4 from weeks 13, 14, 17 and 19 of 
gestation for screening of possible regulators; n = 6 for weeks 19-26 of gestation for TGF-1 
treatment) previously stored in liquid nitrogen were thawed and 30,000 cells/well seeded in 
24-well plates in DMEM/F12 medium containing 5% FCS, 1% penicillin and streptomycin 
sulphate and 0.1% fungizone. The cells were incubated for 24 h at 38.5ºC and 5% CO2 until 
60-70% confluent then the wells were washed with 1X PBS. Different chemical treatments at 
concentration previously reported in the literature [Supplemental Table 2 38] including 5 ng/µl 
or 20 ng/µl TGFβ-1 in DMEM/F12 medium containing 1% FCS, 1% penicillin and 
streptomycin sulphate, and 0.1% fungizone were added then after 18 h, the cells were 








Expression of PCOS candidate genes in the human fetal ovary 
We first analysed the mRNA expression levels of FBN3, HMGA2, TOX3, GATA4, 
DENND1A.V1-7, DENND1A.V1,3,4, FSHB, LHCGR and FSHR in morphologically normal 
human fetal ovaries less than 150 days of gestation (Fig. 1). All genes, except for FSHB, were 
detected in the human fetal ovary (Fig. 1). FBN3, HMGA2 and DENND1A.V1,3,4 were highly 
expressed before 70 days of gestation (Figs 1A, C, G), then their expression levels markedly 
decreased. Additionally, their expression levels were strongly correlated to each other (Table 
1). The expression level of GATA4 was strongly correlated with expression levels of FBN3 (P 
< 0.001), HMGA2 (P < 0.0001) and DENND1A (P < 0.0001) (Table 1). A weaker but 
significant correlation was observed between the GATA4, DENND1A.V1-7 and FSHR 
expression levels and gestational age (Figs 1B, F, H and Table 1).  
 
Expression of PCOS candidate genes in bovine fetal and adult ovaries 
The mRNA levels of PCOS candidate genes were determined in whole ovaries (n = 27) 
collected from bovine fetuses ranging from 8 – 39 weeks gestation and in adult ovaries. Most 
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of the PCOS candidate genes were expressed during the development of the bovine fetus 
(Figs 2 – 4). We could not detect expression of DENND1A.V2 and SUMO1P1 in the bovine 
fetal ovary, nor in the bovine adult thecal cells, ovary, heart, spleen, kidney or liver.  
 Of the PCOS candidate genes that were analysed in the bovine fetal ovary, FBN3, 
GATA4, HMGA2, TOX3 and DENND1A.X1,2,3,4 were expressed early during ovarian 
development and then declined (Figs 2A–D, G). LHCGR was upregulated in early 
development, downregulated to the lowest point around 150 days of gestation, then sharply 
increased in late gestation (Fig. 2E) whereas the other early genes showed no similar increase 
in late gestation. FSHB mRNA levels peaked at around 100 days of gestation then declined 
until the end of gestation, however, the levels were exceedingly low and may not have much 
biological relevance (Fig. 2F). The mRNA levels of three of the PCOS candidate genes 
identified by GWAS studies, INSR, FSHR and AMH, as well as AR and TGFB1I1 were low 
early in gestation gradually increasing until the end of gestation (Figs 3A-E). The other genes, 
C8H9orf3, RAB5B, ERBB4, YAP1, SUOX, RAD50, THADA, and KRR1 were expressed 
throughout development, however, their mRNA levels did not correlate with gestational age 
(Figs 4A-H).  
We also classified the fetal ovary samples into 5 groups reflecting key stages in 
development as shown previously 25 and described in the Materials and Methods. We 
compared the mRNA levels at each stage and with those in the adult ovary. FBN3, HMGA2 
and TOX3 mRNA levels were high in the early stages and decreased significantly from stage 
III to the lowest levels in the adult ovary (Figs 2H, J-K). GATA4, FSHB and 
DENND1A.X1,2,3,4 (Figs 2I, M-N), as well as C8H9orf3, RAB5B, RAD50 and KRR1 (Figs 
4I, J, N, P), mRNA levels were elevated in stages I and II declining significantly at the later 
stages. There was no significant difference between the mRNA levels of YAP1 and SUOX in 
all 5 fetal stages, however, in the adult ovary, their levels were significantly decreased (Figs 
4L, M). FSHR and AMH were expressed highly in the adult ovary compared to all 5 stages in 
the fetal ovary (Figs 3G-H). The mRNA levels of AR and TGFB1I1 peaked at stage V (Figs 
3I, J). Their mRNA levels were significantly lower in the adult ovary compared to stages IV 
and V (Figs 3I, J). No significant differences were observed in the mRNA levels of LHCGR 
(Fig. 2L), INSR (Fig. 3F) and THADA (Fig. 4O) in the fetal and adult ovaries.  
 
Correlations between levels of mRNA 
To analyse the correlation between the expression levels of PCOS candidate genes and 
gestational age in bovine ovaries, we generated a Pearson correlation matrix (Table 2). FBN3 
positively correlated with HMGA2 (P < 0.0001), TOX3 (P < 0.0001), GATA4 (P < 0.0001) 
and DENND1A.X1,2,3,4 (P < 0.0001), HMGA2 positively correlated with TOX3 (P < 0.0001), 
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GATA4 (P < 0.0001) and DENND1A.X1,2,3,4 (P < 0.001), TOX3 positively correlated with 
GATA4 (P < 0.0001) and DENND1A.X1,2,3,4 (P < 0.0001), and GATA4 positively correlated 
with DENND1A.X1,2,3,4 (P < 0.0001) (Table 2). In addition, FBN3, HMGA2 and TOX3 also 
negatively correlated (r > -0.6) with FSHR, AMH, INSR, AR and TGFB1I1. After correlation 
values between genes were identified, a network graph was plotted using the qgraph R 
package 44 to plot an adjacent matrix [Supplemental Fig. 5 38]. Most of the genes, except 
ERBB4, were closely and highly connected with each other as well as with gestational age, 
suggesting a strong correlation between all genes and gestational age.  
 To accommodate the bimodal expression pattern of LHCGR, we additionally analysed 
the correlations between expression levels of genes in bovine fetal ovaries using the data from 
fetuses less than 150 days of gestation [Supplemental Table 3 38]. Our results showed that 
there was a strong correlation (r > 0.6) between the expression levels of the majority of genes 
that were highly expressed in early development (FBN3, GATA4, HMGA2, 
DENND1A.X1,2,3,4 and LHCGR) [Supplemental Table 3 38]. Interestingly, a strong negative 
correlation was observed between LHCGR and INSR (P < 0.01), AR (P < 0.01) and TGFB1I1 
(P < 0.001), which are the genes that were highly expressed in late stages of development 
[Supplemental Table 3 38]. The results also showed a strong correlation (r > 0.6) between 
FSHB and GATA4 and between HMGA2 and LHCGR [Supplemental Table 3 38].  
 
Differential gene expression in the cortex and medulla of fetal ovary 
To study the localization of cells expressing these genes, we conducted laser capture micro-
dissection in the bovine ovarian cortex and medulla at early (10 – 17 weeks) and late (36 – 39 
weeks) stages of gestation. We investigated the mRNA levels of PCOS candidate genes in 
these two areas [Supplemental Figs 6-8 38]. If expressed higher in the medulla we putatively 
interpreted this as being stromal expression and if expressed more highly in the cortex we 
putatively interpreted this as expression in the cortical ovigerous cords or follicles if late in 
gestation. Validation of this approach was confirmed by examining the expression of germ 
cell markers (VASA and OCT4) as well as the epithelial marker KRT19, which is expressed in 
GREL and granulosa cells of the bovine fetal ovary but not in stromal cells 24 [Supplemental 
Fig 9 38], and FBN3 [Supplemental Fig. 6 38], which is expressed in the stroma 8, 24.  
 The level of mRNA of FSHB was significantly higher in the ovarian cortex compared 
with the medulla in the early stage [Supplemental Fig. 6 38], FSHR in the late stage 
[Supplemental Fig. 7 38] and ERBB4 in both the early and late stage of development 
[Supplemental Fig. 8 38]. The expression levels of FBN3 [Supplemental Fig. 6 38], INSR, AR, 
TGFB1I1 [Supplemental Fig. 7 38], YAP1 and SUOX [Supplemental Fig. 8 38] were 
significantly higher in the ovarian medulla compared with the cortex in early development. 
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Other genes did not show any significant difference between cortical and medullar expression 
levels. 
 
Regulation of PCOS related genes in bovine fetal ovary 
We treated bovine fetal fibroblasts (n = 4 from 13-19 weeks of gestation) with 24 growth 
factors and hormones [Supplemental Table 2 38], and observed the effect on the expression of 
PCOS candidate genes [Supplemental Figs 10-12 38]. These factors and hormones have been 
shown to have important physiological roles in the adult ovary, such as cell proliferation and 
the production of extracellular matrices. The average levels of expression (2^delta-delta-Ct) 
for the untreated cells are shown in Supplemental Table 4 38, and compared with the in vivo 
RNA levels from whole ovaries from the same gestational ages as shown in Figs 2-4. Most 
genes were expressed at a lower level except GATA4 and TGFB1I1 which were >20 fold 
higher in vitro [Supplemental Table 4 38]. Treatment with fibroblast growth factor 9 (FGF-9) 
significantly increased mRNA levels of HMGA2 in fetal fibroblasts [Supplemental Fig. 10 38]. 
Other treatments did not affect the expression level of HMGA2 [Supplemental Figs 10-12 38]. 
Other PCOS genes, except FSHR and FSHB, were detected in the cultured bovine fetal 
fibroblasts, however, none were significantly affected by any of the treatments [Supplemental 
Figs 10-12 38].  
Treatment with TGF-1 (5 or 20 ng/ml) of 19-26 weeks bovine fetal fibroblasts 
resulted in a significant reduction in expression levels of INSR, AR, C8H9orf3 and RAD50 
(Fig. 5), compared to the untreated control and this reduction was enhanced by the higher 
TGF-1 concentration. We did not find any significant effect on TGFB1I1 expression in fetal 
fibroblasts treated with 5 ng/ml TGF-1, however, a significant increase was observed with 





To our knowledge, this is the first study that reports the levels of mRNA of PCOS candidate 
genes identified by GWAS in the developing fetal ovary. In both human and bovine ovaries 
we were able to identify a number of candidate genes that were expressed, whose pattern of 
expression changed during gestation, and whose expression levels were highly correlated with 
each other. Additionally in bovine ovaries we identified the region of the ovary where the 
genes were expressed and we examined gene expression in cultured fetal ovarian fibroblasts. 
This study thus identified relationships between the genetic and fetal origins of a 
predisposition to developing PCOS in later life.  
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 It should be noted that this study was limited to the analyses of only 11 human fetal 
ovaries, which is why we additionally undertook bovine analyses. Also human fetal ovaries 
were not available from late gestation for analyses. No direct causality studies were 
conducted. It is difficult to imagine how they could be at this stage, given that ovaries cannot 
readily be sampled during fetal development and linked with PCOS status in later life.  
For discussion we have grouped the genes into three categories based upon their 
expression pattern across gestation. The early genes were expressed highly in the first 
trimester but continued to decline in expression to reach a low at about mid gestation. The late 
genes were first detected midway through gestation and continued to increase in expression 
during the remainder of gestation. The third group of genes were expressed at relatively 
similar levels across all of gestation. Expression of some genes including DENND1A.V2 and 
SUMO1P1 (bovine only examined) was not detected.  
 
The early genes 
The group of bovine genes expressed early in gestation included FBN3, GATA4, HMGA2, 
TOX3 and DENND1A.X1,2,3,4. Their mRNA levels were strongly positively correlated with 
each other and negatively with gestational age. FBN3, GATA4 and DENND1A.X1,2,3,4 were 
elevated in the medulla early in gestation but HMGA2 and TOX3 did not show any differential 
pattern between cortex and medulla. LHCGR expression was also elevated early during 
ovarian development declining to the lowest point around mid-gestation, before sharply 
increasing until the end of gestation. LHCGR expression was also elevated in the medulla at 
the early stages, like FBN3, GATA4 and DENND1A.X1,2,3,4. Examining the data in the first 
half of gestation only, showed that LHCGR expression was positively but weakly correlated 
with most of the other early genes. This early expression of LHCGR precedes follicle 
formation and the expression in the medulla suggests that this is not associated with follicular 
cells at the early stage. 
This same set of genes was examined in human fetal ovaries in the first half of 
gestation. All genes identified in the bovine were expressed in the human ovaries particularly 
at the earliest stages. In the human ovary FBN3, GATA4, HMGA2 and DENND1A (V1-7 and 
V1, 3, 4) were all strongly positively correlated with each other and negatively with 
gestational age. TOX3 only declined in the two oldest samples examined and LHCGR was 
only elevated in two of four youngest samples and hence whilst these genes showed a similar 
patterns of expression to the other early genes their expression was not correlated with them.  
Two other genes were expressed early but differently between bovine and human. 
FSHB, although normally expressed in the anterior pituitary, was detected early in the bovine 
ovary and its expression level peaked at around 100 days of gestation then declined until the 
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end of gestation. However, it should be noted that the levels were very low and may not be of 
biological relevance. In the human FSHB was not detected but FSHR was expressed in three 
of the youngest four ovaries examined and it was very low in the older samples. At this stage 
it is not entirely clear how best to interpret these findings. 
DENND1A encodes DENND1A (DENN domain containing 1A, connecdenn 1) 
protein which is believed to assist endocytosis 46. Human DENND1A possesses 7 variants in 
total (DENND1A.V1-7) as well as 19 predicted variants (DENND1A.X1-19) 
(https://www.ncbi.nlm.nih.gov/). The function of these variants is still unclear, however, 2 
variants, DENND1A.V1 and DENND1A.V2 have been linked to PCOS 47, 48. DENND1A.V1 
encodes a 1009 amino acid protein with C-terminal proline-rich domain, whereas 
DENND1A.V2 encodes a 559 amino acid protein containing three DENN domains and 
additionally a C-terminal 33 amino acid sequence 47. A recent study has found that 
DENND1A.V2 might play an important role in pathophysiology of hyperandrogenemia 
associated with PCOS 47 due to several reasons: significantly elevated levels of 
DENND1A.V2 mRNA and protein in PCOS thecal cells compared to non-PCOS thecal cells; 
significantly elevated levels of DENND1A.V2 mRNA in urine of PCOS women compared to 
women with normal cycles; augmentation of CYP17A1 and CYP11A1 gene transcription, as 
well as increased dehydroepiandrosterone (DHEA) production in response to overexpression 
of DENND1A.V2 in normal thecal cells 48. We were unable to detect the expression of 
DENND1A.V2 in bovine fetal ovaries or adult thecal cells. However, there were elevated 
mRNA levels of DENND1A in early bovine and human fetal ovaries.  
Overall this group of genes expressed early has some unique characteristics. The 
genes are highly expressed when the ovigerous cords are forming by penetration of the stroma 
from the mesonephros 24, 25 and the proteins encoded by these genes have different cellular 
functions including extracellular matrix, transcription factors, hormone receptors and clathrin-
mediated endocytosis. These genes may also be expressed in different cell types as inferred 
from their different expression patterns comparing the cortex and medulla of the ovary. These 
genes are all elevated long before the time of gestation when animal models of PCOS can be 
generated by treating pregnant mothers or newborns with androgens 49. 
 
The late genes 
The mRNA levels of two of the PCOS candidate genes, INSR and FSHR, as well as AMH, AR 
and TGFB1I1 were low early in bovine gestation and then gradually increased from mid 
gestation until the end of gestation. The mRNA levels of these genes were highly correlated 
with each other and with gestational age. INSR, AR and TGFB1I1 were elevated in the 
medulla suggesting that they are expressed in the stroma. FSHR was elevated in the cortex in 
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late gestation suggesting that it is associated, as expected, with granulosa cells of follicles, 
although AMH expression did not show the same localization. The LHCGR gene was also 
upregulated in the second half of gestation and its mRNA levels were highly correlated with 
FSHR and AMH, but not INSR, AR and TGFB1I1 mRNA levels. It is intriguing that 
expression levels correlate with each other yet three of the genes appear to be expressed in 
stroma (INSR, AR and TGFB1I1) and three in follicles (FSHR, LHCGR and AMH). 
Expression of TGFB1I1 and AR suggest that TGFβ signaling could be augmenting AR 
signaling and regulating stromal function during the second half of gestation.  
 
The constantly expressed genes 
The other genes, C8H9orf3, RAB5B, ERBB4, YAP1, SUOX, RAD50, THADA and KRR1 were 
expressed throughout development of the bovine fetal ovary, however, their mRNA levels did 
not correlate with gestational age except for weak negative correlations with C8H9orf3 and 
RAD50. Within this group there were a number of associations, but in particular C8H9orf3, 
RAB5B, SUOX and YAP1 were highly positively correlated with each other and with 
DENND1A.X1,2,3,4 from the early group of genes. C8H9orf3 also showed some weaker but 
positive correlations with some of the other members of the early group of genes. SUOX and 
YAP1 were elevated in the medulla and ERBB4 was elevated in the cortex. There is little 
information regarding the expression and function of SUMO1P1, one of the eight human 
SUMO1 pseudogenes in human or bovine 50. In this study, we could not detect expression of 
SUMO1P1 in the bovine fetal ovary or adult thecal cells, liver, heart, spleen and kidney, 
suggesting that this gene might not be expressed in bovine tissues.  
 
Overall changes in PCOS candidate gene expression 
The mRNA levels of most PCOS candidate genes were correlated with many others in bovine 
fetal ovaries, suggesting a degree of co-regulation or coordination of behaviours of different 
cells in the ovary. Genes that were highly expressed early are thought to be linked to stroma 
development, whereas genes that were upregulated later in the development may have an 
important role in follicular development. Interestingly, strong negative correlations were 
observed between the genes that were upregulated early and those that were upregulated later 
in ovarian development. 
 
Regulation of genes 
Bovine fetal fibroblasts from the second trimester were treated with growth factors and 
hormones and the expression of PCOS candidate genes measured. Previous examination of 
these cells in culture found that FBN3 expression declined whilst FBN1 increased 51, 
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suggesting that the fibroblasts were undergoing maturation similar to changes in fibrillin gene 
expression during fetal ovarian development 8. Most genes were unresponsive to treatments 
except HMGA2 which increased in response to fibroblast growth factor 9 (FGF-9), and INSR, 
AR, C8H9orf3 and RAD50 all decreased while TGFB1I1 increased in response to TGF-1. All 
the components of the TGFβ pathways are expressed in the fetal ovary, changing during the 
course of ovarian development 8. Since TGFβ stimulates stromal growth and collagen 
deposition 29 the concept was developed that increased TGFβ bioactivity during fetal 
development could contribute the mechanism of the fetal disposition to PCOS in later life 8, 30. 
That five of the PCOS candidate genes, including AR and its co-activator TGFB1I1 could be 
regulated by TGF-1 further supports the concept that altered TGFβ signalling during fetal 
development could contribute to the aetiology of the predisposition to PCOS in later life. 
 
Summary and conclusions 
In summary nearly all genes in loci associated with PCOS were expressed in the developing 
fetal ovary. They fell into three groups of early, late and constant expression during 
development. Within each group, the expression levels of many genes were strongly 
correlated with each other, despite, in some instances, being expressed in different cell types 
indicating that gene expression is coordinated and linked to fetal ovarian development. Three 
of the PCOS candidate genes, and AR and its coactivator TGFB1I1, were regulated by TGFβ 
in vitro. This is notable as fetal or neonatal exposure to androgens can induce PCOS in later 
life. Additionally in stroma TGFβ stimulates expansion of the stroma and collagen deposition, 
both known to be elevated in the polycystic ovary. Members of the TGFβ pathway also 
change during development of the ovary suggesting that TGFβ signalling is multifaceted 8. 
We conclude that the expression of these genes might be related to ovarian development, thus 
potentially holding the key to understanding the predisposition to the development of PCOS 
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Table 1. Pearson correlation coefficients (r) of mRNA expression levels of PCOS-candidate 
genes and gestational age in the human fetal ovary (n = 15). 
  





       
GATA4 -0.593a 0.767c 
      
HMGA2 -0.685b 0.852d 0.934d 
     
TOX3 -0.033 -0.134 -0.078 -0.115 
    
LHCGR -0.491 0.421 0.020 0.287 0.081 
   
DENND1A.
V1-7 




-0.674b 0.790c 0.808c 0.904d 0.232 0.357 0.982d 
 
FSHR -0.545a 0.575a 0.680b 0.606a -0.185 -0.033 0.445 0.421 
 
a P < 0.05, b P < 0.01, c P < 0.001, d P < 0.0001 
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Table 2. Pearson correlation coefficients (r) of mRNA expression levels of PCOS-candidate genes and gestational age in bovine fetal ovaries (n = 27). 
 
Age FBN3 GATA4 HMGA2 TOX3 LHCGR FSHB DENND1
A. 
X1,2,3,4 
C8H9orf3 RAB5B ERBB4 YAP1 SUOX RAD50 THADA KRR1 INSR FSHR AMH AR 
FBN3 -0.887d 
                   
GATA4 -0.709d 0.898d                   
HMGA2 -0.898d 0.959d 0.849d                  
TOX3 -0.892d 0.824d 0.670d 0.826d 
          
  
    
LHCGR 0.332 -0.156 -0.079 -0.177 -0.382a 
         
  
    
FSHB -0.563b 0.406a 0.182 0.443a 0.678c -0.403a 








-0.606c 0.696d 0.777d 0.675c 0.731d -0.311 0.347 
             
C8H9orf
3 
-0.393a 0.543b 0.671c 0.506b 0.511b -0.256 0.295 0.841d 
            
RAB5B -0.314 0.246 0.340 0.258 0.485a -0.459a 0.471a 0.714d 0.644c 
           
ERBB4 0.305 -0.240 -0.161 -0.256 -0.164 0.162 0.049 0.010 0.044 0.278 
          
YAP1 -0.080 0.236 0.491b 0.217 0.225 -0.387a 0.064 0.637c 0.716d 0.692d 0.232 
         
SUOX 0.175 0.140 0.403a 0.083 -0.037 0.073 -0.250 0.505b 0.639c 0.392a 0.073 0.722d 
        
RAD50 -0.497b 0.405a 0.359 0.434a 0.600c -0.577b 0.563b 0.526b 0.430a 0.690d 0.186 0.490b 0.054 
       
THADA 0.380 -0.264 0.001 -0.231 -0.268 0.177 -0.176 0.217 0.435a 0.359 0.225 0.557b 0.585b 0.059 
      
KRR1 -0.352 0.379 0.368 0.463a 0.515b -0.478a 0.505b 0.663c 0.586b 0.600c -0.110 0.589b 0.430a 0.591b 0.334 
     
INSR 0.775d -0.601c -0.312 -0.643c -0.632c 0.248 -0.435a -0.143 0.167 0.116 0.369 0.392a 0.572b -0.283 0.756d -0.070 
    
FSHR 0.753d -0.580b -0.436a -0.640c -0.684d 0.675c -0.531b -0.392a -0.203 -0.196 0.451a -0.062 0.256 -0.391a 0.456a -0.432a 0.729d 
   
AMH 0.682d -0.525b -0.408a -0.542b -0.632c 0.846d -0.427a -0.476a -0.310 -0.374 0.242 -0.306 0.153 -0.619c 0.313 -0.438a 0.573b 0.818d 
  
AR 0.765d -0.669c -0.420a -0.654c -0.648c 0.234 -0.452a -0.258 -0.028 -0.047 0.055 0.137 0.420a -0.358 0.491b -0.040 0.696d 0.476a 0.568b 
 
TGFB1I1 0.853d -0.664c -0.413a -0.695d -0.676c 0.231 -0.444a -0.188 0.034 0.024 0.432a 0.292 0.518b -0.352 0.584b -0.032 0.876d 0.669c 0.537b 0.772d 
 






Figure 1. Scatter plot of mRNA expression levels of some PCOS candidate genes analysed in 
human fetal ovaries (n = 15, 8 – 20 weeks of gestation). Pearson correlation coefficient (r) test was 




Figure 2. A-G. Scatter plots of mRNA expression levels of PCOS candidate genes which were 
highly expressed during early gestation in bovine fetal ovaries (n = 27). Pearson correlation 
coefficient (R) test was used to analyse data. H-N. Differential mRNA expression levels in ovaries 
grouped into six stages of ovarian development based on their histological morphology: ovigerous 
cord formation (n = 7, Stage I), ovigerous cord breakdown (n = 4, Stage II), follicle formation (n = 
3, Stage III), surface epithelium formation (n = 8, Stage IV), tunica albuginea formation (n = 5, 
Stage V) and adult (n = 6, Stage VI). Data are presented as mean  s.e.m. (normalised to PPIA and 
RPL32 for scatter plot and RPL19 and RPL32 for bar graphs). One-way ANOVA with post hoc 
Holm-Sidak test were used to analyse the data. Different letters indicate statistically significant 




Figure 3. A-E. Scatter plots of mRNA expression levels from genes which are highly expressed 
late in gestation in bovine fetal ovaries (n = 27). Pearson correlation coefficient (R) test was used to 
analyse data. F-J. Differential mRNA expression levels in ovaries grouped into six stages of 
ovarian development based on their histological morphology: ovigerous cord formation (n = 7, 
Stage I), ovigerous cord breakdown (n = 4, Stage II), follicle formation (n = 3, Stage III), surface 
epithelium formation (n = 8, Stage IV), tunica albuginea formation (n = 5, Stage V) and adult (n = 
6, Stage VI). Data are presented as mean  s.e.m. (normalised to PPIA and RPL32 for scatter plot 
and RPL19 and RPL32 for bar graphs). One-way ANOVA with post hoc Holm-Sidak test were used 




Figure 4. A-H. Scatter plot of mRNA expression levels of PCOS candidate genes which are 
constantly expressed throughout gestation in bovine fetal ovaries (n = 27). Pearson correlation 
coefficient (R) test was used to analyse data. I-M. Differential mRNA expression levels in ovaries 
grouped into six stages of ovarian development based on their histological morphology: ovigerous 
cord formation (n = 7, Stage I), ovigerous cord breakdown (n = 4, Stage II), follicle formation (n = 
3, Stage III), surface epithelium formation (n = 8, Stage IV), tunica albuginea formation (n = 5, 
Stage V) and adult (n = 6, Stage VI). Data are presented as mean  s.e.m. (normalised to PPIA and 
RPL32 for scatter plot and RPL19 and RPL32 for bar graphs). One-way ANOVA with post hoc 
Holm-Sidak test were used to analyse the data. Different letters indicate statistically significant 




Figure 5. Expression of genes in bovine fetal fibroblasts from 19 – 26 weeks of gestation. 
Fibroblasts were cultured in the presence of 5 and 20 ng/mL TGF-1 for 18 h. Data are represented 
as mean  s.e.m. of fold change in gene expression relative to the untreated control (n = 6 ovaries). 
One-way ANOVA with Dunnet’s post hoc test were used to analyse the data. Asterisk symbols 





Supplemental Table 1. List of genes and primers used for qRT-PCR. 
 




Ribosomal protein L32 RPL32 Bovine F : GCCATCAGAATCACCAATCC 
R : AAATGTGCACACGAGCTGTC 
NM_001034783.2 73 





Ribosomal protein L19 RPL19 Bovine F: GATCCGGAAGCTGATCAAAG 
R: TACCCATATGCCTGCCTTTC 
NM_001040516.1 113 
Peptidylprolyl isomerase A 
(cyclophilin A) 
PPIA Bovine F : CTGGCATCTTGTCCATGGCAAA 
R : CCACAGTCAGCAATGGTGATCTTC 
NM_178320.2 202 
Beta-2-microglobulin B2M Human F:ACTGAATTCACCCCCACTGA 
R:CCTCCATGATGCTGCTTACA 
NM_004048 114 
Fibrillin 3 FBN3 Bovine F : GCCACAGCCTGCCTAGATGT 
R : CTGCCCTCAGTGTTTTTGCA 
XM_001254849.2 82 
Fibrillin 3 FBN3 Human F : TGTCGTACCCATCTGTAGGC 
R : GCCCCCATTCATACAGCTCA 
NM_032447 142 
High Mobility Group AT-
Hook 2 
HMGA2  Bovine F : TTATCCGCCCACGATTAGAG 
R : TTGAGTGTGTGTGTGCTTGG 
XM_002704288 72 
High Mobility Group AT-
Hook 2 
HMGA2 Human F : TCAGAAGAGAGGACGCGG 
R : TTGAGCTGCTTTAGAGGGAC 
NM_003483 124 
TOX High Mobility Group 
Box Family Member 3 
TOX3 Bovine F : TATGGCTGAGGCAAACAACG 
R : TTCAAACTCCTCATCCCCAAGG 
XM_015467340 79 
TOX High Mobility Group 
Box Family Member 3 
TOX3 Human F : AGCAAATCCAGCAGCAGATG 
R : GAGGAGAAGGCTGAGACTGG 
NM_001146188 180 
GATA binding protein 4 GATA4 Bovine F : CAGGAGGCAAAAATGCTAGG 
R : ATCACCCGTCGTCTTTCTTC 
NM_001192877.1 82 
GATA binding protein 4 GATA4 Human F : CATCAAGACGGAGCCTGGCC 
R : TGACTGTCGGCCAAGACCAG 
NM_002052 219 
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DENN Domain Containing 
1A 
DENND1A.X1,2,3,4  Bovine F : TGTCGTGATCCTGAATGTGG 
R : ACATCATTTGGGAGGCTCTG 
XM_005213126 71 
Predicted DENN Domain 
Containing 1A Variant 2 
DENND1A.V2 Bovine F : ACCGAAGAGCAACATCACAG 
R : TGACGCAGCAATCTCCTATC 
NM_001193014 306 
DENN Domain Containing 
1A Variant 1-7 
DENND1A.V1-7  Human  F : GTCCATCTCAGCGTGCATTC 
R : CGGCGTTCGTACAGCATAC     
NM_020946 149 
DENN Domain Containing 
1A Variant 1, 3, 4 
DENND1A.V1,3,4  Human F : CAGCCAGGGACCTTTGACTA 
R : CAGAGCTTGTTGTACGGGTG 
NM_020946 104 
Anti-Mullerian hormone AMH  Bovine F : ACACCGGCAAGCTCCTCAT 
R : TCTCGTCCGCTACTCCAAGT 
NM_178318.4 202 
Follicle stimulating hormone 
receptor (FSHR) 
FSHR  Bovine F : GACCCTGATGCCTTCCAGA 
R : TGGCAAGTGCTTAATACCTGTGTT 
NM_174061.1 74 
Follicle stimulating hormone 
receptor (FSHR) 
FSHR Human F: GCTGCCTACTCTGGAAAAGC 
R: ATCTCTGACCCCTAGCCTGA 
NM_000145 173 
Insulin receptor INSR  Bovine F : AGGAGCTGGAGGAGTCCTCGTTCA 
R : CATTCCCCACGTCACCAAGGGCTC 
XM_0154640 111 
Androgen Receptor AR  Bovine F : TGCCCCTGACCTGGTTTTC 
R : TCGGACACACTGGCTGTACATC 
NM_001244127.1 67 
 
Transforming growth factor 
beta 1 induced transcript 1 
TFGB1I1 Bovine F : TCCCCTGTTCTCCCAAAGC 
R : GCCCTGAGGCTGGAAGATG 
NM_001035313.1 109 
Thyroid adenoma associated THADA  Bovine F : TGTGGTTAGGAGGCTTTTGG 
R : ACAGTGAGCTGGTGCATTTG 
XM_015465336 117 
Erb-B2 Receptor Tyrosine 
Kinase 4 
ERBB4  Bovine F : CCTGGAAATAACCAGCATCG 
R : CTTTGTCCCACGGATAATGC 
XM_015462361 142 
RAD50 Double Strand Break 
Repair Protein 
RAD50  Bovine F : GCTTTGAGCTTGGACCATTC 
R : AACAGTTGGCTGGCAGTTTC 
NM_001206868 100 
Chromosome 8 open reading 
frame, human C9orf3 
C8H9orf3 Bovine F : ACAGGGGATGAAAGTTGTGG 
R : AAATCTCAGAAGGGGCTTCC 
NM_001206980 111 
Yes Associated Protein 1 YAP1 Bovine F : GATGGTGGGACTCAAAATCC 
R : TGAGCTATTGGTCGTCATGG 
XM_015474584 75 
RAB5B, Member RAS 
Oncogene Family 
RAB5B Bovine F : AAGCGCATGGTGGAGTATG 




SUMO1P1 Bovine F : CAGGGTTATTGGACAGGATAGC 




gonadotrophin  receptor 
LHCGR  Bovine F : GCCACTGCTGTGCTTTTAGAAA 
R : CCAGCCACTCAGTTCACTCTCA 




gonadotrophin  receptor 
LHCGR Human F : TCAATGTGGTGGCCTTCTTCATA 
R : TTGGCACAAGAATTGATGGGATA 
NM_000233 256 
Sulphite Oxidase SUOX Bovine F : TGGTGATAACTCCAGCACCAG 
R : ATCATGACAGGCCAACACTG 
NM_001034366 79 
KRR1, Small Subunit 
Processome Component 
Homolog 
KRR1 Bovine F : CCGAGATGAATCTGAACTCCTC 
R : TCTGGGATTGTCCTCTTTGG 
NM_001037819 76 
Follicle Stimulating 
Hormone Beta Subunit 
FSHB Bovine F: GTCACCACTCAGACCTGTATTC 
R: GGGATTGCCTGAGAGGATTT 
NM_174060.1  120 
Follicle Stimulating 
Hormone Beta Subunit 
FSHB Human F : TGAGCTGACCAACATCACCA 
R : TGGCTGGGTCCTTATACACC 
NM_000510 122 
Cytokeratin 19 KRT19 Bovine F : AAGCTTTGCGCATGAGTGTG 
R : TCAATCTGCATCTCCAGGTCAG 
NM_001015600.3 97 
DEAD (Asp-Glu-Ala-Asp) 
box polypeptide 4 
VASA Bovine F : ATGAAGCTGATCGCATGCTG 
R : TGACGCTGTTCCTTTGATGG 
NM_001007819.1 91 
POU class 5 homeobox 1 OCT4 Bovine F : AGGCTTTGCAGCTCAGTTTC 








Supplemental Table 2. Treatments used for bovine fetal fibroblasts. 
Category Treatments Concentration Distribution 







Basic fibroblast growth 
factor 
100 ng/mL 
Roche Australia Pty Ltd, 




25 ng/mL Invitrogen/Life Technologies 
















100 ng/mL R&D Systems 












10 ng/mL R&D Systems 
 Activin A 100 ng/mL R&D Systems 
 Epidermal growth factor 10 ng/mL 
Boehringer Ingelheim Pty Ltd, 
North Ryde, NSW, Australia 
 
Fibroblast growth factor 
7 
10 ng/mL R&D Systems 
 
Fibroblast growth factor 
9 
30 ng/mL R&D Systems 
 Retinoic acid 3 g/mL Sigma-Aldrich 
Hormones Dihydroxytestosterone 100 ng/mL Sigma-Aldrich 
 Testosterone 100 ng/mL Sigma-Aldrich 
 Estradiol 100 ng/mL Sigma-Aldrich 
 Insulin-like protein 3 100 ng/mL 
From Dr Ross Bathgate – 






Biogen Idec Australia Pty Ltd, 





GroPep Bioreagents Pty Ltd, 







Supplemental Table 3. Pearson correlation coefficients (r) of mRNA expression levels of PCOS-candidate genes and gestational age in less than 150 
day bovine fetal ovaries (n = 27). 





RAB5B ERBB4 YAP1 SUOX RAD50 THADA 
KRR
1 
INSR FSHR AMH AR 
FBN3 -0.675a                    
GATA4 -0.650a 0.920d                   
HMGA2 -0.651a 0.850c 0.802b                  
TOX3 0.223 0.119 0.219 0.021                 
LHCGR -0.922d 0.609a 0.719a 0.651a -0.126                




-0.165 0.641a 0.708a 0.591 0.502 0.295 0.518              
C8H9or
f3 
-0.163 0.723a 0.572 0.536 0.168 0.006 0.128 0.569             
RAB5B 0.592 -0.325 -0.216 -0.231 0.375 -0.504 -0.314 0.088 -0.095            
ERBB4 0.426 -0.266 -0.237 -0.049 0.287 -0.412 -0.045 -0.047 -0.038 0.758b           
YAP1 -0.064 0.617a 0.671a 0.632a 0.553 0.159 0.448 0.607a 0.501 0.324 0.335          
SUOX -0.253 0.821b 0.819b 0.761b 0.491 0.300 0.424 0.817b 0.720a 0.048 -0.027 0.841b         
RAD50 0.237 0.043 0.0510 0.118 0.473 -0.247 0.014 0.048 0.092 0.679a 0.872c 0.628a 0.234        
THADA -0.189 0.139 0.104 0.436 0.242 0.222 0.420 0.172 -0.158 0.225 0.600 0.389 0.159 0.629a       
KRR1 0.392 -0.081 -0.155 0.146 0.460 -0.355 0.151 0.180 0.017 0.385 0.688a 0.489 0.192 0.695a 0.740b      
INSR 0.764b -0.114 -0.165 -0.245 0.387 -0.773b -0.323 0.208 0.469 0.393 0.289 0.333 0.256 0.276 -0.287 0.385     
FSHR 0.276 0.418 0.381 0.155 0.570 -0.291 -0.183 0.565 0.661a 0.316 -0.030 0.625a 0.708a 0.217 -0.281 0.119 0.707a    
AMH 0.719a -0.615a -0.458 -0.453 0.327 -0.470 -0.050 -0.014 -0.435 0.237 0.100 -0.034 -0.188 -0.047 -0.065 0.385 0.434 0.064   
AR 0.939d -0.584 -0.561 -0.520 0.133 -0.811b -0.319 -0.051 -0.139 0.377 0.266 -0.054 -0.186 0.064 -0.178 0.417 0.742b 0.224 0.811b  
TGF1I
1 
0.951d -0.456 -0.411 -0.488 0.371 -0.848c -0.404 0.088 0.071 0.553 0.344 0.132 0.019 0.216 -0.261 0.372 0.887c 0.504 0.707a 0.921d 
 
a P < 0.05, b P < 0.01, c P < 0.001, d P < 0.0001 
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Supplemental Table 4. Normalized gene expression in cultured bovine fetal fibroblast (in vitro, n 
= 4) and whole bovine fetal ovaries (in vivo, n = 5) at 13-28 weeks of gestation.  
 
Genes In vitro In vivo 
FBN3 0.0009  0.0002 0.008 ± 0.002 
GATA4 0.136  0.0212 0.004 ± 0.001 
HMGA2 0.0005  0.0001 0.003 ± 0.0004 
TOX3 0.005  0.003 0.342 ± 0.037 
LHCGR 0.0005  0.0003 0.040 ± 0.003 
FSHB Not detected 0.004 ± 0.001 
DENND1A.X1,2,3,4 0.022  0.005 0.151 ± 0.026 
INSR 0.0166  0.004 0.044 ± 0.002 
FSHR Not detected 0.536 ± 0.046 
AMH 0.0004  0.0001 0.004 ± 0.0008 
AR 0.012  0.004 0.315 ± 0.024 
TGFB1I1 0.231  0.050 0.010 ± 0.0008 
C8H9orf3 0.008  0.001 0.061 ± 0.004 
RAB5B 0.112  0.024 0.052 ± 0.008 
ERBB4 0.002  0.002 0.057 ± 0.013 
YAP1 0.330  0.063 0.081 ± 0.005 
SUOX 0.007  0.002 0.073 ± 0.011 
RAD50 0.043  0.008 0.127 ± 0.023 
THADA 0.0276  0.007 0.096 ± 0.017 
KRR1 0.025  0.007 0.002 ± 0.0006 
 

















Supplemental Fig. S1 
Representative images of bovine fetal ovary showing the cortical and medullar areas prior to 
and post LCM. The whole ovary was embedded into cryomold filled with OCT compound 
with the hilum on the side of the mold. For confirming the cortical and medullar areas, 5-20 
section of 8 μm thickness were cut and mounted into colourfrost glass slides (HD Scientific 
Supplies). Slides were then fixed and stained in 1% cresyl violet acetate (pH 7.75) in 70% 
ethanol using the same protocol as described in this study. The cortical area was identified as 
the outer area lying beneath the tunica albugines, composed of connective tissue and fibers, as 
well as scattered ovigerous cords and/or primordial/primary follicles. The medullar area was 
identified as the middle area, composed of connective tissue and fibers with cvarious szes of 
vasculature. After those areas were identified using microscope Olympus BX-50, then 10-12 
sections of 8um thickness were cut and transferred into the PET membrane frame slides. 
























Supplemental Fig. S2. Alignment of the exons of human DENND1A.V1; bovine DENND1A; predicted 
bovine DENND1A.X1,2,3,4; and DENND1A.X1,2,3,4 primer sequences. Alignment was generated with 
CLUSTAL multiple sequence alignment by Kalign (2.0) based on sequences available at Ensembl Asia with 
transcript ID for human DENND1A.V1 (ENST00000373624.6) and bovine DENND1A 
(ENSBTAG00000003610) and at NCBI PubMed with accession numbers: predicted bovine DENND1A.X1 
(XM_005213126.4); DENND1A.X2 (XM_015473579.2); DENND1A.X3 (XM_015473580.2); and 
DENND1A.X4 (XM_024998568.1). The alignment was analysed with T-COFFEE (1) and colored based on 
the consistency: red (high), yellow (average); green and blue (poor). Consistency is estimated from CORE 
index. Bright aqua highlighted areas represent the primer sequences. ……………… represent intronic areas not 
shown so as to reduce the size of this file. 
 
1. Notredame C, Higgins DG, Heringa J. T-Coffee: A novel method for fast and accurate multiple 








DENND1A_BOVINE     ------------------------------------------------------------------------------------ 
DENND1A.V1_HUMAN CGCGCGCCGGGCACGCGCGCCGGCGACCATGGCGTTCGCCGGGCTGGAGCGAGTACATTAACCCCTGGAGGCGGCGGCGGC--- 
DENND1A.X1_BOVINE    -------------------CCGGCGACCATGGCGTTCGCCCGGCTGAAGCGAGTGCATTAACCCCGGGAGGCGGCGGCGGCGGC 
DENND1A.X2_BOVINE    --------------------CGGCGACCATGGCGTTCGCCCGGCTGAAGCGAGTGCATTAACCCCGGGAGGCGGCGGCGGCGGC 
DENND1A.X3_BOVINE    --------------------CGGCGACCATGGCGTTCGCCCGGCTGAAGCGAGTGCATTAACCCCGGGAGGCGGCGGCGGCGGC 
DENND1A.X4_BOVINE    -----------------------CGACCATGGCGTTCGCCCGGCTGAAGCGAGTGCATTAACCCCGGGAGGCGGCGGCGGCGGC 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     --------------------------------------------------------------------------------GGCC 
DENND1A.V1_HUMAN    ---GGCGAGGGAGCGAGCCTCGAGCGGGCGGGCCCCAGCCTGAGGGAAGGGAGGAAGGGGCGGGGAGAGCGCCAGAGGGAGGCC 
DENND1A.X1_BOVINE    TGCGGCTGGGGAGCGAGACTCGAGCGGGCGGGC-TCAGCCTGAGGGAAGGGAGGAAGGGGCGGGGAGAGCGCCGGAGGGAGGCC 
DENND1A.X2_BOVINE    TGCGGCTGGGGAGCGAGACTCGAGCGGGCGGGC-TCAGCCTGAGGGAAGGGAGGAAGGGGCGGGGAGAGCGCCGGAGGGAGGCC 
DENND1A.X3_BOVINE    TGCGGCTGGGGAGCGAGACTCGAGCGGGCGGGC-TCAGCCTGAGGGAAGGGAGGAAGGGGCGGGGAGAGCGCCGGAGGGAGGCC 
DENND1A.X4_BOVINE    TGCGGCTGGGGAGCGAGACTCGAGCGGGCGGGC-TCAGCCTGAGGGAAGGGAGGAAGGGGCGGGGAGAGCGCCGGAGGGAGGCC 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     GGTCGGCCGGTCGGCCGCAGGCGGGCGGGCAGCGCAGCGCAGCGCCGAGCGGGGCCCGCGGGCCCATGAGGAGGCCGGGGGACC 
DENND1A.V1_HUMAN    GGTCG--------GCCGCGGGCGGGCGGGCAG-----CGCAGCGCCGAGCGGGGCCCGCGGGCCCATGAGGAGGCCTGGGGACC 
DENND1A.X1_BOVINE    GGTCGGCCGGTCGGCCGCAGGCGGGCGGGCAGCGCAGCGCAGCGCCGAGCGGGGCCCGCGGGCCCATGAGGAGGCCGGGGGACC 
DENND1A.X2_BOVINE    GGTCGGCCGGTCGGCCGCAGGCGGGCGGGCAGCGCAGCGCAGCGCCGAGCGGGGCCCGCGGGCCCATGAGGAGGCCGGGGGACC 
DENND1A.X3_BOVINE    GGTCGGCCGGTCGGCCGCAGGCGGGCGGGCAGCGCAGCGCAGCGCCGAGCGGGGCCCGCGGGCCCATGAGGAGGCCGGGGGACC 
DENND1A.X4_BOVINE    GGTCGGCCGGTCGGCCGCAGGCGGGCGGGCAGCGCAGCGCAGCGCCGAGCGGGGCCCGCGGGCCCATGAGGAGGCCGGGGGACC 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     ATGGGCTCCAGGATCAAgtgagtgtggtcggcct……………………………………………………………cagtaatcacggtctgtttcttttgta 
DENND1A.V1_HUMAN    ATGGGCTCCAGGATCAAgtgagtgcggccgggcc……………………………………………………………cagtaatcatgatctgtttcttttgta 
DENND1A.X1_BOVINE    ATGGGCTCCAGGATCAA------------------------------------------------------------------- 
DENND1A.X2_BOVINE    ATGGGCTCCAGGATCAA------------------------------------------------------------------- 
DENND1A.X3_BOVINE    ATGGGCTCCAGGATCAA------------------------------------------------------------------- 
DENND1A.X4_BOVINE    ATGGGCTCCAGGATCAA------------------------------------------------------------------- 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     GCAAAACCCAGAGACCACCTTTGAAGTGTATGTTGAAGTGGCCTGTCCTAGGACAGGTGGCACTCTTTCAGgta……………attta 
DENND1A.V1_HUMAN    GCAGAATCCAGAGACCACATTTGAAGTATATGTTGAAGTGGCCTATCCCAGGACAGGTGGCACTCTTTCAGgta……………attta 
DENND1A.X1_BOVINE    GCAAAACCCAGAGACCACCTTTGAAGTGTATGTTGAAGTGGCCTGTCCTAGGACAGGTGGCACTCTTTCAG------------- 
DENND1A.X2_BOVINE    GCAAAACCCAGAGACCACCTTTGAAGTGTATGTTGAAGTGGCCTGTCCTAGGACAGGTGGCACTCTTTCAG------------- 
DENND1A.X3_BOVINE    GCAAAACCCAGAGACCACCTTTGAAGTGTATGTTGAAGTGGCCTGTCCTAGGACAGGTGGCACTCTTTCAG------------- 
DENND1A.X4_BOVINE    GCAAAACCCAGAGACCACCTTTGAAGTGTATGTTGAAGTGGCCTGTCCTAGGACAGGTGGCACTCTTTCAG------------- 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 



















































DENND1A_BOVINE     ATCCTGAGGTGCAGAGGCAATTCCCGGAGGACTACAGTGACCAGgttcggaatg……………………………………………tttctctccacag 
DENND1A.V1_HUMAN    ATCCTGAGGTGCAGAGGCAATTCCCGGAGGACTACAGTGACCAGgttcggaatg……………………………………………tttctctccacag 
DENND1A.X1_BOVINE    ATCCTGAGGTGCAGAGGCAATTCCCGGAGGACTACAGTGACCAG---------------------------------------- 
DENND1A.X2_BOVINE    ATCCTGAGGTGCAGAGGCAATTCCCGGAGGACTACAGTGACCAG---------------------------------------- 
DENND1A.X3_BOVINE    ATCCTGAGGTGCAGAGGCAATTCCCGGAGGACTACAGTGACCAG---------------------------------------- 
DENND1A.X4_BOVINE    ATCCTGAGGTGCAGAGGCAATTCCCGGAGGACTACAGTGACCAG---------------------------------------- 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     GAAGTTCTACAGACTCTGACCAAGTTTTGTTTCCCCTTCTATGTGGACAGgtagtatcagattt………………………ctttggcgcag 
DENND1A.V1_HUMAN    GAAGTTCTACAGACTTTGACCAAGTTTTGTTTCCCCTTCTATGTGGACAGgtagtatcagattt………………………ctttgctgcag 
DENND1A.X1_BOVINE    GAAGTTCTACAGACTCTGACCAAGTTTTGTTTCCCCTTCTATGTGGACAG---------------------------------- 
DENND1A.X2_BOVINE    GAAGTTCTACAGACTCTGACCAAGTTTTGTTTCCCCTTCTATGTGGACAG---------------------------------- 
DENND1A.X3_BOVINE    GAAGTTCTACAGACTCTGACCAAGTTTTGTTTCCCCTTCTATGTGGACAG---------------------------------- 
DENND1A.X4_BOVINE    GAAGTTCTACAGACTCTGACCAAGTTTTGTTTCCCCTTCTATGTGGACAG---------------------------------- 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     CCTCACAGTTAGCCAAGTTGGCCAGAACTTCACATTCGTGCTCACTGACATTGACAGCAAACAGAGATTCGGGTTCTGCCGCTT  
DENND1A.V1_HUMAN    CCTCACAGTTAGCCAAGTTGGCCAGAACTTCACATTCGTGCTCACTGACATTGACAGCAAACAGAGATTCGGGTTCTGCCGCTT 
DENND1A.X1_BOVINE    CCTCACAGTTAGCCAAGTTGGCCAGAACTTCACATTCGTGCTCACTGACATTGACAGCAAACAGAGATTCGGGTTCTGCCGCTT 
DENND1A.X2_BOVINE    CCTCACAGTTAGCCAAGTTGGCCAGAACTTCACATTCGTGCTCACTGACATTGACAGCAAACAGAGATTCGGGTTCTGCCGCTT 
DENND1A.X3_BOVINE    CCTCACAGTTAGCCAAGTTGGCCAGAACTTCACATTCGTGCTCACTGACATTGACAGCAAACAGAGATTCGGGTTCTGCCGCTT 
DENND1A.X4_BOVINE    CCTCACAGTTAGCCAAGTTGGCCAGAACTTCACATTCGTGCTCACTGACATTGACAGCAAACAGAGATTCGGGTTCTGCCGCTT 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     ATCTTCAGGAGCAAAGAGTTGCTTCTGTATCTTAAGgtaaggaaaatgg………………………………………………………tcttcttccctcag 
DENND1A.V1_HUMAN    ATCTTCAGGAGCGAAGAGCTGCTTCTGTATCTTAAGgtaagggagaagg………………………………………………………tcttcttcctccag 
DENND1A.X1_BOVINE    ATCTTCAGGAGCAAAGAGTTGCTTCTGTATCTTAAG------------------------------------------------ 
DENND1A.X2_BOVINE    ATCTTCAGGAGCAAAGAGTTGCTTCTGTATCTTAAG------------------------------------------------ 
DENND1A.X3_BOVINE    ATCTTCAGGAGCAAAGAGTTGCTTCTGTATCTTAAG------------------------------------------------ 
DENND1A.X4_BOVINE    ATCTTCAGGAGCAAAGAGTTGCTTCTGTATCTTAAG------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     CTATCTCCCCTGGTTCGAAGTATTTTATAAGCTACTTAACATCTTGGCAGATTACACGACAAAAGGACAGgtat…………tttcag 
DENND1A.V1_HUMAN    CTATCTCCCCTGGTTCGAGGTATTTTATAAGCTGCTTAACATCCTGGCAGATTACACGACAAAAAGACAGgtat…………tttcag 
DENND1A.X1_BOVINE    CTATCTCCCCTGGTTCGAAGTATTTTATAAGCTACTTAACATCTTGGCAGATTACACGACAAAAGGACAG-------------- 
DENND1A.X2_BOVINE    CTATCTCCCCTGGTTCGAAGTATTTTATAAGCTACTTAACATCTTGGCAGATTACACGACAAAAGGACAG-------------- 
DENND1A.X3_BOVINE    CTATCTCCCCTGGTTCGAAGTATTTTATAAGCTACTTAACATCTTGGCAGATTACACGACAAAAGGACAG-------------- 
DENND1A.X4_BOVINE    CTATCTCCCCTGGTTCGAAGTATTTTATAAGCTACTTAACATCTTGGCAGATTACACGACAAAAGGACAG-------------- 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     GAGAGTCAGTGGAATGAGCTTCTTGAAACTCTGTACAAACTTCCTATCCCTGACCCAGGAGTGTCTGTTCATCTCAGTGTGg…ag 
DENND1A.V1_HUMAN    GAAAATCAGTGGAATGAGCTTCTTGAAACTCTGCACAAACTTCCCATCCCTGACCCAGGAGTGTCTGTCCATCTCAGCGTGg…ag 
DENND1A.X1_BOVINE    GAGAGTCAGTGGAATGAGCTTCTTGAAACTCTGTACAAACTTCCTATCCCTGACCCAGGAGTGTCTGTTCATCTCAGTGTG--- 
DENND1A.X2_BOVINE    GAGAGTCAGTGGAATGAGCTTCTTGAAACTCTGTACAAACTTCCTATCCCTGACCCAGGAGTGTCTGTTCATCTCAGTGTG--- 
DENND1A.X3_BOVINE    GAGAGTCAGTGGAATGAGCTTCTTGAAACTCTGTACAAACTTCCTATCCCTGACCCAGGAGTGTCTGTTCATCTCAGTGTG--- 
DENND1A.X4_BOVINE    GAGAGTCAGTGGAATGAGCTTCTTGAAACTCTGTACAAACTTCCTATCCCTGACCCAGGAGTGTCTGTTCATCTCAGTGTG--- 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     CATTCTTATTTTACTGTGCCTGATACCAGAGAACTTCCCAGCATCCCTGAGAATgtaagtactt…………………………tttctcctag 
DENND1A.V1_HUMAN    CATTCTTATTTTACTGTGCCTGATACCAGAGAACTTCCCAGCATACCTGAGAATgtaagtactt…………………………tttctcctag 
DENND1A.X1_BOVINE    CATTCTTATTTTACTGTGCCTGATACCAGAGAACTTCCCAGCATCCCTGAGAAT------------------------------ 
DENND1A.X2_BOVINE    CATTCTTATTTTACTGTGCCTGATACCAGAGAACTTCCCAGCATCCCTGAGAAT------------------------------ 
DENND1A.X3_BOVINE    CATTCTTATTTTACTGTGCCTGATACCAGAGAACTTCCCAGCATCCCTGAGAAT------------------------------ 
DENND1A.X4_BOVINE    CATTCTTATTTTACTGTGCCTGATACCAGAGAACTTCCCAGCATCCCTGAGAAT------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 

















































DENND1A_BOVINE     AGAAATCTGACAGAATATTTTGTGGCTGTGGATGTAAACAACATGTTACATCTGTATGCCAGTATGCTCTACGAACGCCGGATA 
DENND1A.V1_HUMAN    AGAAATCTGACAGAATATTTTGTGGCTGTGGATGTTAACAACATGTTGCATCTGTACGCCAGTATGCTGTACGAACGCCGGATA 
DENND1A.X1_BOVINE    AGAAATCTGACAGAATATTTTGTGGCTGTGGATGTAAACAACATGTTACATCTGTATGCCAGTATGCTCTACGAACGCCGGATA 
DENND1A.X2_BOVINE    AGAAATCTGACAGAATATTTTGTGGCTGTGGATGTAAACAACATGTTACATCTGTATGCCAGTATGCTCTACGAACGCCGGATA 
DENND1A.X3_BOVINE    AGAAATCTGACAGAATATTTTGTGGCTGTGGATGTAAACAACATGTTACATCTGTATGCCAGTATGCTCTACGAACGCCGGATA 
DENND1A.X4_BOVINE    AGAAATCTGACAGAATATTTTGTGGCTGTGGATGTAAACAACATGTTACATCTGTATGCCAGTATGCTCTACGAACGCCGGATA 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     CTCATCATTTGCAGCAAACTCAGCACTgtgagtagacagtctt……………………………………………………aatctttaatctctgttgcag 
DENND1A.V1_HUMAN    CTCATCATTTGCAGCAAACTCAGCACTgtgagtagacagtctt……………………………………………………ctctgctttgctctgttccag 
DENND1A.X1_BOVINE    CTCATCATTTGCAGCAAACTCAGCACT--------------------------------------------------------- 
DENND1A.X2_BOVINE    CTCATCATTTGCAGCAAACTCAGCACT--------------------------------------------------------- 
DENND1A.X3_BOVINE    CTCATCATTTGCAGCAAACTCAGCACT--------------------------------------------------------- 
DENND1A.X4_BOVINE    CTCATCATTTGCAGCAAACTCAGCACT--------------------------------------------------------- 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     TTGACTGCCTGCATCCACGGGTCTGCTGCGATGCTCTACCCCATGTTCTGGCAGCACGTGTACATCCCTGTCCTGCCTCCACAT  
DENND1A.V1_HUMAN    CTGACTGCCTGCATCCACGGGTCTGCGGCGATGCTCTACCCCATGTACTGGCAGCACGTGTACATCCCCGTGCTGCCGCCGCAT 
DENND1A.X1_BOVINE    TTGACTGCCTGCATCCACGGGTCTGCTGCGATGCTCTACCCCATGTTCTGGCAGCACGTGTACATCCCTGTCCTGCCTCCACAT 
DENND1A.X2_BOVINE    TTGACTGCCTGCATCCACGGGTCTGCTGCGATGCTCTACCCCATGTTCTGGCAGCACGTGTACATCCCTGTCCTGCCTCCACAT 
DENND1A.X3_BOVINE    TTGACTGCCTGCATCCACGGGTCTGCTGCGATGCTCTACCCCATGTTCTGGCAGCACGTGTACATCCCTGTCCTGCCTCCACAT 
DENND1A.X4_BOVINE    TTGACTGCCTGCATCCACGGGTCTGCTGCGATGCTCTACCCCATGTTCTGGCAGCACGTGTACATCCCTGTCCTGCCTCCACAT 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     CTGCTGGACTACTGCTGgtaaggccactg……………………………………………………………………………………………gtctctgtttctcttcacag 
DENND1A.V1_HUMAN    CTGCTGGACTACTGCTGgtaaggccactg……………………………………………………………………………………………gtctctgtttctcttcacag 
DENND1A.X1_BOVINE    CTGCTGGACTACTGCTG------------------------------------------------------------------- 
DENND1A.X2_BOVINE    CTGCTGGACTACTGCTG------------------------------------------------------------------- 
DENND1A.X3_BOVINE    CTGCTGGACTACTGCTG------------------------------------------------------------------- 
DENND1A.X4_BOVINE    CTGCTGGACTACTGCTG------------------------------------------------------------------- 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     TGCTCCCATGCCCTACCTCATAGGAATCCATTTAAGTTTAATGGAGgtaagttgacttct………………………………ttttacttgcag 
DENND1A.V1_HUMAN    TGCTCCCATGCCCTACCTCATAGGAATCCATTTAAGTTTAATGGAGgtaagttgacttct………………………………ttctccttgcag 
DENND1A.X1_BOVINE    TGCTCCCATGCCCTACCTCATAGGAATCCATTTAAGTTTAATGGAG-------------------------------------- 
DENND1A.X2_BOVINE    TGCTCCCATGCCCTACCTCATAGGAATCCATTTAAGTTTAATGGAG-------------------------------------- 
DENND1A.X3_BOVINE    TGCTCCCATGCCCTACCTCATAGGAATCCATTTAAGTTTAATGGAG-------------------------------------- 
DENND1A.X4_BOVINE    TGCTCCCATGCCCTACCTCATAGGAATCCATTTAAGTTTAATGGAG-------------------------------------- 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     AAAGTCAGAAGCATGGCCCTGGATGATGTCGTGATCCTGAATGTGGACACCAACACCCTGGAAACCCCCTTTGATGACCTCCAG  
DENND1A.V1_HUMAN    AAAGTCAGAAACATGGCCCTGGATGATGTCGTGATCCTGAATGTGGACACCAACACCCTGGAAACCCCCTTCGATGACCTCCAG 
DENND1A.X1_BOVINE    AAAGTCAGAAGCATGGCCCTGGATGATGTCGTGATCCTGAATGTGGACACCAACACCCTGGAAACCCCCTTTGATGACCTCCAG 
DENND1A.X2_BOVINE    AAAGTCAGAAGCATGGCCCTGGATGATGTCGTGATCCTGAATGTGGACACCAACACCCTGGAAACCCCCTTTGATGACCTCCAG 
DENND1A.X3_BOVINE    AAAGTCAGAAGCATGGCCCTGGATGATGTCGTGATCCTGAATGTGGACACCAACACCCTGGAAACCCCCTTTGATGACCTCCAG 
DENND1A.X4_BOVINE    AAAGTCAGAAGCATGGCCCTGGATGATGTCGTGATCCTGAATGTGGACACCAACACCCTGGAAACCCCCTTTGATGACCTCCAG 
DENND1A.X1-4_F     --------------------------TGTCGTGATCCTGAATGTGG-------------------------------------- 
DENND1A.X1-4_R     ---------------------------------------------------------------------------------CAG 
 
 
DENND1A_BOVINE     AGCCTCCCAAATGATGTGgtgggtaatgagctctcgagt…………………………………………………………………………ctcctttctgtcatcag 
DENND1A.V1_HUMAN    AGCCTCCCAAACGACGTGgtaggtaatgagcttgcgagg…………………………………………………………………………cttctctccatcaccag 
DENND1A.X1_BOVINE    AGCCTCCCAAATGATGTG------------------------------------------------------------------ 
DENND1A.X2_BOVINE    AGCCTCCCAAATGATGTG------------------------------------------------------------------ 
DENND1A.X3_BOVINE    AGCCTCCCAAATGATGTG------------------------------------------------------------------ 
DENND1A.X4_BOVINE    AGCCTCCCAAATGATGTG------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 




















































DENND1A_BOVINE     ATCTCTTCCTTGAAGAGCCGGCTGAAGAAGGTGTCCACGACAACTGGTGATGGTGTGGCCAGAGCCTTCCTCAAGGCCCAGGCC 
DENND1A.V1_HUMAN    ATCTCTTCCCTGAAGAACAGGCTGAAAAAGGTCTCCACAACCACTGGGGATGGTGTGGCCAGAGCGTTCCTCAAGGCCCAGGCT 
DENND1A.X1_BOVINE    ATCTCTTCCTTGAAGAGCCGGCTGAAGAAGGTGTCCACGACAACTGGTGATGGTGTGGCCAGAGCCTTCCTCAAGGCCCAGGCC 
DENND1A.X2_BOVINE    ATCTCTTCCTTGAAGAGCCGGCTGAAGAAGGTGTCCACGACAACTGGTGATGGTGTGGCCAGAGCCTTCCTCAAGGCCCAGGCC 
DENND1A.X3_BOVINE    ATCTCTTCCTTGAAGAGCCGGCTGAAGAAGGTGTCCACGACAACTGGTGATGGTGTGGCCAGAGCCTTCCTCAAGGCCCAGGCC 
DENND1A.X4_BOVINE    ATCTCTTCCTTGAAGAGCCGGCTGAAGAAGGTGTCCACGACAACTGGTGATGGTGTGGCCAGAGCCTTCCTCAAGGCCCAGGCC 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     GCTTTCTTCGGCAGCTACCGAAACGCTCTGAAAATCGAGCCGgtgagtagc…………………………………………………tctctgtctcccag 
DENND1A.V1_HUMAN    GCTTTCTTCGGTAGCTACCGAAACGCTCTGAAAATCGAGCCGgtgagtagc…………………………………………………tctctgtctcccag 
DENND1A.X1_BOVINE    GCTTTCTTCGGCAGCTACCGAAACGCTCTGAAAATCGAGCCG------------------------------------------ 
DENND1A.X2_BOVINE    GCTTTCTTCGGCAGCTACCGAAACGCTCTGAAAATCGAGCCG------------------------------------------ 
DENND1A.X3_BOVINE    GCTTTCTTCGGCAGCTACCGAAACGCTCTGAAAATCGAGCCG------------------------------------------ 
DENND1A.X4_BOVINE    GCTTTCTTCGGCAGCTACCGAAACGCTCTGAAAATCGAGCCG------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     GAGGAGCCAATCACCTTCTGCGAGGAAGCCTTCGTGTCGCACTATCGCTCAGGAGCCATGAGGCAGTTCCTGCAGAATGCCACC 
DENND1A.V1_HUMAN    GAGGAGCCGATCACTTTCTGTGAGGAAGCCTTCGTGTCCCACTACCGCTCCGGAGCCATGAGGCAGTTCCTGCAGAACGCCACA 
DENND1A.X1_BOVINE    GAGGAGCCAATCACCTTCTGCGAGGAAGCCTTCGTGTCGCACTATCGCTCAGGAGCCATGAGGCAGTTCCTGCAGAATGCCACC 
DENND1A.X2_BOVINE    GAGGAGCCAATCACCTTCTGCGAGGAAGCCTTCGTGTCGCACTATCGCTCAGGAGCCATGAGGCAGTTCCTGCAGAATGCCACC 
DENND1A.X3_BOVINE    GAGGAGCCAATCACCTTCTGCGAGGAAGCCTTCGTGTCGCACTATCGCTCAGGAGCCATGAGGCAGTTCCTGCAGAATGCCACC 
DENND1A.X4_BOVINE    GAGGAGCCAATCACCTTCTGCGAGGAAGCCTTCGTGTCGCACTATCGCTCAGGAGCCATGAGGCAGTTCCTGCAGAATGCCACC 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     CAGCTGCAGCTCTTTAAACAGgtgcccagcctcccttg………………………………………………………………………………ttctttctttgtatag 
DENND1A.V1_HUMAN    CAGCTGCAGCTCTTCAAGCAGgtgcctc-cctccctgg………………………………………………………………………………ttccttctttctatag 
DENND1A.X1_BOVINE    CAGCTGCAGCTCTTTAAACAG--------------------------------------------------------------- 
DENND1A.X2_BOVINE    CAGCTGCAGCTCTTTAAACAG--------------------------------------------------------------- 
DENND1A.X3_BOVINE    CAGCTGCAGCTCTTTAAACAG--------------------------------------------------------------- 
DENND1A.X4_BOVINE    CAGCTGCAGCTCTTTAAACAG--------------------------------------------------------------- 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     TTTATCGATGGTAGATTAGACCTTCTCAATTCTGGCGAGGGCTTCAGTGATGTTTTTGAAGAGGAGATCAACATGAGCGAGTAT 
DENND1A.V1_HUMAN    TTTATTGATGGTCGATTAGATCTTCTCAATTCCGGCGAAGGTTTCAGTGATGTTTTTGAAGAGGAAATCAACATGGGCGAGTAC 
DENND1A.X1_BOVINE    TTTATCGATGGTAGATTAGACCTTCTCAATTCTGGCGAGGGCTTCAGTGATGTTTTTGAAGAGGAGATCAACATGAGCGAGTAT 
DENND1A.X2_BOVINE    TTTATCGATGGTAGATTAGACCTTCTCAATTCTGGCGAGGGCTTCAGTGATGTTTTTGAAGAGGAGATCAACATGAGCGAGTAT 
DENND1A.X3_BOVINE    TTTATCGATGGTAGATTAGACCTTCTCAATTCTGGCGAGGGCTTCAGTGATGTTTTTGAAGAGGAGATCAACATGAGCGAGTAT 
DENND1A.X4_BOVINE    TTTATCGATGGTAGATTAGACCTTCTCAATTCTGGCGAGGGCTTCAGTGATGTTTTTGAAGAGGAGATCAACATGAGCGAGTAT 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     GCTGgtaagg-gcagttcatttttcttta…………………………………………………………………………………cttctctgcctcctctttccccag 
DENND1A.V1_HUMAN    GCTGgtgagaagcaactcattttccttcc…………………………………………………………………………………cttctctgaattctctttccccag 
DENND1A.X1_BOVINE    GCTG-------------------------------------------------------------------------------- 
DENND1A.X2_BOVINE    GCTG-------------------------------------------------------------------------------- 
DENND1A.X3_BOVINE    GCTG-------------------------------------------------------------------------------- 
DENND1A.X4_BOVINE    GCTG-------------------------------------------------------------------------------- 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     GGAGTGATAAGCTATACCACCAGTGGCTCTCCACAGTCCGGgtaag—tgccaccccc………………………………………tttttattatag 
DENND1A.V1_HUMAN    GCAGTGACAAACTGTACCATCAGTGGCTCTCCACTGTCCGGgtaagcatgcacccaa………………………………………tttttattatag 
DENND1A.X1_BOVINE    GGAGTGATAAGCTATACCACCAGTGGCTCTCCACAGTCCGG------------------------------------------- 
DENND1A.X2_BOVINE    GGAGTGATAAGCTATACCACCAGTGGCTCTCCACAGTCCGG------------------------------------------- 
DENND1A.X3_BOVINE    GGAGTGATAAGCTATACCACCAGTGGCTCTCCACAGTCCGG------------------------------------------- 
DENND1A.X4_BOVINE    GGAGTGATAAGCTATACCACCAGTGGCTCTCCACAGTCCGG------------------------------------------- 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 


























































DENND1A_BOVINE     AAAGGAAGTGGAGCAATTTTGAATACTGTAAAAACGAAAGCAAACCCGGCCATGAAGACTGTCTATAAGTTCgtaa…………gcag 
DENND1A.V1_HUMAN    AAAGGAAGTGGAGCAATTCTGAATACTGTAAAGACCAAAGCAAATCCGGCCATGAAGACTGTCTACAAGTTCgtaa…………gcag 
DENND1A.X1_BOVINE    AAAGGAAGTGGAGCAATTTTGAATACTGTAAAAACGAAAGCAAACCCGGCCATGAAGACTGTCTATAAGTTC------------ 
DENND1A.X2_BOVINE    AAAGGAAGTGGAGCAATTTTGAATACTGTAAAAACGAAAGCAAACCCGGCCATGAAGACTGTCTATAAGTTC------------ 
DENND1A.X3_BOVINE    AAAGGAAGTGGAGCAATTTTGAATACTGTAAAAACGAAAGCAAACCCGGCCATGAAGACTGTCTATAAGTTC------------ 
DENND1A.X4_BOVINE    AAAGGAAGTGGAGCAATTTTGAATACTGTAAAAACGAAAGCAAACCCGGCCATGAAGACTGTCTATAAGTTC------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     GCAAAAGATCATGCAAAAATGGGAATAAAAGAGGTGAAAAACCGCTTGAAGCAAAAGgtacttgaag……………………tccttgcag 
DENND1A.V1_HUMAN    GCAAAAGATCATGCAAAAATGGGAATAAAAGAGGTGAAAAACCGCTTGAAGCAAAAGgtacttgaag……………………tccctacag 
DENND1A.X1_BOVINE    GCAAAAGATCATGCAAAAATGGGAATAAAAGAGGTGAAAAACCGCTTGAAGCAAAAG--------------------------- 
DENND1A.X2_BOVINE    GCAAAAGATCATGCAAAAATGGGAATAAAAGAGGTGAAAAACCGCTTGAAGCAAAAG--------------------------- 
DENND1A.X3_BOVINE    GCAAAAGATCATGCAAAAATGGGAATAAAAGAGGTGAAAAACCGCTTGAAGCAAAAG--------------------------- 
DENND1A.X4_BOVINE    GCAAAAGATCATGCAAAAATGGGAATAAAAGAGGTGAAAAACCGCTTGAAGCAAAAG--------------------------- 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     GACATCACTGAGAATGGCTGTGCCCCCACCACAGAAGAGCAGCTGCCAAAGACTGTGCCGTCCCCACTGGTAGAGGCCAAGGAC 
DENND1A.V1_HUMAN    GACATTGCCGAGAATGGCTGCGCCCCCACCCCAGAAGAGCAGCTGCCAAAGACTGCACCGTCCCCACTGGTGGAGGCCAAGGAC 
DENND1A.X1_BOVINE    GACATCACTGAGAATGGCTGTGCCCCCACCACAGAAGAGCAGCTGCCAAAGACTGTGCCGTCCCCACTGGTAGAGGCCAAGGAC 
DENND1A.X2_BOVINE    GACATCACTGAGAATGGCTGTGCCCCCACCACAGAAGAGCAGCTGCCAAAGACTGTGCCGTCCCCACTGGTAGAGGCCAAGGAC 
DENND1A.X3_BOVINE    GACATCACTGAGAATGGCTGTGCCCCCACCACAGAAGAGCAGCTGCCAAAGACTGTGCCGTCCCCACTGGTAGAGGCCAAGGAC 
DENND1A.X4_BOVINE    GACATCACTGAGAATGGCTGTGCCCCCACCACAGAAGAGCAGCTGCCAAAGACTGTGCCGTCCCCACTGGTAGAGGCCAAGGAC 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     CCCAAGTTCCGAGAGGACCGGCGGCCAATCACAGTCCACTTTGGACAGgtatgta…………cagccacagagactccgtcccactc 
DENND1A.V1_HUMAN    CCCAAGCTCCGAGAAGACCGGCGGCCAATCACAGTCCACTTTGGACAGgtgtgta…………cagctgcagagactgcgtcccaccc 
DENND1A.X1_BOVINE    CCCAAGTTCCGAGAGGACCGGCGGCCAATCACAGTCCACTTTGGACAG--------------CCACAGAGACTCCGTCCCACTC 
DENND1A.X2_BOVINE    CCCAAGTTCCGAGAGGACCGGCGGCCAATCACAGTCCACTTTGGACAG------------------------------------ 
DENND1A.X3_BOVINE    CCCAAGTTCCGAGAGGACCGGCGGCCAATCACAGTCCACTTTGGACAG--------------CCACAGAGACTCCGTCCCACTC 
DENND1A.X4_BOVINE    CCCAAGTTCCGAGAGGACCGGCGGCCAATCACAGTCCACTTTGGACAG------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     gcccactgcctcccaagatacagcgctcgaggcccgtgagtag………………………………………………attttcccc-atgcccattctag 
DENND1A.V1_HUMAN    g---accgcctcccaagatacagcgctcgaggcccgtgagtag………………………………………………ctctccccctgtacctcctctag 
DENND1A.X1_BOVINE    GCCCACTGCCTCCCAAGATACAGCGCTCGAGGCCC------------------------------------------------- 
DENND1A.X2_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X3_BOVINE    GCCCACTGCCTCCCAAGATACAGCGCTCGAGGCCC------------------------------------------------- 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     GTGCGCCCTCCCCGTCCACACGTCGTTAAAAGACCGAAGAGCAACATCACAGTGGAAGCCCGAAGGACGTCCGTCTCGAGCCCC 
DENND1A.V1_HUMAN    GTGCGCCCACCTCGTCCACATGTTGTTAAGAGACCAAAGAGCAACATCGCAGTGGAAGGCCGGAGGACGTCTGTGCCGAGCCCT 
DENND1A.X1_BOVINE    GTGCGCCCTCCCCGTCCACACGTCGTTAAAAGACCGAAGAGCAACATCACAGTGGAAGCCCGAAGGACGTCCGTCTCGAGCCCC 
DENND1A.X2_BOVINE    GTGCGCCCTCCCCGTCCACACGTCGTTAAAAGACCGAAGAGCAACATCACAGTGGAAGCCCGAAGGACGTCCGTCTCGAGCCCC 
DENND1A.X3_BOVINE    GTGCGCCCTCCCCGTCCACACGTCGTTAAAAGACCGAAGAGCAACATCACAGTGGAAGCCCGAAGGACGTCCGTCTCGAGCCCC 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     GACCAgtgagtac……………gccccagcctcgtaaggcccttgcgacactatgctgtcttcctctccgaagactcctctgacgatg 
DENND1A.V1_HUMAN    GAGCAgtgagtat……………gccccagcctggtaaagcccttgcgacactatgcggtcttcctctccgaagactcctctgatgatg 
DENND1A.X1_BOVINE    GACCA--------------------CCTCGTAAGGCCCTTGCGACACTATGCTGTCTTCCTCTCCGAAGACTCCTCTGACGATG 
DENND1A.X2_BOVINE    GACCA--------------------CCTCGTAAGGCCCTTGCGACACTATGCTGTCTTCCTCTCCGAAGACTCCTCTGACGATG 
DENND1A.X3_BOVINE    GACCA-------------------------------------------------------------------------------
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 












































DENND1A_BOVINE     agtgccagcgggaagagggcccgagctctggcttcaccgaaagctttttcttctccactccctttgaatggtctc…ccccccag 
DENND1A.V1_HUMAN    aatgccagcgggaagagggcccgagctctggcttcaccgagagctttttcttctccgctccctttgaatggtctc…cccgacag 
DENND1A.X1_BOVINE    AGTGCCAGCGGGAAGAGGGCCCGAGCTCTGGCTTCACCGAAAGCTTTTTCTTCTCCACTCCCTTTGAATGG------------- 
DENND1A.X2_BOVINE    AGTGCCAGCGGGAAGAGGGCCCGAGCTCTGGCTTCACCGAAAGCTTTTTCTTCTCCACTCCCTTTGAATGG------------- 
DENND1A.X3_BOVINE    ------------------------------------------------------------------------------------
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     GCCACAGCCATATCGGACACTCAAGGAGTCAGACAGTGC---AGGGGACGAGGCCGAAAGCCCGGAGCAGCGAGCGCGGGAGCC 
DENND1A.V1_HUMAN    GCCGCAGCCGTATCGGACACTCAGGGAGTCAGACAGCGCGGAAGGCGACGAGGCAGAGAGTCCAGAGCAGCAAGTGCGGAAGTC 
DENND1A.X1_BOVINE    -CCACAGCCATATCGGACACTCAAGGAGTCAGACAGTGC---AGGGGACGAGGCCGAAAGCCCGGAGCAGCGAGCGCGGGAGCC 
DENND1A.X2_BOVINE    -CCACAGCCATATCGGACACTCAAGGAGTCAGACAGTGC---AGGGGACGAGGCCGAAAGCCCGGAGCAGCGAGCGCGGGAGCC 
DENND1A.X3_BOVINE    GCCACAGCCATATCGGACACTCAAGGAGTCAGACAGTGC---AGGGGACGAGGCCGAAAGCCCGGAGCAGCGAGCGCGGGAGCC 
DENND1A.X4_BOVINE    GCCACAGCCATATCGGACACTCAAGGAGTCAGACAGTGC---AGGGGACGAGGCCGAAAGCCCGGAGCAGCGAGCGCGGGAGCC 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     TGTGGGCCCCACCCCAGCTCCACACGACCGGGCCGCCAGCATCAACCTCCTGGAGGATGTCTTCAGCAACCTCGACATGGAAGT 
DENND1A.V1_HUMAN    CACAGGCCCTGTCCCAGCTCCCCCTGACCGGGCTGCCAGCATCGACCTTCTGGAAGACGTCTTCAGCAACCTGGACATGGAGGC 
DENND1A.X1_BOVINE    TGTGGGCCCCACCCCAGCTCCACACGACCGGGCCGCCAGCATCAACCTCCTGGAGGATGTCTTCAGCAACCTCGACATGGAAGT 
DENND1A.X2_BOVINE    TGTGGGCCCCACCCCAGCTCCACACGACCGGGCCGCCAGCATCAACCTCCTGGAGGATGTCTTCAGCAACCTCGACATGGAAGT 
DENND1A.X3_BOVINE    TGTGGGCCCCACCCCAGCTCCACACGACCGGGCCGCCAGCATCAACCTCCTGGAGGATGTCTTCAGCAACCTCGACATGGAAGT 
DENND1A.X4_BOVINE    TGTGGGCCCCACCCCAGCTCCACACGACCGGGCCGCCAGCATCAACCTCCTGGAGGATGTCTTCAGCAACCTCGACATGGAAGT 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     CCCGCTGCAGCAGCTGGGCCAGGCCAAAAGCTTGGAAGACCTTCGGACCCCCAAAGACCTGAGGGAGCAGCCGGGGACCTTTGA 
DENND1A.V1_HUMAN    CGCACTGCAGCCACTGGGCCAGGCCAAGAGCTTAGAGGACCTTCGTGCCCCCAAAGACCTGAGGGAGCAGCCAGGGACCTTTGA 
DENND1A.X1_BOVINE    CCCGCTGCAGCAGCTGGGCCAGGCCAAAAGCTTGGAAGACCTTCGGACCCCCAAAGACCTGAGGGAGCAGCCGGGGACCTTTGA 
DENND1A.X2_BOVINE    CCCGCTGCAGCAGCTGGGCCAGGCCAAAAGCTTGGAAGACCTTCGGACCCCCAAAGACCTGAGGGAGCAGCCGGGGACCTTTGA 
DENND1A.X3_BOVINE    CCCGCTGCAGCAGCTGGGCCAGGCCAAAAGCTTGGAAGACCTTCGGACCCCCAAAGACCTGAGGGAGCAGCCGGGGACCTTTGA 
DENND1A.X4_BOVINE    CCCGCTGCAGCAGCTGGGCCAGGCCAAAAGCTTGGAAGACCTTCGGACCCCCAAAGACCTGAGGGAGCAGCCGGGGACCTTTGA 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     CTATCAGgtatgg--tggttggag………………………………………………………………………gcagtcattgcctccctcgctctctcc-ggcag 
DENND1A.V1_HUMAN    CTATCAGgtatggcatgggcaagg………………………………………………………………………gtggtcactgccgccctccttccctcccaacag 
DENND1A.X1_BOVINE    CTATCAG----------------------------------------------------------------------------- 
DENND1A.X2_BOVINE    CTATCAG----------------------------------------------------------------------------- 
DENND1A.X3_BOVINE    CTATCAG----------------------------------------------------------------------------- 
DENND1A.X4_BOVINE    CTATCAG----------------------------------------------------------------------------- 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     AGGCTGGACCTGGGCAGAAGTGACAGGAGCCGTGGGACACCAGGGGCCTTGAAGCTCGCCCACCCGCACAGCAGGCTCTGGAGC 
DENND1A.V1_HUMAN    AGGCTGGATCTGGGCGGGAGTGAGAGGAGCCGCGGGGTGACAGTGGCCTTGAAGCTTACCCACCCGTACAACAAGCTCTGGAGC 
DENND1A.X1_BOVINE    AGGCTGGACCTGGGCAGAAGTGACAGGAGCCGTGGGACACCAGGGGCCTTGAAGCTCGCCCACCCGCACAGCAGGCTCTGGAGC 
DENND1A.X2_BOVINE    AGGCTGGACCTGGGCAGAAGTGACAGGAGCCGTGGGACACCAGGGGCCTTGAAGCTCGCCCACCCGCACAGCAGGCTCTGGAGC 
DENND1A.X3_BOVINE    AGGCTGGACCTGGGCAGAAGTGACAGGAGCCGTGGGACACCAGGGGCCTTGAAGCTCGCCCACCCGCACAGCAGGCTCTGGAGC 
DENND1A.X4_BOVINE    AGGCTGGACCTGGGCAGAAGTGACAGGAGCCGTGGGACACCAGGGGCCTTGAAGCTCGCCCACCCGCACAGCAGGCTCTGGAGC 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     CTAGGCCAGGATGACATGGCCATCCCCAGCAAGCCGCCCGCCGCCTGCCCCGAGAAGCCCTCAGCCCTGCTCGGGAACTCCCTG 
DENND1A.V1_HUMAN    CTGGGCCAGGACGACATGGCCATCCCCAGCAAGCCCCCAGCTGCCTCCCCTGAGAAGCCCTCGGCCCTGCTCGGGAACTCCCTG 
DENND1A.X1_BOVINE    CTAGGCCAGGATGACATGGCCATCCCCAGCAAGCCGCCCGCCGCCTGCCCCGAGAAGCCCTCAGCCCTGCTCGGGAACTCCCTG 
DENND1A.X2_BOVINE    CTAGGCCAGGATGACATGGCCATCCCCAGCAAGCCGCCCGCCGCCTGCCCCGAGAAGCCCTCAGCCCTGCTCGGGAACTCCCTG 
DENND1A.X3_BOVINE    CTAGGCCAGGATGACATGGCCATCCCCAGCAAGCCGCCCGCCGCCTGCCCCGAGAAGCCCTCAGCCCTGCTCGGGAACTCCCTG 
DENND1A.X4_BOVINE    CTAGGCCAGGATGACATGGCCATCCCCAGCAAGCCGCCCGCCGCCTGCCCCGAG------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 


















DENND1A_BOVINE     GCCTCACCCTGCAGGCCCCAGAACCAGAATGGCCTCCTGAACCCCAGCGACAAGGAGGAGGTGCCCACACCCACCCTGGGCAGC 
DENND1A.V1_HUMAN    GCCCTGCCTCGAAGGCCCCAGAACCGGGACAGCATCCTGAACCCCAGTGACAAGGAGGAGGTGCCCACCCCTACTCTGGGCAGC 
DENND1A.X1_BOVINE    GCCTCACCCTGCAGGCCCCAGAACCAGAATGGCCTCCTGAACCCCAGCGACAAGGAGGAGGTGCCCACACCCACCCTGGGCAGC 
DENND1A.X2_BOVINE    GCCTCACCCTGCAGGCCCCAGAACCAGAATGGCCTCCTGAACCCCAGCGACAAGGAGGAGGTGCCCACACCCACCCTGGGCAGC 
DENND1A.X3_BOVINE    GCCTCACCCTGCAGGCCCCAGAACCAGAATGGCCTCCTGAACCCCAGCGACAAGGAGGAGGTGCCCACACCCACCCTGGGCAGC 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     ATCACTATCCCCCGGCCCCAGGGCAGGAAGACCCCAGAGCTGGGCATCGTGCCCCCGCCTCCTACTGCCCGCCCAGCCAAGCTC 
DENND1A.V1_HUMAN    ATCACCATCCCCCGGCCCCAAGGCAGGAAGACCCCAGAGCTGGGCATCGTGCCTCCACCGCCCATTCCCCGCCCGGCCAAGCTC 
DENND1A.X1_BOVINE    ATCACTATCCCCCGGCCCCAGGGCAGGAAGACCCCAGAGCTGGGCATCGTGCCCCCGCCTCCTACTGCCCGCCCAGCCAAGCTC 
DENND1A.X2_BOVINE    ATCACTATCCCCCGGCCCCAGGGCAGGAAGACCCCAGAGCTGGGCATCGTGCCCCCGCCTCCTACTGCCCGCCCAGCCAAGCTC 
DENND1A.X3_BOVINE    ATCACTATCCCCCGGCCCCAGGGCAGGAAGACCCCAGAGCTGGGCATCGTGCCCCCGCCTCCTACTGCCCGCCCAGCCAAGCTC 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     CAGGCCCCCGGCATCGCCCTTGGCGACTTCTTGGAACAACTGCCGGCTGAGCGGGAAAGGCGGGCTGCCCTCAGCTCAACCCCA 
DENND1A.V1_HUMAN    CAGGCTGCCGGCGCCGCACTTGGTGACGTCTCAGAGCGGCTGCAGACGGATCGGGACAGGCGAGCTGCCCTGAGTCC------- 
DENND1A.X1_BOVINE    CAGGCCCCCGGCATCGCCCTTGGCGACTTCTTGGAACAACTGCCGGCTGAGCGGGAAAGGCGGGCTGCCCTCAGCTCAACCCCA 
DENND1A.X2_BOVINE    CAGGCCCCCGGCATCGCCCTTGGCGACTTCTTGGAACAACTGCCGGCTGAGCGGGAAAGGCGGGCTGCCCTCAGCTCAACCCCA 
DENND1A.X3_BOVINE    CAGGCCCCCGGCATCGCCCTTGGCGACTTCTTGGAACAACTGCCGGCTGAGCGGGAAAGGCGGGCTGCCCTCAGCTCAACCCCA 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     TTCCCTGGGCTCCTCTCCAGTGCTGCACCCCAAGACCCCACTGAACTGCTCCAGCCACTCAGCCTGGCCCCAGGGGCTGCCGGC 
DENND1A.V1_HUMAN    -----AGGGCTCCTGCCTGGTGTTGTCCCCCAAGGCCCCACTGAACTGCTCCAGCCGCTCAGCCCTGGCCCCGGGGCTGCCGGC 
DENND1A.X1_BOVINE    TTCCCTGGGCTCCTCTCCAGTGCTGCACCCCAAGACCCCACTGAACTGCTCCAGCCACTCAGCCTGGCCCCAGGGGCTGCCGGC 
DENND1A.X2_BOVINE    TTCCCTGGGCTCCTCTCCAGTGCTGCACCCCAAGACCCCACTGAACTGCTCCAGCCACTCAGCCTGGCCCCAGGGGCTGCCGGC 
DENND1A.X3_BOVINE    TTCCCTGGGCTCCTCTCCAGTGCTGCACCCCAAGACCCCACTGAACTGCTCCAGCCACTCAGCCTGGCCCCAGGGGCTGCCGGC 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     AGCAGCAGTGATGCCCTGCTGGCCCTGCTGGATCCACTTAACACAACCTGGTCGGGCAGCTCCCTTCCACCAGGCCCTACAGCC 
DENND1A.V1_HUMAN    ACGAGCAGTGACGCCCTGCTCGCCCTCCTGGACCCGCTCAGCACAGCCTGGTCAGGCAGCACCCTCCCGTCACGCCCCGCCACC 
DENND1A.X1_BOVINE    AGCAGCAGTGATGCCCTGCTGGCCCTGCTGGATCCACTTAACACAACCTGGTCGGGCAGCTCCCTTCCACCAGGCCCTACAGCC 
DENND1A.X2_BOVINE    AGCAGCAGTGATGCCCTGCTGGCCCTGCTGGATCCACTTAACACAACCTGGTCGGGCAGCTCCCTTCCACCAGGCCCTACAGCC 
DENND1A.X3_BOVINE    AGCAGCAGTGATGCCCTGCTGGCCCTGCTGGATCCACTTAACACAACCTGGTCGGGCAGCTCCCTTCCACCAGGCCCTACAGCC 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     CCAAATGTAGCCACCCCATTTACTCCCCAATTTAGTTTTCCCCCCATGGGGACCCCCACCCCATTTCCACAGCCATCACTCAAC 
DENND1A.V1_HUMAN    CCGAATGTAGCCACCCCATTCACCCCCCAATTCAGCTTCCCCCCTGCAGGGACACCCACCCCATTCCCACAGCCACCACTCAAC 
DENND1A.X1_BOVINE    CCAAATGTAGCCACCCCATTTACTCCCCAATTTAGTTTTCCCCCCATGGGGACCCCCACCCCATTTCCACAGCCATCACTCAAC 
DENND1A.X2_BOVINE    CCAAATGTAGCCACCCCATTTACTCCCCAATTTAGTTTTCCCCCCATGGGGACCCCCACCCCATTTCCACAGCCATCACTCAAC 
DENND1A.X3_BOVINE    CCAAATGTAGCCACCCCATTTACTCCCCAATTTAGTTTTCCCCCCATGGGGACCCCCACCCCATTTCCACAGCCATCACTCAAC 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     CCCTTTGTCCCACCTCTGCCAGCGACACTGCCCACCATGCCCCTGGTCTCTGCACCAGCTGGGCCTTTTGGGGCCCCTCCTGCT 
DENND1A.V1_HUMAN    CCCTTTGTCCCATCCATGCCAGCAGCCCCACCCACCCTGCCCCTGGTCTCCACACCAGCCGGGCCTTTCGGGGCCCCTCCAGCT 
DENND1A.X1_BOVINE    CCCTTTGTCCCACCTCTGCCAGCGACACTGCCCACCATGCCCCTGGTCTCTGCACCAGCTGGGCCTTTTGGGGCCCCTCCTGCT 
DENND1A.X2_BOVINE    CCCTTTGTCCCACCTCTGCCAGCGACACTGCCCACCATGCCCCTGGTCTCTGCACCAGCTGGGCCTTTTGGGGCCCCTCCTGCT 
DENND1A.X3_BOVINE    CCCTTTGTCCCACCTCTGCCAGCGACACTGCCCACCATGCCCCTGGTCTCTGCACCAGCTGGGCCTTTTGGGGCCCCTCCTGCT 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 




















DENND1A_BOVINE     TCCCTGGGGCCAGCCTTTGCCCCCAGCCTCCTGCTGTCCAATTCTGGCTTCTGTGCCCCACATCGATCTCAGCCCAACCTGTCT 
DENND1A.V1_HUMAN    TCCCTGGGGCCGGCTTTTGCGTCCGGCCTCCTGCTGTCCAGTGCTGGCTTCTGTGCCCCTCACAGGTCTCAGCCCAACCTCTCC 
DENND1A.X1_BOVINE    TCCCTGGGGCCAGCCTTTGCCCCCAGCCTCCTGCTGTCCAATTCTGGCTTCTGTGCCCCACATCGATCTCAGCCCAACCTGTCT 
DENND1A.X2_BOVINE    TCCCTGGGGCCAGCCTTTGCCCCCAGCCTCCTGCTGTCCAATTCTGGCTTCTGTGCCCCACATCGATCTCAGCCCAACCTGTCT 
DENND1A.X3_BOVINE    TCCCTGGGGCCAGCCTTTGCCCCCAGCCTCCTGCTGTCCAATTCTGGCTTCTGTGCCCCACATCGATCTCAGCCCAACCTGTCT 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     GCCCTCTCCATGCCCAACCTCTTTGGCCAAGTGCCCATGGGTACCCAC------TCCCTGCAGCCTCTGGGTCCCCCAGCAGTC 
DENND1A.V1_HUMAN    GCCCTCTCCATGCCCAACCTCTTTGGCCAGATGCCCATGGGCACCCACACGAGCCCCCTACAGCCGCTGGGTCCCCCAGCAGTT 
DENND1A.X1_BOVINE    GCCCTCTCCATGCCCAACCTCTTTGGCCAAGTGCCCATGGGTACCCAC------TCCCTGCAGCCTCTGGGTCCCCCAGCAGTC 
DENND1A.X2_BOVINE    GCCCTCTCCATGCCCAACCTCTTTGGCCAAGTGCCCATGGGTACCCAC------TCCCTGCAGCCTCTGGGTCCCCCAGCAGTC 
DENND1A.X3_BOVINE    GCCCTCTCCATGCCCAACCTCTTTGGCCAAGTGCCCATGGGTACCCAC------TCCCTGCAGCCTCTGGGTCCCCCAGCAGTC 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     GCCCCCTCAAGGATCCGAACATTGCCCCTGGCCCGCTCAAGTGCCAGGGCCGCCGAGGCCAAGCAAGGGCTGGCCCTGAGGCCT 
DENND1A.V1_HUMAN    GCCCCGTCGAGGATCCGAACGTTGCCCCTGGCCCGCTCAAGTGCCAGGGCTGCTGAGACCAAGCAGGGGCTGGCCCTGAGGCCT 
DENND1A.X1_BOVINE    GCCCCCTCAAGGATCCGAACATTGCCCCTGGCCCGCTCAAGTGCCAGGGCCGCCGAGGCCAAGCAAGGGCTGGCCCTGAGGCCT 
DENND1A.X2_BOVINE    GCCCCCTCAAGGATCCGAACATTGCCCCTGGCCCGCTCAAGTGCCAGGGCCGCCGAGGCCAAGCAAGGGCTGGCCCTGAGGCCT 
DENND1A.X3_BOVINE    GCCCCCTCAAGGATCCGAACATTGCCCCTGGCCCGCTCAAGTGCCAGGGCCGCCGAGGCCAAGCAAGGGCTGGCCCTGAGGCCT 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     GGAGAACCCCCACTCCTCCCAGCCAGGCCCCCCCAGGGCCTGGAGCCAGCACTGCAGCCCTCTGCTCCACGAGAGGCCAGAGAC 
DENND1A.V1_HUMAN    GGAGACCCCCCGCTTCTGCCTCCCAGGCCCCCTCAAGGCCTGGAGCCAACACTGCAGCCCTCTGCTCCTCAACAGGCCAGAGAC 
DENND1A.X1_BOVINE    GGAGAACCCCCACTCCTCCCAGCCAGGCCCCCCCAGGGCCTGGAGCCAGCACTGCAGCCCTCTGCTCCACGAGAGGCCAGAGAC 
DENND1A.X2_BOVINE    GGAGAACCCCCACTCCTCCCAGCCAGGCCCCCCCAGGGCCTGGAGCCAGCACTGCAGCCCTCTGCTCCACGAGAGGCCAGAGAC 
DENND1A.X3_BOVINE    GGAGAACCCCCACTCCTCCCAGCCAGGCCCCCCCAGGGCCTGGAGCCAGCACTGCAGCCCTCTGCTCCACGAGAGGCCAGAGAC 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     CCCTTTGAGGATTTGTTACGGAAAACCAAGCAAGATGTGAGCTCG------------GCCCCAGCCCCCGGCTCCGTGGAGCAG 
DENND1A.V1_HUMAN    CCCTTTGAGGATTTGTTACAGAAAACCAAGCAAGACGTGAGCCCGAGTCCGGCCCTGGCCCCGGCCCCAGACTCGGTGGAGCAG 
DENND1A.X1_BOVINE    CCCTTTGAGGATTTGTTACGGAAAACCAAGCAAGATGTGAGCTCG------------GCCCCAGCCCCCGGCTCCGTGGAGCAG 
DENND1A.X2_BOVINE    CCCTTTGAGGATTTGTTACGGAAAACCAAGCAAGATGTGAGCTCG------------GCCCCAGCCCCCGGCTCCGTGGAGCAG 
DENND1A.X3_BOVINE    CCCTTTGAGGATTTGTTACGGAAAACCAAGCAAGATGTGAGCTCG------------GCCCCAGCCCCCGGCTCCGTGGAGCAG 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     CTCAGGAAGCAATGGGAGACCTTCGAGTGAGCAGC--GCTGAGGGTGGGGCGAG--CCAAGGCCGGCCGGCCCTGCTTCCCCTG 
DENND1A.V1_HUMAN    CTCAGGAAGCAGTGGGAGACCTTCGAGTGAGCCGGGCCCTGAGGGTGGGGGATGCACCGAGGCCCGAGGG---TCCGTCCACTG 
DENND1A.X1_BOVINE    CTCAGGAAGCAATGGGAGACCTTCGAGTGAGCAGC--GCTGAGGGTGGGGCGAG--CCAAGGCCGGCCGGCCCTGCTTCCCCTG 
DENND1A.X2_BOVINE    CTCAGGAAGCAATGGGAGACCTTCGAGTGAGCAGC--GCTGAGGGTGGGGCGAG--CCAAGGCCGGCCGGCCCTGCTTCCCCTG 
DENND1A.X3_BOVINE    CTCAGGAAGCAATGGGAGACCTTCGAGTGAGCAGC--GCTGAGGGTGGGGCGAG--CCAAGGCCGGCCGGCCCTGCTTCCCCTG 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     CTG------------------------CTGTTTCTACCCAGGTTCTACTGGTGGGAAGGGATGGGAACCCTCTCTGCCGCC-CC 
DENND1A.V1_HUMAN    CTGCGGTTCCGAGGCTCCCCCGCCACTCTCTCTCTGCCCAGGTTCTGCTGGTGGGAAGGGATGGGACCCCTCTCTGCTGCCCCC 
DENND1A.X1_BOVINE    CTG------------------------CTGTTTCTACCCAGGTTCTACTGGTGGGAAGGGATGGGAACCCTCTCTGCCGCC-CC 
DENND1A.X2_BOVINE    CTG------------------------CTGTTTCTACCCAGGTTCTACTGGTGGGAAGGGATGGGAACCCTCTCTGCCGCC-CC 
DENND1A.X3_BOVINE    CTG------------------------CTGTTTCTACCCAGGTTCTACTGGTGGGAAGGGATGGGAACCCTCTCTGCCGCC-CC 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 



















DENND1A_BOVINE     TCCTCCTTTCCACACTGCCCATCTCT-------------GGAGAATGGCGCCAGTTCCAGCCTGGGAATCGACCCAGCTCCTGG 
DENND1A.V1_HUMAN    TCCTCCCCTCCACACTGCCCATCTCTGATGTCTGGCCCTGGGGAATGGCACCAGTTCCAGCCTGGGAATCAACCCAGTTCCTGA 
DENND1A.X1_BOVINE    TCCTCCTTTCCACACTGCCCATCTCT-------------GGAGAATGGCGCCAGTTCCAGCCTGGGAATCGACCCAGCTCCTGG 
DENND1A.X2_BOVINE    TCCTCCTTTCCACACTGCCCATCTCT-------------GGAGAATGGCGCCAGTTCCAGCCTGGGAATCGACCCAGCTCCTGG 
DENND1A.X3_BOVINE    TCCTCCTTTCCACACTGCCCATCTCT-------------GGAGAATGGCGCCAGTTCCAGCCTGGGAATCGACCCAGCTCCTGG 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     GTGCCTGTCCTGTCCCGACCC-----TTCCCCTGCCCCCCTAGTTGGGTTTTGCACTAAAGAGGTCAGCTGGGCCAGCG--ATT 
DENND1A.V1_HUMAN    GTGCCCATCCCACCCCGCGGTTGCCTCTCCTCGGCACCCTTGATTGGGTTTTGCACTAAAGAGGTCAGCTGGGCCAATGATATT 
DENND1A.X1_BOVINE    GTGCCTGTCCTGTCCCGACCC-----TTCCCCTGCCCCCCTAGTTGGGTTTTGCACTAAAGAGGTCAGCTGGGCCAGCG--ATT 
DENND1A.X2_BOVINE    GTGCCTGTCCTGTCCCGACCC-----TTCCCCTGCCCCCCTAGTTGGGTTTTGCACTAAAGAGGTCAGCTGGGCCAGCG--ATT 
DENND1A.X3_BOVINE    GTGCCTGTCCTGTCCCGACCC-----TTCCCCTGCCCCCCTAGTTGGGTTTTGCACTAAAGAGGTCAGCTGGGCCAGCG--ATT 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     GCCCCAGGCCACATCTTACCCACCTTCCCTCTGGAAACTGCCCACCAGGAGCCCCGCGCGTCCTCAGGATGTCTC-CTCCTGAG 
DENND1A.V1_HUMAN    GCTCCAGACCGAGTCCTACCCACCTTCCCCCGGAAG-TGTCCCAAGAGGCTCC-------------GAAGGCCTCCCCTCCGAG 
DENND1A.X1_BOVINE    GCCCCAGGCCACATCTTACCCACCTTCCCTCTGGAAACTGCCCACCAGGAGCCCCGCGCGTCCTCAGGATGTCTC-CTCCTGAG 
DENND1A.X2_BOVINE    GCCCCAGGCCACATCTTACCCACCTTCCCTCTGGAAACTGCCCACCAGGAGCCCCGCGCGTCCTCAGGATGTCTC-CTCCTGAG 
DENND1A.X3_BOVINE    GCCCCAGGCCACATCTTACCCACCTTCCCTCTGGAAACTGCCCACCAGGAGCCCCGCGCGTCCTCAGGATGTCTC-CTCCTGAG 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     CCCCGTTCTCTTGCCCCAGCTGCAGCCCAGCCCGCACACCCCACCTTGATGGGCACGAGTGTTGGCGGTACA--------CCAG 
DENND1A.V1_HUMAN    CCCAGCTCTCCTGTCTCCTCCACAGCCAGGCCCTGCACGCCCACCTCCTCGGACACAGGTGACAGGGTTACCCTCCAGTTTGAG 
DENND1A.X1_BOVINE    CCCCGTTCTCTTGCCCCAGCTGCAGCCCAGCCCGCACACCCCACCTTGATGGGCACGAGTGTTGGCGGTACA--------CCAG 
DENND1A.X2_BOVINE    CCCCGTTCTCTTGCCCCAGCTGCAGCCCAGCCCGCACACCCCACCTTGATGGGCACGAGTGTTGGCGGTACA--------CCAG 
DENND1A.X3_BOVINE    CCCCGTTCTCTTGCCCCAGCTGCAGCCCAGCCCGCACACCCCACCTTGATGGGCACGAGTGTTGGCGGTACA--------CCAG 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     CTCGTCTGCACGAGAGGCACGTGGTTTGGAGTTTGAAGTAAGGAACCCCCCTCCCCCACCCCTCCCCAGCTGGAGGATCTACCT 
DENND1A.V1_HUMAN    CTCATCTGCACGAGACACAGGTAGCTTGGGGT-TGAAGTTAGGACT--------------CCTCCTGGGCTGGAGGATTTACCT 
DENND1A.X1_BOVINE    CTCGTCTGCACGAGAGGCACGTGGTTTGGAGTTTGAAGTAAGGAACCCCCCTCCCCCACCCCTCCCCAGCTGGAGGATCTACCT 
DENND1A.X2_BOVINE    CTCGTCTGCACGAGAGGCACGTGGTTTGGAGTTTGAAGTAAGGAACCCCCCTCCCCCACCCCTCCCCAGCTGGAGGATCTACCT 
DENND1A.X3_BOVINE    CTCGTCTGCACGAGAGGCACGTGGTTTGGAGTTTGAAGTAAGGAACCCCCCTCCCCCACCCCTCCCCAGCTGGAGGATCTACCT 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     GGCGAGGCATTTCCAAACCCTGTCTAGCAATATGCACACTCTTTCTTTACTGAGTCTTCACCCCAACCCCTCCACCTCCG-TTT 
DENND1A.V1_HUMAN    GGTGGGGCACTTCCAGACTGTTTCTAGCAATATACACACACGTTCTTTCCTGTGTCTTCACCCCAAAACTTC------AGTTGA 
DENND1A.X1_BOVINE    GGCGAGGCATTTCCAAACCCTGTCTAGCAATATGCACACTCTTTCTTTACTGAGTCTTCACCCCAACCCCTCCACCTCCG-TTT 
DENND1A.X2_BOVINE    GGCGAGGCATTTCCAAACCCTGTCTAGCAATATGCACACTCTTTCTTTACTGAGTCTTCACCCCAACCCCTCCACCTCCG-TTT 
DENND1A.X3_BOVINE    GGCGAGGCATTTCCAAACCCTGTCTAGCAATATGCACACTCTTTCTTTACTGAGTCTTCACCCCAACCCCTCCACCTCCG-TTT 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     TTCTGACTTGGTTGGGATCTGGGGGC---------------------------------------------------------- 
DENND1A.V1_HUMAN    TTCTGACCTGGG-AGGATCTGGGGACCAGGGGG-TCTTGGGCTGCCTTGTGATACAC------AGCCCCAGCCA-CCCTGCATG 
DENND1A.X1_BOVINE    TTCTGACTTGGTTGGGATCTGGGGGCTGAGGGATCCACGGGATCCCTTGTGGTAACCAAACCAAGCCCCAGCCAGCCCTGCATG 
DENND1A.X2_BOVINE    TTCTGACTTGGTTGGGATCTGGGGGCTGAGGGATCCACGGGATCCCTTGTGGTAACCAAACCAAGCCCCAGCCAGCCCTGCATG 
DENND1A.X3_BOVINE    TTCTGACTTGGTTGGGATCTGGGGGCTGAGGGATCCACGGGATCCCTTGTGGTAACCAAACCAAGCCCCAGCCAGCCCTGCATG 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 



















DENND1A_BOVINE     ------------------------------------------------------------------------------------ 
DENND1A.V1_HUMAN    GGGGCTGCGAGCACCAGCAACTTTGATTTATAGAAGGAAA-ATGGAAACCCC--CATCTGAGTATTTTGGGAGGAGCCCCCAGC 
DENND1A.X1_BOVINE    AGGGCCGGGAGCACCAGCAACTTTGATT-ATAGAAGACAAGACGGCAACAGGCAAACCCAAGAGCATTGGGACGGGTCCG--GC 
DENND1A.X2_BOVINE    AGGGCCGGGAGCACCAGCAACTTTGATT-ATAGAAGACAAGACGGCAACAGGCAAACCCAAGAGCATTGGGACGGGTCCG--GC 
DENND1A.X3_BOVINE    AGGGCCGGGAGCACCAGCAACTTTGATT-ATAGAAGACAAGACGGCAACAGGCAAACCCAAGAGCATTGGGACGGGTCCG--GC 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     ------------------------------------------------------------------------------------ 
DENND1A.V1_HUMAN    CCTCATCCAGCTCTGGCACGCTGATACCTCCAGGTACTCCC--------CTCACTGTCAAAGCTGGGGCTCAGCCTCTTGTCAT 
DENND1A.X1_BOVINE    CGCTGTCCA-CACTCTCCCTTGGGTCCCTAGAGGTTCTCCTGGTCTCCAGTTATGATC--ACATGAGGCTCAGACTCTTGTCGA 
DENND1A.X2_BOVINE    CGCTGTCCA-CACTCTCCCTTGGGTCCCTAGAGGTTCTCCTGGTCTCCAGTTATGATC--ACATGAGGCTCAGACTCTTGTCGA 
DENND1A.X3_BOVINE    CGCTGTCCA-CACTCTCCCTTGGGTCCCTAGAGGTTCTCCTGGTCTCCAGTTATGATC--ACATGAGGCTCAGACTCTTGTCGA 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     ------------------------------------------------------------------------------------ 
DENND1A.V1_HUMAN    CTGGAGCTTTGTGGGCAAAGCTGAGAAGCTGCAACCCAGATTTCAACCCAAAAAGGTCAAGCTGAATGCCTCAGACTGATGTGG 
DENND1A.X1_BOVINE    GTGGGTCTCAGGGGGCAGAGCTGAGAAGCAGACACCCAGACCCCCACT--GGAAGGCCAAGCTTACCACCACAGA----GATGC 
DENND1A.X2_BOVINE    GTGGGTCTCAGGGGGCAGAGCTGAGAAGCAGACACCCAGACCCCCACT--GGAAGGCCAAGCTTACCACCACAGA----GATGC 
DENND1A.X3_BOVINE    GTGGGTCTCAGGGGGCAGAGCTGAGAAGCAGACACCCAGACCCCCACT--GGAAGGCCAAGCTTACCACCACAGA----GATGC 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     ------------------------------------------------------------------------------------ 
DENND1A.V1_HUMAN    AAGGCAG------CTGGCCTTCCTGGGTTGGAACGAGGCAGTGGCCCTGAGCCCCTTCTCCAGGGCCAGGTAGAAAGGACAAAC 
DENND1A.X1_BOVINE    AAGGGTCCCAGTGCCTGGCTCCTTGGGGCAGGAGGGGGCAG-GGCACTAAGCC-CCTCTCCAGGCCCCTGGTGAGTGAGCAGGC 
DENND1A.X2_BOVINE    AAGGGTCCCAGTGCCTGGCTCCTTGGGGCAGGAGGGGGCAG-GGCACTAAGCC-CCTCTCCAGGCCCCTGGTGAGTGAGCAGGC 
DENND1A.X3_BOVINE    AAGGGTCCCAGTGCCTGGCTCCTTGGGGCAGGAGGGGGCAG-GGCACTAAGCC-CCTCTCCAGGCCCCTGGTGAGTGAGCAGGC 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     ------------------------------------------------------------------------------------ 
DENND1A.V1_HUMAN    TTGGTCTCTGCCTCG-GGGAAGCAGGAGGAGGGCTAGAAGCCAGTCCCTCCCCACCTGCCCAGAGCTCCAGGCCAGCACAGAAA 
DENND1A.X1_BOVINE    TTGGCTTCTGGCAGCCTGGAG---GCAGGAGGGCTTGGAGTCACCCCCTCCCTGCCCACCTTGTGATTCCTGCCAGCATAGAAG 
DENND1A.X2_BOVINE    TTGGCTTCTGGCAGCCTGGAG---GCAGGAGGGCTTGGAGTCACCCCCTCCCTGCCCACCTTGTGATTCCTGCCAGCATAGAAG 
DENND1A.X3_BOVINE    TTGGCTTCTGGCAGCCTGGAG---GCAGGAGGGCTTGGAGTCACCCCCTCCCTGCCCACCTTGTGATTCCTGCCAGCATAGAAG 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     ------------------------------------------------------------------------------------ 
DENND1A.V1_HUMAN    TTCCTGAGGCCAACGTCACCAAAGTTAGATTGAAT-GTT-------------TATTATCTTTCTTTTTCCTTTTTACCTTATTG 
DENND1A.X1_BOVINE    TTCCTGAGGCCAACATCACCAAAGCTGAATTGAAATGTTTTGTTATTATTTCTTTTATCTTTCTTTTCCTTTTTACTTTTATTG 
DENND1A.X2_BOVINE    TTCCTGAGGCCAACATCACCAAAGCTGAATTGAAATGTTTTGTTATTATTTCTTTTATCTTTCTTTTCCTTTTTACTTTTATTG 
DENND1A.X3_BOVINE    TTCCTGAGGCCAACATCACCAAAGCTGAATTGAAATGTTTTGTTATTATTTCTTTTATCTTTCTTTTCCTTTTTACTTTTATTG 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     ------------------------------------------------------------------------------------ 
DENND1A.V1_HUMAN    ATTTGATG-AATCTTGAAATGGATTCATTTCCATAAACCAAGTTAAAGTATGGCCCGACCATTTAAGAAAACAACCATCTGAGA 
DENND1A.X1_BOVINE    ATTTGATGGAATCTTGAAATTGACTAGTTTCAATAAACCAAGTTAAAATATGGCCCAACCATTTAAGAAAACAACCATCTGAGA 
DENND1A.X2_BOVINE    ATTTGATGGAATCTTGAAATTGACTAGTTTCAATAAACCAAGTTAAAATATGGCCCAACCATTTAAGAAAACAACCATCTGAGA 
DENND1A.X3_BOVINE    ATTTGATGGAATCTTGAAATTGACTAGTTTCAATAAACCAAGTTAAAATATGGCCCAACCATTTAAGAAAACAACCATCTGAGA 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 



















DENND1A_BOVINE     ------------------------------------------------------------------------------------ 
DENND1A.V1_HUMAN    CACGCAGGAAATTGTGAGCATTTCGACCCGAGCTCTCATTTCCTATTTGTGAAGGGTCAGACACAGTCTACCCAGGGGTGTCTG 
DENND1A.X1_BOVINE    CATGCAGGAAATTGTGAACATTTTGACCTGATTTCTCATTTCCTATTTGTGAATGGTCAGACACACAGT-CTCAGGGGTGTCTG 
DENND1A.X2_BOVINE    CATGCAGGAAATTGTGAACATTTTGACCTGATTTCTCATTTCCTATTTGTGAATGGTCAGACACACAGT-CTCAGGGGTGTCTG 
DENND1A.X3_BOVINE    CATGCAGGAAATTGTGAACATTTTGACCTGATTTCTCATTTCCTATTTGTGAATGGTCAGACACACAGT-CTCAGGGGTGTCTG 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     ------------------------------------------------------------------------------------ 
DENND1A.V1_HUMAN    GG-GGACAAGGGGGTCTCTGGAGATG----TC-ACCCAGGGAGCCCCCTCTATGTCTGAGAGGCTGCCACTGCTGCAC-A-TGC 
DENND1A.X1_BOVINE    AGGGGGCAAGGGGGTTTCTAGAGGCCCCTATAACCCCAGGGAGCCTTGTCATCATCTGAGGGACTGGGAGATCACCCCCACCCG 
DENND1A.X2_BOVINE    AGGGGGCAAGGGGGTTTCTAGAGGCCCCTATAACCCCAGGGAGCCTTGTCATCATCTGAGGGACTGGGAGATCACCCCCACCCG 
DENND1A.X3_BOVINE    AGGGGGCAAGGGGGTTTCTAGAGGCCCCTATAACCCCAGGGAGCCTTGTCATCATCTGAGGGACTGGGAGATCACCCCCACCCG 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     ------------------------------------------------------------------------------------ 
DENND1A.V1_HUMAN    TCAGT-----------------GAGGCTTGGC-------------------GGCCATCCTGG-----CACATGGCTCTT----- 
DENND1A.X1_BOVINE    TGAGTGAGCGAGGCCCGACCCTGAGGTTTGCTCCAACAGCATGGGGTGTGAAGGGCTGCTGGCCCCACACGAGCACCTTCGTCA 
DENND1A.X2_BOVINE    TGAGTGAGCGAGGCCCGACCCTGAGGTTTGCTCCAACAGCATGGGGTGTGAAGGGCTGCTGGCCCCACACGAGCACCTTCGTCA 
DENND1A.X3_BOVINE    TGAGTGAGCGAGGCCCGACCCTGAGGTTTGCTCCAACAGCATGGGGTGTGAAGGGCTGCTGGCCCCACACGAGCACCTTCGTCA 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     ------------------------------------------------------------------------------------ 
DENND1A.V1_HUMAN    ---------CCTGGGTCAACCGTGACCTGTCTGGCTCAGGAATGGGCTCTGGCTGCTGG-----GGGAGCCGTGTCACTCCTGG 
DENND1A.X1_BOVINE    GTCCCGGCCCCTGGGGCAAGTCCTCTCTTTCAGTCT-CGCAATGTCCTCTGGCCACCGGAAGCAGGGCGCTGTGTCACGCCTGG 
DENND1A.X2_BOVINE    GTCCCGGCCCCTGGGGCAAGTCCTCTCTTTCAGTCT-CGCAATGTCCTCTGGCCACCGGAAGCAGGGCGCTGTGTCACGCCTGG 
DENND1A.X3_BOVINE    GTCCCGGCCCCTGGGGCAAGTCCTCTCTTTCAGTCT-CGCAATGTCCTCTGGCCACCGGAAGCAGGGCGCTGTGTCACGCCTGG 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     ------------------------------------------------------------------------------------ 
DENND1A.V1_HUMAN    GCCATGGGGGCACCTCCTGGGCACTTAGGTGTTTCAGCATAGATTCCAGTTTCGCACCCTGGGCAGACCCCCAGGCCCCATCCG 
DENND1A.X1_BOVINE    GCCACACGGGTGCCTCTAGGACACTCAGGTGTTTCAGCAGAGATTGCAGATC--CATCCTGGGCAGACCCCCGAGCCCTGTCCT 
DENND1A.X2_BOVINE    GCCACACGGGTGCCTCTAGGACACTCAGGTGTTTCAGCAGAGATTGCAGATC--CATCCTGGGCAGACCCCCGAGCCCTGTCCT 
DENND1A.X3_BOVINE    GCCACACGGGTGCCTCTAGGACACTCAGGTGTTTCAGCAGAGATTGCAGATC--CATCCTGGGCAGACCCCCGAGCCCTGTCCT 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     ------------------------------------------------------------------------------------ 
DENND1A.V1_HUMAN    GGATA-GGGCAG-----------AGGAGGTGCTG-GCGGCCCCAGGGAAGGAGGGTGTGTACCCCAAGGC-CCCCTGGCTGTGC 
DENND1A.X1_BOVINE    GACGGGGGGCAGAGTCTTAAGGCAAGAGGTGCTCGGTGGCCTCAGGGAAGCCGAG--CCCACCCCATGGTCTCCCTGGCTGGGG 
DENND1A.X2_BOVINE    GACGGGGGGCAGAGTCTTAAGGCAAGAGGTGCTCGGTGGCCTCAGGGAAGCCGAG--CCCACCCCATGGTCTCCCTGGCTGGGG 
DENND1A.X3_BOVINE    GACGGGGGGCAGAGTCTTAAGGCAAGAGGTGCTCGGTGGCCTCAGGGAAGCCGAG--CCCACCCCATGGTCTCCCTGGCTGGGG 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 
DENND1A.X1-4_R     ------------------------------------------------------------------------------------ 
 
 
DENND1A_BOVINE     ------------------------------------------------------------------------------------ 
DENND1A.V1_HUMAN    TGAGGGGCTGGGGTGAGCGCTCCATGTTCACATGAGCACTGCTGCCTCTTCACTTGTGGGACTT--TTTGCAAACCCAAGGATG 
DENND1A.X1_BOVINE    ------CCAGTGGCAAGAGCACCATGTTCACAAGAGCACTGCTGTCTCTTCCCTTGCTGGACTGAGTCTGCAAATCCAAGGATG 
DENND1A.X2_BOVINE    ------CCAGTGGCAAGAGCACCATGTTCACAAGAGCACTGCTGTCTCTTCCCTTGCTGGACTGAGTCTGCAAATCCAAGGATG 
DENND1A.X3_BOVINE    ------CCAGTGGCAAGAGCACCATGTTCACAAGAGCACTGCTGTCTCTTCCCTTGCTGGACTGAGTCTGCAAATCCAAGGATG 
DENND1A.X4_BOVINE    ------------------------------------------------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------------------------------------------------ 


















DENND1A_BOVINE     ------------------------------------------ 
DENND1A.V1_HUMAN    AACTTTGT--GTGCATTCAATAAAATCATCTTGGGGAAGAGG 
DENND1A.X1_BOVINE    AATTTTGTGTGTGCGTTCAATAAAATCTTCTTGGAGAGAAA- 
DENND1A.X2_BOVINE    AATTTTGTGTGTGCGTTCAATAAAATCTTCTTGGAGAGAAA- 
DENND1A.X3_BOVINE    AATTTTGTGTGTGCGTTCAATAAAATCTTCTTGGAGAGAAA- 
DENND1A.X4_BOVINE    ------------------------------------------ 
DENND1A.X1-4_F     ------------------------------------------ 








































Supplemental Fig. S3. Alignment of the exons of human DENND1A V1, V3 and V4 and DENND1A.V1,3,4 
primer sequences. Alignment was generated with CLUSTAL O (1.2.4) multiple sequence alignment based on 
sequences available at Ensembl Asia with transcript ID: human DENND1A.V1 (ENST00000373624.6) and at 
NCBI PubMed with accession numbers: DENND1A.V3 (NM_001352964) and DENND1A.V4 
(NM_001352965). The alignment was analysed with T-COFFEE (1) and colored based on the consistency: red 
(high), yellow (average); green and blue (poor). Consistency is estimated from CORE index.  Bright aqua 
highlighted areas represent the primer sequences. ………… represent intronic areas not shown so as to reduce the 
size of this file. 
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DENND1A.V1       CGCGCGCCGGGCACGCGCGCCGGCGACCATGGCGTTCGCCGGGCTGGAGCGAGTACATTAACCCCTGGAGGCGGCGGCGGCGGCGAGGGAGCG 
DENND1A.V3       CGCGCGCCGGGCACGCGCGCCGGCGACCATGGCGTTCGCCGGGCTGGAGCGAGTACATTAACCCCTGGAGGCGGCGGCGGCGGCGAGGGAGCG 
DENND1A.V4       CGCGCGCCGGGCACGCGCGCCGGCGACCATGGCGTTCGCCGGGCTGGAGCGAGTACATTAACCCCTGGAGGCGGCGGCGGCGGCGAGGGAGCG 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       AGCCTCGAGCGGGCGGGCCCCAGCCTGAGGGAAGGGAGGAAGGGGCGGGGAGAGCGCCAGAGGGAGGCCGGTCGGCCGCGGGCGGGCGGGCAG 
DENND1A.V3       AGCCTCGAGCGGGCGGGCCCCAGCCTGAGGGAAGGGAGGAAGGGGCGGGGAGAGCGCCAGAGGGAGGCCGGTCGGCCGCGGGCGGGCGGGCAG 
DENND1A.V4       AGCCTCGAGCGGGCGGGCCCCAGCCTGAGGGAAGGGAGGAAGGGGCGGGGAGAGCGCCAGAGGGAGGCCGGTCGGCCGCGGGCGGGCGGGCAG 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       CGCAGCGCCGAGCGGGGCCCGCGGGCCCATGAGGAGGCCTGGGGACCATGGGCTCCAGGATCAAgtgagtgcggcc………gtttcttttgtag 
DENND1A.V3       CGCAGCGCCGAGCGGGGCCCGCGGGCCCATGAGGAGGCCTGGGGACCATGGGCTCCAGGATCAA 
DENND1A.V4       CGCAGCGCCGAGCGGGGCCCGCGGGCCCATGAGGAGGCCTGGGGACCATGGGCTCCAGGATCAA----------------------------- 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       GCAGAATCCAGAGACCACATTTGAAGTATATGTTGAAGTGGCCTATCCCAGGACAGGTGGCACTCTTTCAGgtacttt……………ttatttacag 
DENND1A.V3       GCAGAATCCAGAGACCACATTTGAAGTATATGTTGAAGTGGCCTATCCCAGGACAGGTGGCACTCTTTCAG 
DENND1A.V4       --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       ATCCTGAGGTGCAGAGGCAATTCCCGGAGGACTACAGTGACCAGgttcggaatgcgt………………………………………………………tctttctctccacag 
DENND1A.V3       ATCCTGAGGTGCAGAGGCAATTCCCGGAGGACTACAGTGACCAG------------------------------------------------- 
DENND1A.V4       --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       GAAGTATCTACAGACTTTGACCAAGTTTTGTTTCCCCTTCTATGTGGACAGgtagtgtcagattttcaaa…………gtagtgtcagattttcaaa 
DENND1A.V3       GAAGTATCTACAGACTTTGACCAAGTTTTGTTTCCCCTTCTATGTGGACAG------------------------------------------ 
DENND1A.V4       GAAGTATCTACAGACTTTGACCAAGTTTTGTTTCCCCTTCTATGTGGACAG------------------------------------------ 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       CCTCACAGTTAGCCAAGTTGGCCAGAACTTCACATTCGTGCTCACTGCATTGACAGCAAACAGAGATTCGGGTTCTGCCGCTTATCTTCAGGA 
DENND1A.V3       CCTCACAGTTAGCCAAGTTGGCCAGAACTTCACATTCGTGCTCACTGCATTGACAGCAAACAGAGATTCGGGTTCTGCCGCTTATCTTCAGGA 
DENND1A.V4       CCTCACAGTTAGCCAAGTTGGCCAGAACTTCACATTCGTGCTCACTGCATTGACAGCAAACAGAGATTCGGGTTCTGCCGCTTATCTTCAGGA 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       GCGAAGAGCTGCTTCTGTATCTTAAGgtaagggagaaggcttgggctgt…………………………………………………………………tttcctcttcttcctccag 
DENND1A.V3       GCGAAGAGCTGCTTCTGTATCTTAAG------------------------------------------------------------------- 
DENND1A.V4       GCGAAGAGCTGCTTCTGTATCTTAAG------------------------------------------------------------------- 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 





































































DENND1A.V1       CTATCTCCCCTGGTTCGAGGTATTTTATAAGCTGCTTAACATCCTGGCAGATTACACGACAAAAAGACAGgtatttacc……… tttctttcag 
DENND1A.V3       CTATCTCCCCTGGTTCGAGGTATTTTATAAGCTGCTTAACATCCTGGCAGATTACACGACAAAAAGACAG----------------------- 
DENND1A.V4       CTATCTCCCCTGGTTCGAGGTATTTTATAAGCTGCTTAACATCCTGGCAGATTACACGACAAAAAGACAG----------------------- 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       GAAAATCAGTGGAATGAGCTTCTTGAAACTCTGCACAAACTTCCCATCCCTGACCCAGGAGTGTCTGTCCATCTCAGCGTGgtaa……ttctag 
DENND1A.V3       GAAAATCAGTGGAATGAGCTTCTTGAAACTCTGCACAAACTTCCCATCCCTGACCCAGGAGTGTCTGTCCATCTCAGCGTG------------ 
DENND1A.V4       GAAAATCAGTGGAATGAGCTTCTTGAAACTCTGCACAAACTTCCCATCCCTGACCCAGGAGTGTCTGTCCATCTCAGCGTG------------ 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       CATTCTTATTTTACTGTGCCTGATACCAGAGAACTTCCCAGCATACCTGAGAATgtaagtacttggg………………………………cttctttctcctag 
DENND1A.V3       CATTCTTATTTTACTGTGCCTGATACCAGAGAACTTCCCAGCATACCTGAGAAT--------------------------------------- 
DENND1A.V4       CATTCTTATTTTACTGTGCCTGATACCAGAGAACTTCCCAGCATACCTGAGAAT--------------------------------------- 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       AGAAATCTGACAGAATATTTTGTGGCTGTGGATGTTAACAACATGTTGCATCTGTACGCCAGTATGCTGTACGAACGCCGGATACTCATCATT 
DENND1A.V3       AGAAATCTGACAGAATATTTTGTGGCTGTGGATGTTAACAACATGTTGCATCTGTACGCCAGTATGCTGTACGAACGCCGGATACTCATCATT 
DENND1A.V4       AGAAATCTGACAGAATATTTTGTGGCTGTGGATGTTAACAACATGTTGCATCTGTACGCCAGTATGCTGTACGAACGCCGGATACTCATCATT 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       TGCAGCAAACTCAGCACTgtgagtagacagtcttaagact……………………………………………………………………………………ctctgctttgctctgttccag 
DENND1A.V3       TGCAGCAAACTCAGCACT--------------------------------------------------------------------------- 
DENND1A.V4       TGCAGCAAACTCAGCACT--------------------------------------------------------------------------- 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       CTGACTGCCTGCATCCACGGGTCTGCGGCGATGCTCTACCCCATGTACTGGCAGCACGTGTACATCCCCGTGCTGCCGCCGCATCTGCTGGAC 
DENND1A.V3       CTGACTGCCTGCATCCACGGGTCTGCGGCGATGCTCTACCCCATGTACTGGCAGCACGTGTACATCCCCGTGCTGCCGCCGCATCTGCTGGAC 
DENND1A.V4       CTGACTGCCTGCATCCACGGGTCTGCGGCGATGCTCTACCCCATGTACTGGCAGCACGTGTACATCCCCGTGCTGCCGCCGCATCTGCTGGAC 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       TACTGCTGgtaaggtggctggccctgtcctctgcttctcctttgccctg……………………………aaagcagctgtgtgtctctgtttctcttcacag 
DENND1A.V3       TACTGCTG------------------------------------------------------------------------------------- 
DENND1A.V4       TACTGCTG------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       TGCTCCCATGCCCTACCTCATAGGAATCCATTTAAGTTTAATGGAGgtaagttggcttctttcct………………………gtaagttggcttctttcct 
DENND1A.V3       TGCTCCCATGCCCTACCTCATAGGAATCCATTTAAGTTTAATGGAG----------------------------------------------- 
DENND1A.V4       TGCTCCCATGCCCTACCTCATAGGAATCCATTTAAGTTTAATGGAG----------------------------------------------- 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       AAAGTCAGAAACATGGCCCTGGATGATGTCGTGATCCTGAATGTGGACACCAACACCCTGGAAACCCCCTTCGATGACCTCCAGAGCCTCCCA 
DENND1A.V3       AAAGTCAGAAACATGGCCCTGGATGATGTCGTGATCCTGAATGTGGACACCAACACCCTGGAAACCCCCTTCGATGACCTCCAGAGCCTCCCA 
DENND1A.V4       AAAGTCAGAAACATGGCCCTGGATGATGTCGTGATCCTGAATGTGGACACCAACACCCTGGAAACCCCCTTCGATGACCTCCAGAGCCTCCCA 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       AACGACGTGgtaggtaatgagcttgcgaggatctcacttctg…………………………………………………………………tgtgttttccttctctccatcaccag 
DENND1A.V3       AACGACGTG------------------------------------------------------------------------------------ 
DENND1A.V4       AACGACGTG------------------------------------------------------------------------------------ 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       ATCTCTTCCCTGAAGAACAGGCTGAAAAAGGTCTCCACAACCACTGGGGATGGTGTGGCCAGAGCGTTCCTCAAGGCCCAGGCTGCTTTCTTC 
DENND1A.V3       ATCTCTTCCCTGAAGAACAGGCTGAAAAAGGTCTCCACAACCACTGGGGATGGTGTGGCCAGAGCGTTCCTCAAGGCCCAGGCTGCTTTCTTC 
DENND1A.V4       ATCTCTTCCCTGAAGAACAGGCTGAAAAAGGTCTCCACAACCACTGGGGATGGTGTGGCCAGAGCGTTCCTCAAGGCCCAGGCTGCTTTCTTC 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
















































































DENND1A.V1       GGTAGCTACCGAAACGCTCTGAAAATCGAGCCGgtgagtagccttggcatgtca………………………………cccacctctcccctctgcacttcccag 
DENND1A.V3       GGTAGCTACCGAAACGCTCTGAAAATCGAGCCG------------------------------------------------------------ 
DENND1A.V4       GGTAGCTACCGAAACGCTCTGAAAATCGAGCCG------------------------------------------------------------ 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       GAGGAGCCGATCACTTTCTGTGAGGAAGCCTTCGTGTCCCACTACCGCTCCGGAGCCATGAGGCAGTTCCTGCAGAACGCCACACAGCTGCAG 
DENND1A.V3       GAGGAGCCGATCACTTTCTGTGAGGAAGCCTTCGTGTCCCACTACCGCTCCGGAGCCATGAGGCAGTTCCTGCAGAACGCCACACAGCTGCAG 
DENND1A.V4       GAGGAGCCGATCACTTTCTGTGAGGAAGCCTTCGTGTCCCACTACCGCTCCGGAGCCATGAGGCAGTTCCTGCAGAACGCCACACAGCTGCAG 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       CTCTTCAAGCAGgtgcctccctccctggtctggcctgggtctgg…………………………ttgtacgagctgttgtgcttttgttccttctttctatag 
DENND1A.V3       CTCTTCAAGCAG--------------------------------------------------------------------------------- 
DENND1A.V4       CTCTTCAAGCAG--------------------------------------------------------------------------------- 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       TTTATTGATGGTCGATTAGATCTTCTCAATTCCGGCGAAGGTTTCAGTGATGTTTTTGAAGAGGAAATCAACATGGGCGAGTACGCTGgt…ag 
DENND1A.V3       TTTATTGATGGTCGATTAGATCTTCTCAATTCCGGCGAAGGTTTCAGTGATGTTTTTGAAGAGGAAATCAACATGGGCGAGTACGCTG----- 
DENND1A.V4       TTTATTGATGGTCGATTAGATCTTCTCAATTCCGGCGAAGGTTTCAGTGATGTTTTTGAAGAGGAAATCAACATGGGCGAGTACGCTG----- 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       GCAGTGACAAACTGTACCATCAGTGGCTCTCCACTGTCCGGgtaagcatgcacccaattcaga………aattgctaattgacatttttattatag 
DENND1A.V3       GCAGTGACAAACTGTACCATCAGTGGCTCTCCACTGTCCGG---------------------------------------------------- 
DENND1A.V4       GCAGTGACAAACTGTACCATCAGTGGCTCTCCACTGTCCGG---------------------------------------------------- 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       AAAGGAAGTGGAGCAATTCTGAATACTGTAAAGACCAAAGCAAATCCGGCCATGAAGACTGTCTACAAGTTCgtaagtact……tttcatgcag 
DENND1A.V3       AAAGGAAGTGGAGCAATTCTGAATACTGTAAAGACCAAAGCAAATCCGGCCATGAAGACTGTCTACAAGTTC--------------------- 
DENND1A.V4       AAAGGAAGTGGAGCAATTCTGAATACTGTAAAGACCAAAGCAAATCCGGCCATGAAGACTGTCTACAAGTTC--------------------- 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       GCAAAAGATCATGCAAAAATGGGAATAAAAGAGGTGAAAAACCGCTTGAAGCAAAAGgtacttgaagttcttatt…………ccttctccctacag 
DENND1A.V3       GCAAAAGATCATGCAAAAATGGGAATAAAAGAGGTGAAAAACCGCTTGAAGCAAAAG------------------------------------ 
DENND1A.V4       GCAAAAGATCATGCAAAAATGGGAATAAAAGAGGTGAAAAACCGCTTGAAGCAAAAG------------------------------------ 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       GACATTGCCGAGAATGGCTGCGCCCCCACCCCAGAAGAGCAGCTGCCAAAGACTGCACCGTCCCCACTGGTGGAGGCCAAGGACCCCAAGCTC 
DENND1A.V3       GACATTGCCGAGAATGGCTGCGCCCCCACCCCAGAAGAGCAGCTGCCAAAGACTGCACCGTCCCCACTGGTGGAGGCCAAGGACCCCAAGCTC 
DENND1A.V4       GACATTGCCGAGAATGGCTGCGCCCCCACCCCAGAAGAGCAGCTGCCAAAGACTGCACCGTCCCCACTGGTGGAGGCCAAGGACCCCAAGCTC 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       CGAGAAGACCGGCGGCCAATCACAGTCCACTTTGGACAGgtgtgtaccctggccctcct………ttccactttaatgcagctgcagagactgcgt 
DENND1A.V3       CGAGAAGACCGGCGGCCAATCACAGTCCACTTTGGACAG---------------------------------------CTGCAGAGACTGCGT 
DENND1A.V4       CGAGAAGACCGGCGGCCAATCACAGTCCACTTTGGACAG------------------------------------------------------ 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       cccacccgaccgcctcccaagatacagcgctcgaggcccgtgagtagctgg……………………………………………………………ccccctgtacctcctctag 
DENND1A.V3       CCCACCCGACCGCCTCCCAAGATACAGCGCTCGAGGCCCG----------------------------------------------------- 
DENND1A.V4       --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       GTGCGCCCACCTCGTCCACATGTTGTTAAGAGACCAAAGAGCAACATCGCAGTGGAAGGCCGGAGGACGTCTGTGCCGAGCCCTGAGCAgtg… 
DENND1A.V3       GTGCGCCCACCTCGTCCACATGTTGTTAAGAGACCAAAGAGCAACATCGCAGTGGAAGGCCGGAGGACGTCTGTGCCGAGCCCTGAGCA---- 
DENND1A.V4       GTGCGCCCACCTCGTCCACATGTTGTTAAGAGACCAAAGAGCAACATCGCAGTGGAAGGCCGGAGGACGTCTGTGCCGAGCCCTGAGCA---- 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 









































DENND1A.V1       ccccagcctggtaaagcccttgcgacactatgcggtcttcctctccgaagactcctctgatgatgaatgccagcgggaagagggcccgagctc 
DENND1A.V3       ------CCTGGTAAAGCCCTTGCGACACTATGCGGTCTTCCTCTCCGAAGACTCCTCTGATGATGAATGCCAGCGGGAAGAGGGCCCGAGCTC 
DENND1A.V4       ------CCTGGTAAAGCCCTTGCGACACTATGCGGTCTTCCTCTCCGAAGACTCCTCTGATGATGAATGCCAGCGGGAAGAGGGCCCGAGCTC 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       tggcttcaccgagagctttttcttctccgctccctttgaatggtctctccttcc……………………………………………………cctgctctgtccccgacag 
DENND1A.V3       TGGCTTCACCGAGAGCTTTTTCTTCTCCGCTCCCTTTGAATGG-------------------------------------------------- 
DENND1A.V4       TGGCTTCACCGAGAGCTTTTTCTTCTCCGCTCCCTTTGAATGG-------------------------------------------------- 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       GCCGCAGCCGTATCGGACACTCAGGGAGTCAGACAGCGCGGAAGGCGACGAGGCAGAGAGTCCAGAGCAGCAAGTGCGGAAGTCCACAGGCCC 
DENND1A.V3       GCCGCAGCCGTATCGGACACTCAGGGAGTCAGACAGCGCGGAAGGCGACGAGGCAGAGAGTCCAGAGCAGCAAGTGCGGAAGTCCACAGGCCC 
DENND1A.V4       GCCGCAGCCGTATCGGACACTCAGGGAGTCAGACAGCGCGGAAGGCGACGAGGCAGAGAGTCCAGAGCAGCAAGTGCGGAAGTCCACAGGCCC 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       TGTCCCAGCTCCCCCTGACCGGGCTGCCAGCATCGACCTTCTGGAAGACGTCTTCAGCAACCTGGACATGGAGGCCGCACTGCAGCCACTGGG 
DENND1A.V3       TGTCCCAGCTCCCCCTGACCGGGCTGCCAGCATCGACCTTCTGGAAGACGTCTTCAGCAACCTGGACATGGAGGCCGCACTGCAGCCACTGGG 
DENND1A.V4       TGTCCCAGCTCCCCCTGACCGGGCTGCCAGCATCGACCTTCTGGAAGACGTCTTCAGCAACCTGGACATGGAGGCCGCACTGCAGCCACTGGG 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       CCAGGCCAAGAGCTTAGAGGACCTTCGTGCCCCCAAAGACCTGAGGGAGCAGCCAGGGACCTTTGACTATCAGgtatggc………………ccaacag 
DENND1A.V3       CCAGGCCAAGAGCTTAGAGGACCTTCGTGCCCCCAAAGACCTGAGGGAGCAGCCAGGGACCTTTGACTATCAG-------------------- 
DENND1A.V4       CCAGGCCAAGAGCTTAGAGGACCTTCGTGCCCCCAAAGACCTGAGGGAGCAGCCAGGGACCTTTGACTATCAG-------------------- 
DENND1A.V1,3,4_F  -------------------------------------------------CAGCCAGGGACCTTTGACTA------------------------ 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       AGGCTGGATCTGGGCGGGAGTGAGAGGAGCCGCGGGGTGACAGTGGCCTTGAAGCTTACCCACCCGTACAACAAGCTCTGGAGCCTGGGCCAG 
DENND1A.V3       AGGCTGGATCTGGGCGGGAGTGAGAGGAGCCGCGGGGTGACAGTGGCCTTGAAGCTTACCCACCCGTACAACAAGCTCTGGAGCCTGGGCCAG 
DENND1A.V4       AGGCTGGATCTGGGCGGGAGTGAGAGGAGCCGCGGGGTGACAGTGGCCTTGAAGCTTACCCACCCGTACAACAAGCTCTGGAGCCTGGGCCAG 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  ------------------------------------------------------------CACCCGTACAACAAGCTCTG------------- 
 
 
DENND1A.V1       GACGACATGGCCATCCCCAGCAAGCCCCCAGCTGCCTCCCCTGAGAAGCCCTCGGCCCTGCTCGGGAACTCCCTGGCCCTGCCTCGAAGGCCC 
DENND1A.V3       GACGACATGGCCATCCCCAGCAAGCCCCCAGCTGCCTCCCCTGAGAAGCCCTCGGCCCTGCTCGGGAACTCCCTGGCCCTGCCTCGAAGGCCC 
DENND1A.V4       GACGACATGGCCATCCCCAGCAAGCCCCCAGCTGCCTCCCCTGAGAAGCCCTCGGCCCTGCTCGGGAACTCCCTGGCCCTGCCTCGAAGGCCC 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       CAGAACCGGGACAGCATCCTGAACCCCAGTGACAAGGAGGAGGTGCCCACCCCTACTCTGGGCAGCATCACCATCCCCCGGCCCCAAGGCAG 
DENND1A.V3       CAGAACCGGGACAGCATCCTGAACCCCAGTGACAAGGAGGAGGTGCCCACCCCTACTCTGGGCAGCATCACCATCCCCCGGCCCCAAGGCAG 
DENND1A.V4       CAGAACCGGGACAGCATCCTGAACCCCAGTGACAAGGAGGAGGTGCCCACCCCTACTCTGGGCAGCATCACCATCCCCCGGCCCCAAGGCAG 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       GAAGACCCCAGAGCTGGGCATCGTGCCTCCACCGCCCATTCCCCGCCCGGCCAAGCTCCAGGCTGCCGGCGCCGCACTTGGTGACGTCTCAGA 
DENND1A.V3       GAAGACCCCAGAGCTGGGCATCGTGCCTCCACCGCCCATTCCCCGCCCGGCCAAGCTCCAGGCTGCCGGCGCCGCACTTGGTGACGTCTCAGA 
DENND1A.V4       GAAGACCCCAGAGCTGGGCATCGTGCCTCCACCGCCCATTCCCCGCCCGGCCAAGCTCCAGGCTGCCGGCGCCGCACTTGGTGACGTCTCAGA 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       GCGGCTGCAGACGGATCGGGACAGGCGAGCTGCCCTGAGTCCAGGGCTCCTGCCTGGTGTTGTCCCCCAAGGCCCCACTGAACTGCTCCAGCC 
DENND1A.V3       GCGGCTGCAGACGGATCGGGACAGGCGAGCTGCCCTGAGTCCAGGGCTCCTGCCTGGTGTTGTCCCCCAAGGCCCCACTGAACTGCTCCAGCC 
DENND1A.V4       GCGGCTGCAGACGGATCGGGACAGGCGAGCTGCCCTGAGTCCAGGGCTCCTGCCTGGTGTTGTCCCCCAAGGCCCCACTGAACTGCTCCAGCC 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       GCTCAGCCCTGGCCCCGGGGCTGCAGGCACGAGCAGTGACGCCCTGCTCGCCCTCCTGGACCCGCTCAGCACAGCCTGGTCAGGCAGCACCCT 
DENND1A.V3       GCTCAGCCCTGGCCCCGGGGCTGCAGGCACGAGCAGTGACGCCCTGCTCGCCCTCCTGGACCCGCTCAGCACAGCCTGGTCAGGCAGCACCCT 
DENND1A.V4       GCTCAGCCCTGGCCCCGGGGCTGCAGGCACGAGCAGTGACGCCCTGCTCGCCCTCCTGGACCCGCTCAGCACAGCCTGGTCAGGCAGCACCC 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 


















DENND1A.V1       CCCGTCACGCCCCGCCACCCCGAATGTAGCCACCCCATTCACCCCCCAATTCAGCTTCCCCCCTGCAGGGACACCCACCCCATTCCCACAGCC 
DENND1A.V3       CCCGTCACGCCCCGCCACCCCGAATGTAGCCACCCCATTCACCCCCCAATTCAGCTTCCCCCCTGCAGGGACACCCACCCCATTCCCACAGCC 
DENND1A.V4       CCCGTCACGCCCCGCCACCCCGAATGTAGCCACCCCATTCACCCCCCAATTCAGCTTCCCCCCTGCAGGGACACCCACCCCATTCCCACAGCC 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       ACCACTCAACCCCTTTGTCCCATCCATGCCAGCAGCCCCACCCACCCTGCCCCTGGTCTCCACACCAGCCGGGCCTTTCGGGGCCCCTCCAGC 
DENND1A.V3       ACCACTCAACCCCTTTGTCCCATCCATGCCAGCAGCCCCACCCACCCTGCCCCTGGTCTCCACACCAGCCGGGCCTTTCGGGGCCCCTCCAGC 
DENND1A.V4       ACCACTCAACCCCTTTGTCCCATCCATGCCAGCAGCCCCACCCACCCTGCCCCTGGTCTCCACACCAGCCGGGCCTTTCGGGGCCCCTCCAGC 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       TTCCCTGGGGCCGGCTTTTGCGTCCGGCCTCCTGCTGTCCAGTGCTGGCTTCTGTGCCCCTCACAGGTCTCAGCCCAACCTCTCCGCCCTCTC 
DENND1A.V3       TTCCCTGGGGCCGGCTTTTGCGTCCGGCCTCCTGCTGTCCAGTGCTGGCTTCTGTGCCCCTCACAGGTCTCAGCCCAACCTCTCCGCCCTCTC 
DENND1A.V4       TTCCCTGGGGCCGGCTTTTGCGTCCGGCCTCCTGCTGTCCAGTGCTGGCTTCTGTGCCCCTCACAGGTCTCAGCCCAACCTCTCCGCCCTCTC 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       CATGCCCAACCTCTTTGGCCAGATGCCCATGGGCACCCACACGAGCCCCCTACAGCCGCTGGGTCCCCCAGCAGTTGCCCCGTCGAGGATCCG 
DENND1A.V3       CATGCCCAACCTCTTTGGCCAGATGCCCATGGGCACCCACACGAGCCCCCTACAGCCGCTGGGTCCCCCAGCAGTTGCCCCGTCGAGGATCCG 
DENND1A.V4       CATGCCCAACCTCTTTGGCCAGATGCCCATGGGCACCCACACGAGCCCCCTACAGCCGCTGGGTCCCCCAGCAGTTGCCCCGTCGAGGATCCG 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       AACGTTGCCCCTGGCCCGCTCAAGTGCCAGGGCTGCTGAGACCAAGCAGGGGCTGGCCCTGAGGCCTGGAGACCCCCCGCTTCTGCCTCCCAG 
DENND1A.V3       AACGTTGCCCCTGGCCCGCTCAAGTGCCAGGGCTGCTGAGACCAAGCAGGGGCTGGCCCTGAGGCCTGGAGACCCCCCGCTTCTGCCTCCCAG 
DENND1A.V4       AACGTTGCCCCTGGCCCGCTCAAGTGCCAGGGCTGCTGAGACCAAGCAGGGGCTGGCCCTGAGGCCTGGAGACCCCCCGCTTCTGCCTCCCAG 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       GCCCCCTCAAGGCCTGGAGCCAACACTGCAGCCCTCTGCTCCTCAACAGGCCAGAGACCCCTTTGAGGATTTGTTACAGAAAACCAAGCAAGA 
DENND1A.V3       GCCCCCTCAAGGCCTGGAGCCAACACTGCAGCCCTCTGCTCCTCAACAGGCCAGAGACCCCTTTGAGGATTTGTTACAGAAAACCAAGCAAGA 
DENND1A.V4       GCCCCCTCAAGGCCTGGAGCCAACACTGCAGCCCTCTGCTCCTCAACAGGCCAGAGACCCCTTTGAGGATTTGTTACAGAAAACCAAGCAAGA 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       CGTGAGCCCGAGTCCGGCCCTGGCCCCGGCCCCAGACTCGGTGGAGCAGCTCAGGAAGCAGTGGGAGACCTTCGAGTGAGCCGGGCCCTGAGG 
DENND1A.V3       CGTGAGCCCGAGTCCGGCCCTGGCCCCGGCCCCAGACTCGGTGGAGCAGCTCAGGAAGCAGTGGGAGACCTTCGAGTGAGCCGGGCCCTGAGG 
DENND1A.V4       CGTGAGCCCGAGTCCGGCCCTGGCCCCGGCCCCAGACTCGGTGGAGCAGCTCAGGAAGCAGTGGGAGACCTTCGAGTGAGCCGGGCCCTGAGG 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       GTGGGGGATGCACCGAGGCCCGAGGGTCCGTCCACTGCTGCGGTTCCGAGGCTCCCCCGCCACTCTCTCTCTGCCCAGGTTCTGCTGGTGGGA 
DENND1A.V3       GTGGGGGATGCACCGAGGCCCGAGGGTCCGTCCACTGCTGCGGTTCCGAGGCTCCCCCGCCACTCTCTCTCTGCCCAGGTTCTGCTGGTGGGA 
DENND1A.V4       GTGGGGGATGCACCGAGGCCCGAGGGTCCGTCCACTGCTGCGGTTCCGAGGCTCCCCCGCCACTCTCTCTCTGCCCAGGTTCTGCTGGTGGGA 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       AGGGATGGGACCCCTCTCTGCTGCCCCCTCCTCCCCTCCACACTGCCCATCTCTGATGTCTGGCCCTGGGGAATGGCACCAGTTCCAGCCTGG 
DENND1A.V3       AGGGATGGGACCCCTCTCTGCTGCCCCCTCCTCCCCTCCACACTGCCCATCTCTGATGTCTGGCCCTGGGGAATGGCACCAGTTCCAGCCTGG 
DENND1A.V4       AGGGATGGGACCCCTCTCTGCTGCCCCCTCCTCCCCTCCACACTGCCCATCTCTGATGTCTGGCCCTGGGGAATGGCACCAGTTCCAGCCTGG 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       GAATCAACCCAGTTCCTGAGTGCCCATCCCACCCCGCGGTTGCCTCTCCTCGGCACCCTTGATTGGGTTTTGCACTAAAGAGGTCAGCTGGGC 
DENND1A.V3       GAATCAACCCAGTTCCTGAGTGCCCATCCCACCCCGCGGTTGCCTCTCCTCGGCACCCTTGATTGGGTTTTGCACTAAAGAGGTCAGCTGGGC 
DENND1A.V4       GAATCAACCCAGTTCCTGAGTGCCCATCCCACCCCGCGGTTGCCTCTCCTCGGCACCCTTGATTGGGTTTTGCACTAAAGAGGTCAGCTGGGC 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       CAATGATATTGCTCCAGACCGAGTCCTACCCACCTTCCCCCGGAAGTGTCCCAAGAGGCTCCGAAGGCCTCCCCTCCGAGCCCAGCTCTCCTG 
DENND1A.V3       CAATGATATTGCTCCAGACCGAGTCCTACCCACCTTCCCCCGGAAGTGTCCCAAGAGGCTCCGAAGGCCTCCCCTCCGAGCCCAGCTCTCCTG 
DENND1A.V4       CAATGATATTGCTCCAGACCGAGTCCTACCCACCTTCCCCCGGAAGTGTCCCAAGAGGCTCCGAAGGCCTCCCCTCCGAGCCCAGCTCTCCTG 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 


















DENND1A.V1       TCTCCTCCACAGCCAGGCCCTGCACGCCCACCTCCTCGGACACAGGTGACAGGGTTACCCTCCAGTTTGAGCTCATCTGCACGAGACACAGGT 
DENND1A.V3       TCTCCTCCACAGCCAGGCCCTGCACGCCCACCTCCTCGGACACAGGTGACAGGGTTACCCTCCAGTTTGAGCTCATCTGCACGAGACACAGGT 
DENND1A.V4       TCTCCTCCACAGCCAGGCCCTGCACGCCCACCTCCTCGGACACAGGTGACAGGGTTACCCTCCAGTTTGAGCTCATCTGCACGAGACACAGGT 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       AGCTTGGGGTTGAAGTTAGGACTCCTCCTGGGCTGGAGGATTTACCTGGTGGGGCACTTCCAGACTGTTTCTAGCAATATACACACACGTTCT 
DENND1A.V3       AGCTTGGGGTTGAAGTTAGGACTCCTCCTGGGCTGGAGGATTTACCTGGTGGGGCACTTCCAGACTGTTTCTAGCAATATACACACACGTTCT 
DENND1A.V4       AGCTTGGGGTTGAAGTTAGGACTCCTCCTGGGCTGGAGGATTTACCTGGTGGGGCACTTCCAGACTGTTTCTAGCAATATACACACACGTTCT 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       TTCCTGTGTCTTCACCCCAAAACTTCAGTTGATTCTGACCTGGGAGGATCTGGGGACCAGGGGGTCTTGGGCTGCCTTGTGATACACAGCCCC 
DENND1A.V3       TTCCTGTGTCTTCACCCCAAAACTTCAGTTGATTCTGACCTGGGAGGATCTGGGGACCAGGGGGTCTTGGGCTGCCTTGTGATACACAGCCCC 
DENND1A.V4       TTCCTGTGTCTTCACCCCAAAACTTCAGTTGATTCTGACCTGGGAGGATCTGGGGACCAGGGGGTCTTGGGCTGCCTTGTGATACACAGCCCC 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       AGCCACCCTGCACGGGGGCTGCGAGCACCAGCAACTTTGATTTATAGAAGGAAAATGGAAACCCCCATCTGAGTATTTTGGGAGGAGCCCCCA 
DENND1A.V3       AGCCACCCTGCACGGGGGCTGCGAGCACCAGCAACTTTGATTTATAGAAGGAAAATGGAAACCCCCATCTGAGTATTTTGGGAGGAGCCCCCA 
DENND1A.V4       AGCCACCCTGCACGGGGGCTGCGAGCACCAGCAACTTTGATTTATAGAAGGAAAATGGAAACCCCCATCTGAGTATTTTGGGAGGAGCCCCCA 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       GCCCTCATCCAGCTCTGGCACGCTGATACCTCCAGGTACTCCCCTCACTGTCAAAGCTGGGGCTCAGCCTCTTGTCATCTGGAGCTTTGTGGG 
DENND1A.V3       GCCCTCATCCAGCTCTGGCACGCTGATACCTCCAGGTACTCCCCTCACTGTCAAAGCTGGGGCTCAGCCTCTTGTCATCTGGAGCTTTGTGGG 
DENND1A.V4       GCCCTCATCCAGCTCTGGCACGCTGATACCTCCAGGTACTCCCCTCACTGTCAAAGCTGGGGCTCAGCCTCTTGTCATCTGGAGCTTTGTGGG 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       CAAAGCTGAGAAGCTGCAACCCAGATTTCAACCCAAAAAGGTCAAGCTGAATGCCTCAGACTGATGTGGAAGGCAGCTGGCCTTCCTGGGTTG 
DENND1A.V3       CAAAGCTGAGAAGCTGCAACCCAGATTTCAACCCAAAAAGGTCAAGCTGAATGCCTCAGACTGATGTGGAAGGCAGCTGGCCTTCCTGGGTTG 
DENND1A.V4       CAAAGCTGAGAAGCTGCAACCCAGATTTCAACCCAAAAAGGTCAAGCTGAATGCCTCAGACTGATGTGGAAGGCAGCTGGCCTTCCTGGGTTG 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       GAACGAGGCAGTGGCCCTGAGCCCCTTCTCCAGGGCCAGGTAGAAAGGACAAACTTGGTCTCTGCCTCGGGGAAGCAGGAGGAGGGCTAGAAG 
DENND1A.V3       GAACGAGGCAGTGGCCCTGAGCCCCTTCTCCAGGGCCAGGTAGAAAGGACAAACTTGGTCTCTGCCTCGGGGAAGCAGGAGGAGGGCTAGAAG 
DENND1A.V4       GAACGAGGCAGTGGCCCTGAGCCCCTTCTCCAGGGCCAGGTAGAAAGGACAAACTTGGTCTCTGCCTCGGGGAAGCAGGAGGAGGGCTAGAAG 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       CCAGTCCCTCCCCACCTGCCCAGAGCTCCAGGCCAGCACAGAAATTCCTGAGGCCAACGTCACCAAAGTTAGATTGAATGTTTATTATCTTTC 
DENND1A.V3       CCAGTCCCTCCCCACCTGCCCAGAGCTCCAGGCCAGCACAGAAATTCCTGAGGCCAACGTCACCAAAGTTAGATTGAATGTTTATTATCTTTC 
DENND1A.V4       CCAGTCCCTCCCCACCTGCCCAGAGCTCCAGGCCAGCACAGAAATTCCTGAGGCCAACGTCACCAAAGTTAGATTGAATGTTTATTATCTTTC 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       TTTTTCCTTTTTACCTTATTGATTTGATGAATCTTGAAATGGATTCATTTCCATAAACCAAGTTAAAGTATGGCCCGACCATTTAAGAAAACA 
DENND1A.V3       TTTTTCCTTTTTACCTTATTGATTTGATGAATCTTGAAATGGATTCATTTCCATAAACCAAGTTAAAGTATGGCCCGACCATTTAAGAAAACA 
DENND1A.V4       TTTTTCCTTTTTACCTTATTGATTTGATGAATCTTGAAATGGATTCATTTCCATAAACCAAGTTAAAGTATGGCCCGACCATTTAAGAAAACA 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       ACCATCTGAGACACGCAGGAAATTGTGAGCATTTCGACCCGAGCTCTCATTTCCTATTTGTGAAGGGTCAGACACAGTCTACCCAGGGGTGTC 
DENND1A.V3       ACCATCTGAGACACGCAGGAAATTGTGAGCATTTCGACCCGAGCTCTCATTTCCTATTTGTGAAGGGTCAGACACAGTCTACCCAGGGGTGTC 
DENND1A.V4       ACCATCTGAGACACGCAGGAAATTGTGAGCATTTCGACCCGAGCTCTCATTTCCTATTTGTGAAGGGTCAGACACAGTCTACCCAGGGGTGTC 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       TGGGGGACAAGGGGGTCTCTGGAGATGTCACCCAGGGAGCCCCCTCTATGTCTGAGAGGCTGCCACTGCTGCACATGCTCAGTGAGGCTTGGC 
DENND1A.V3       TGGGGGACAAGGGGGTCTCTGGAGATGTCACCCAGGGAGCCCCCTCTATGTCTGAGAGGCTGCCACTGCTGCACATGCTCAGTGAGGCTTGGC 
DENND1A.V4       TGGGGGACAAGGGGGTCTCTGGAGATGTCACCCAGGGAGCCCCCTCTATGTCTGAGAGGCTGCCACTGCTGCACATGCTCAGTGAGGCTTGGC 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
















DENND1A.V1       GGCCATCCTGGCACATGGCTCTTCCTGGGTCAACCGTGACCTGTCTGGCTCAGGAATGGGCTCTGGCTGCTGGGGGAGCCGTGTCACTCCTGG 
DENND1A.V3       GGCCATCCTGGCACATGGCTCTTCCTGGGTCAACCGTGACCTGTCTGGCTCAGGAATGGGCTCTGGCTGCTGGGGGAGCCGTGTCACTCCTGG 
DENND1A.V4       GGCCATCCTGGCACATGGCTCTTCCTGGGTCAACCGTGACCTGTCTGGCTCAGGAATGGGCTCTGGCTGCTGGGGGAGCCGTGTCACTCCTGG 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       GCCATGGGGGCACCTCCTGGGCACTTAGGTGTTTCAGCATAGATTCCAGTTTCGCACCCTGGGCAGACCCCCAGGCCCCATCCGGGATAGGGC 
DENND1A.V3       GCCATGGGGGCACCTCCTGGGCACTTAGGTGTTTCAGCATAGATTCCAGTTTCGCACCCTGGGCAGACCCCCAGGCCCCATCCGGGATAGGGC 
DENND1A.V4       GCCATGGGGGCACCTCCTGGGCACTTAGGTGTTTCAGCATAGATTCCAGTTTCGCACCCTGGGCAGACCCCCAGGCCCCATCCGGGATAGGGC 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       AGAGGAGGTGCTGGCGGCCCCAGGGAAGGAGGGTGTGTACCCCAAGGCCCCCTGGCTGTGCTGAGGGGCTGGGGTGAGCGCTCCATGTTCACA 
DENND1A.V3       AGAGGAGGTGCTGGCGGCCCCAGGGAAGGAGGGTGTGTACCCCAAGGCCCCCTGGCTGTGCTGAGGGGCTGGGGTGAGCGCTCCATGTTCACA 
DENND1A.V4       AGAGGAGGTGCTGGCGGCCCCAGGGAAGGAGGGTGTGTACCCCAAGGCCCCCTGGCTGTGCTGAGGGGCTGGGGTGAGCGCTCCATGTTCACA 
DENND1A.V1,3,4_F  --------------------------------------------------------------------------------------------- 
DENND1A.V1,3,4_R  --------------------------------------------------------------------------------------------- 
 
 
DENND1A.V1       TGAGCACTGCTGCCTCTTCACTTGTGGGACTTTTTGCAAACCCAAGGATGAACTTTGTGTGCATTCAATAAAATCATCTTGGGGAAGAGG 
DENND1A.V3       TGAGCACTGCTGCCTCTTCACTTGTGGGACTTTTTGCAAACCCAAGGATGAACTTTGTGTGCATTCAATAAAATCATCTTGGGGAAGAGG 
DENND1A.V4       TGAGCACTGCTGCCTCTTCACTTGTGGGACTTTTTGCAAACCCAAGGATGAACTTTGTGTGCATTCAATAAAATCATCTTGGGGAAGAGG 
DENND1A.V1,3,4_F  ------------------------------------------------------------------------------------------ 




Supplemental Fig. S4. Alignment of human DENND1A.V2; bovine DENND1A; and predicted bovine 
DENND1A.V2 primer sequences. Alignment was generated with CLUSTAL multiple sequence alignment by 
Kalign (2.0) based on sequences available at Ensembl Asia with transcript ID: human DENND1A.V2 
(ENST00000373620.7) and bovine DENND1A (ENSBTAG00000003610). Uppercase letters represent the 
exons, whereas lowercase letters represent the introns and only the sequence encompassing the exons is 
shown. Highlighted areas represent the primer sequences. …………………… represent areas of intronic sequence that 





















































































































































































































































































































































































































DENND1A.V2_HUMAN   TGTTTAATATGCCCTGTTTTCTACTTCTGTTGGA-AAATATTTGGGGTTGAAATAAACCAGTGGGAGCATGGG-AGCCAGTTTG 















































































































































































































































































DENND1A.V2_HUMAN   ------------------------------------------------------------------------------------ 













































































































































































































Supplemental Fig. 5. An adjacent matrix network graph of bovine gene expression using 
correlation coefficients from Tables II generated with R-program. The closeness of the genes 
and the thickness of the interconnecting lines indicate the strength of the correlations between 






Supplemental Fig. 6. Differential mRNA expression levels of PCOS candidate genes which 
are highly expressed during early gestation in the cortex and medulla of bovine fetal ovaries. 
Samples were grouped into early (n = 5, 10 – 17 weeks of gestation) and later (n= 5, 36 – 39 
weeks of gestation) time of gestation. Data are presented as mean  s.e.m. (normalised to 
PPIA and RPL32). Black and grey bars represent cortex and medulla, respectively. Unpaired 




Supplemental Fig. 7. Differential mRNA expression levels of genes which are highly 
expressed late in gestation in the cortex and medulla of bovine fetal ovaries. Samples were 
grouped into early (n = 5, 10 – 17 weeks of gestation) and later (n= 5, 36 – 39 weeks of 
gestation) stages of gestation. Data are presented as mean  s.e.m. (normalised to PPIA and 
RPL32). Black and grey bars represent cortex and medulla, respectively. Unpaired t-test were 




Supplementary Figure 8. Differential mRNA expression levels of PCOS candidate genes 
which are evenly expressed throughout gestation in the cortex and medulla of bovine fetal 
ovaries. Samples were grouped into early (n = 5, 10 – 17 weeks of gestation) and late (n= 5, 
36 – 39 weeks of gestation) stages of gestation. Data are presented as mean  s.e.m. 
(normalised to PPIA and RPL32). Black and grey bars represent cortex and medulla, 




Supplemental Fig. 9. Differential mRNA expression levels of (A) VASA, (B) OCT4 and (C) 
KRT19 throughout gestation in the cortex and medulla of bovine fetal ovaries. Samples were 
grouped into early (n = 5, 10 – 17 weeks of gestation) and late (n= 5, 36 – 39 weeks of 
gestation) stages of gestation. Data are presented as mean  s.e.m. (normalised to PPIA and 
RPL32). Black and grey bars represent cortex and medulla, respectively. Unpaired t-test were 




Supplemental Fig. 10. Differential mRNA expression levels of PCOS candidate genes which 
are highly expressed during early gestation in bovine fetal fibroblasts from less than 150 days 
of gestation cultured for 18 h in the presence of 24 different hormones and growth factors as 
indicated (A to F). Data are represented as mean  s.e.m. of fold change in expression relative 
to the untreated control (n = 4 ovaries, each from 13, 14, 17 and 19 weeks of gestation). One-
way ANOVA with Dunnet’s post hoc test were used to analyse the data. Asterisk symbols 





Supplemental Fig. 11. Differential mRNA expression levels of PCOS candidate genes which 
are highly expressed late during gestation in bovine fetal fibroblasts from less than 150 days 
of gestation cultured for 18 h in the presence of 24 different hormones and growth factors as 
indicated (A to F). Data are represented as mean  s.e.m. of fold change in expression relative 
to the untreated control (n = 4 ovaries, each from 13, 14, 17 and 19 weeks of gestation). One-
way ANOVA with Dunnet’s post hoc test were used to analyse the data. Asterisk symbols 





Supplemental Fig. 12. Differential mRNA expression levels of PCOS candidate genes which 
are evenly expressed throughout gestation in bovine fetal fibroblasts from less than 150 days 
of gestation cultured for 18 h in the presence of 24 different hormones and growth factors as 
indicated (A to F). Data are represented as mean  s.e.m. of fold change in expression relative 
to the untreated control (n = 4 ovaries, each from 13, 14, 17 and 19 weeks of gestation). One-
way ANOVA with Dunnet’s post hoc test were used to analyse the data. Asterisk symbols 
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Introduction to chapter IV 
The development of fetal ovary begins at the surface of mesonephros, a temporary kidney 
during fetal life. The mesonephric epithelial cells differentiate into GREL cells and then 
proliferate, forming the developing ovary along with germ cells. Once the mesonephric stroma 
penetrates and branches, some GREL cells and germ cells are clustered into ovigerous cords. 
GREL cells give rise to granulosa cells, forming primordial follicles first located in the inner 
ovarian cortex. In this publication, my contribution was 15%, morphometrically analysing the 
non-stroma component of ovarian cortex morphometrically throughout gestation. My aim for this 
publication is to analyse the behaviour of GREL and germ cells during bovine fetal ovarian 
development, in relation with the changes in the stromal-areas. The non-stromal areas containing 
GREL cells and germ cells were morphometrically analysed across gestation. Using a stromal 
marker, collagen type I, and proliferation marker, Ki67, the non-stromal area was identified by 
subtracting the total cortical area with the stromal area. The total volume, volume density, 
proliferation index and numerical density of proliferating cells as well as all cells in the non-
stromal area were counted and analysed in the five different stages of development, based on the 
morphological characteristics. The total volume of non-stromal areas in the ovarian cortex 
inclined significantly, however the volume density of non-stromal areas declined significantly 
throughout gestation. This study was conducted by Monica Dwi Hartanti.  
For publication purposes, we combined these results with another gene expression study 
done by our group, analysing germ cell, stem cell, GREL cell and granulosa markers throughout 
gestations. We concluded that these genes had a relationships between each other and might 
indicate their parts in critical points during ovarian development, such as differentiation of 
GREL cells to granulosa cells.  We managed to produce one paper published in PLos One and I 
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Cells on the surface of the mesonephros give rise to replicating Gonadal Ridge Epithelial-
Like (GREL) cells, the first somatic cells of the gonadal ridge. Later germ cells associate
with the GREL cells in the ovigerous cords, and the GREL cells subsequently give rise to the
granulosa cells in follicles. To examine these events further, 27 bovine fetal ovaries of differ-
ent gestational ages were collected and prepared for immunohistochemical localisation of
collagen type I and Ki67 to identify regions of the ovary and cell proliferation, respectively.
The non-stromal cortical areas (collagen-negative) containing GREL cells and germ cells
and later in development, the follicles with oocytes and granulosa cells, were analysed mor-
phometrically. Another set of ovaries (n = 17) were collected and the expression of genes
associated with germ cell lineages and GREL/granulosa cells were quantitated by RT-PCR.
The total volume of non-stromal areas in the cortex increased significantly and progressively
with ovarian development, plateauing at the time the surface epithelium developed. How-
ever, the proportion of non-stromal areas in the cortex declined significantly and progres-
sively throughout gestation, largely due to a cessation in growth of the non-stroma cells and
the continued growth of stroma. The proliferation index in the non-stromal area was very
high initially and then declined substantially at the time follicles formed. Thereafter, it
remained low. The numerical density of the non-stromal cells was relatively constant
throughout ovarian development. The expression levels of a number of genes across gesta-
tion either increased (AMH, FSHR, ESR1, INHBA), declined (CYP19A1, ESR2, ALDH1A1,
DSG2, OCT4, LGR5) or showed no particular pattern (CCND2, CTNNB1, DAZL, FOXL2,
GATA4, IGFBP3, KRT19, NR5A1, RARRES1, VASA, WNT2B). Many of the genes whose
expression changed across gestation, were positively or negatively correlated with each
other. The relationships between these genes may reflect their roles in the important events
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Introduction
The ovary development starts with the formation of the genital ridge formed by increased pro-
liferation of the surface epithelium on the ventromedial side of the mesonephros. These prolif-
erating cells are now termed the gonadal ridge epithelial-like (GREL) cells [1] and express
cytokeratin 19 (KRT19) and desmosomal proteins such as desmoglein-2 (DSG2) and plako-
philin-2. Later in development the GREL cells differentiate into pre-granulosa or surface epi-
thelial cells. The formation of the genital ridge requires the expression of empty spiracles
homeobox protein 2 (EMX2), LIM homeobox protein 9 (LHX9), Wilms Tumor 1 (WT1), ste-
roidogenic factor (SF1/NR5A1) [2, 3] and GATA binding protein 4 (GATA4) [4]. The absence
of sex determining region Y (SRY) results in the bipotential gonad committing to the ovary-
determining pathway. This is accompanied by the expression of Wingless-related MMTV
integration site family member 4 (Wnt4) [5], β-catenin (CTNNB1) [6], R-spondin 1 (Rspo1)
[7] and Forkhead box L2 (FOXL2) [8, 9] [10].
The primordial germ cells arise from the yolk sac and migrate under the influence of kit
ligand and its receptor towards the gonad. After colonising the developing gonad composed of
GREL cells, the primordial germ cells start proliferating and express pluripotency markers
such as octamer binding protein 4 (OCT4) [11]. Later in the developing ovary the mitotically
active germ cells, termed oogonia, become oocytes after entering meiosis. The entry into meio-
sis is accompanied by expression of deleted in azoospermia-like (DAZL) and induced by reti-
noic acid, which is synthesised by aldehyde dehydrogenases (ALDH1-3) [12]. Subsequently
germ cells switch from expressing DAZL to VASA [11]. Oocytes arrest in the dictyate phase of
meiosis I until shortly before ovulation when meiosis is resumed.
The ovarian stroma arises from the mesonephric connective tissue after breakdown of the
basal lamina underlying the surface epithelium [1]. This stroma, including its vasculature, pen-
etrates the mass of GREL cells and PGCs/oogonia, branching as it does and so corralling the
GREL and germ cells into forming the ovigerous cords [1]. Subsequently the continued expan-
sion of the stroma [13] likely separates the ovigerous cords into smaller cords until the first pri-
mordial follicles are formed, consisting of one layer of flattened pre-granulosa cells and a
meiotically-arrested oocyte [1, 14, 15]. In the mouse, two different populations of primordial
follicles have been identified [16]. Medullary follicles are activated shortly after birth, while
cortically located follicles activate gradually throughout life. In addition, medullary pre-granu-
losa cells express FOXL2 while cortical pre-granulosa cells express Leucine Rich Repeat Con-
taining G Protein-Coupled Receptor 5 (LGR5) [17].
Lateral spread of the stroma below the surface of the ovary partitions some GRELs to the
surface, which become the surface epithelial cells. Fibroblasts, the major cell type of the stroma,
express Nuclear Receptor Subfamily 2 Group F Member 2 (NR2F2/COUP-TFII) and produce
fibrillar extracellular matrix components, such as collagen type I (COL1A1), collagen type III
(COL3A1) and fibrillins (FBN1-3) [1, 18]. Members of the TGFβ-superfamily have important
roles during oogenesis and folliculogenesis [19–22]. Activin or inhibin (INHBA), anti-Mulle-
rian hormone (AMH) and FSH receptor (FSHR) are involved in granulosa cell proliferation
and differentiation [19].
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Many of the recent discoveries of the developing ovary come from studies of mice using
lineage tracing techniques and manipulation of gene expression during development. Whilst
these have helped to make substantial gains on our knowledge, these studies generally have not
fully assessed the behaviours of the different somatic cell types, such as GREL cells and fibro-
blasts, and the processes that these can undertake in unison at different stages of ovarian devel-
opment. To address this, the current study first examined replication of non-stromal cells and
the changes in their volume during gestation and compares this with changes in the stromal
compartments [13]. The expression patterns of genes related to germ and stem cells, and
GREL and granulosa cells in fetal ovaries across gestation were also examined and discussed in
relation to changes occurring in the ovary at those times. Genes related to stromal cells and the
extracellular matrix have been discussed in a companion publication [23].
Materials and methods
Tissues
Fetuses of pregnant Bos taurus cows were collected at T&R Pastoral abattoir at Murray Bridge,
SA, Australia and then transported on ice to the laboratory. Crown-rump length was measured
to estimate gestational age [24]. Some ovaries were fixed in 4% paraformaldehyde (Merck Pty
Ltd, Kilsyth, VIC, Australia) in 0.1 M phosphate buffer (pH 7.4) for immunohistochemistry
and morphometric analyses (n = 27) and others from different animals were frozen at -80˚C
for subsequent RNA analyses (n = 17).
Gender determination
To confirm the gender of young fetuses (smaller than 8 cm), genomic DNA was extracted
from the tail samples using the Wizard SV Genomic DNA Purification System (Promega Aus-
tralia, Alexandria, NSW, Australia) according to the manufacturer’s instructions. Genomic
DNA was amplified with a primer pair (sense primer: 5’-TCACTCCTGCAAAAGGAGCA-3’,
antisense primer: 5’-TTATTGTGGCCCAGGCTTG-3’), specific for a region in the SRY-
determining sequence, and primers specific for the 18S ribosomal RNA gene sequence [25] in
separate reactions. SRY product sequences were verified by automated sequencing (3730 DNA
analyser; Applied Biosystems, Mulgrave, VIC, Australia).
Histology and immunohistochemistry
Fixed ovaries, as used previously [13] were embedded in paraffin using a Leica EG 1140H
(Leica Microsystems, Nussloch, Germany). Six-μm sections were cut using a CM1850 V2.2
Leica microtome (Leica Microsystems), mounted on Superfrost glass slides (HD Scientific
Supplies, Wetherill Park, NSW, Australia) and stored at RT until used for haematoxylin-eosin
(H&E) staining and immunohistochemistry. H&E-stained sections were used for sample
grouping based on histological morphology: stage 1—ovigerous cord formation (n = 7, 79 ± 6
days of gestation), stage 2—ovigerous cord breakdown (n = 4, 127 ± 6 days), stage 3—follicle
formation (n = 3, 173 ± 12 days), stage 4—ovarian surface epithelium formation (n = 8,
234 ± 9 days) and stage 5—tunica albuginea formation (n = 5, 264 ± 6 days)] [13].
An indirect immunofluorescence method was used for colocalisation of Ki-67 and collagen
type I as previously described in detail previously [13] and illustrated in Fig 1. Primary anti-
bodies were mouse anti-human Ki67 (1:800; M7240/MIB-1; DAKO Australia Pty Ltd, Botany,
NSW, Australia) to identify proliferating cells in combination with rabbit anti-human collagen
type I (1:400; 20μg/ml; ab34710; Abcam, Sapphire Bioscience Pty Ltd., Waterloo, NSW, Aus-
tralia) to identify the stroma. Secondary antibodies were donkey anti-mouse IgG conjugated
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to Cy3 (1:100; 715-166-151) and biotin-SP-conjugated AffiniPure donkey anti-rabbit IgG
(1:100; 711-066-152) followed by fluorescein DTAF-conjugated streptavidin (1:100; 016-010-
084). All secondary antibodies and conjugated streptavidin were from Jackson ImmunoRe-
search Laboratories Inc. (West Grove, PA, USA). Cell nuclei were counterstained with 4’,6’-
diamidino-2-phenylindole dihydrochloride (DAPI) solution (Molecular Probes, Eugene, OR,
USA). Non-immune mouse and rabbit sera (Sigma-Aldrich, New South Wales, Australia)
were used as negative controls. All sections were photographed with an Olympus BX50 micro-
scope (Olympus, Tokyo, Japan) with an epifluorescence attachment and a Spot RT digital cam-
era (Diagnostic Instruments, Sterling Heights, MI, USA) at a magnification of 40x.
Image analyses
Fluorescence images were analysed with ImageJ software. For this purpose, the cortical region
of the largest section from each ovary was examined morphometrically. Ten fields of view
were analysed for ovaries from fetuses with CRL< 50 cm (182 days of gestation) and 20 fields
of view (0.06 mm2) for a CRL> 50 cm. The image analysis procedure has been described in
detail by Hartanti et al. [13]. To identify the amount of non-stromal compartment in the cortex
containing the ovigerous cords and follicles, the stromal area identified by collagen type I
staining was subtracted from the total cortical area. The proportion of non-stromal in the cor-
tex (volume density) was calculated as the ratio between the non-stromal area and the total
cortical area. The ovarian volume was estimated using the ovarian weight and assuming a den-
sity of 1g/cm3. The volume of the cortex was then derived from the volume of the ovary and
the volume density of the cortex. Similarly, the non-stromal volume was calculated from the
volume of cortex and the volume density of non-stroma in the cortex. The number of prolifer-
ating cells (KI-67 positive) in ovigerous cords or follicles and the total number of non-stromal
cells (DAPI positive) in a field of view were counted. Results of proliferating cells were pre-
sented as a proliferation index and as a numerical density in the non-stromal area.
RNA extraction, cDNA synthesis and quantitative real time PCR
All fetal ovary samples for RNA sample extraction were homogenised with 1 ml of Trizol (Cat
# 15596–026, Thermo Fisher Scientific, Waltham, MA, USA) each for two 10 s cycles at 3,500
rpm in a PowerLyzer 24 Bench Top Bead-Based Homogeniser (MoBio, Carlsbad, Ca, USA).
Fig 1. Representative photographs from stage I (the formation of ovigerous cords) (A) and stage III (the formation of follicles) (B).
Collagen type I (green) is colocalised with the proliferation marker Ki67 (red, marked with arrow). Nuclei are counterstained with DAPI.
Scale bar: 25 μm. � ovigerous cords/ primordial follicles, S stroma.
https://doi.org/10.1371/journal.pone.0214130.g001
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The samples were then processed according to the standard Trizol protocol and resuspended
in 30 μl of nuclease free H2O. Ten μg or less of each sample was treated with 2 U of DNAse 1
for 20 min at 37˚ C and the enzyme removed using DNAse inactivation reagent (Thermo
Fisher Scientific). Two hundred ng of DNAse-treated RNA was used for reverse transcription
reactions with or without Superscript RT III (Thermo Fisher Scientific) to generate cDNA or
negative control to detect genomic contaminant, respectively.
PCR primers pairs were designed where possible to span intron-exon junctions or from dif-
ferent exons for quantitative real time PCR (qRT-PCR) using the free web-based software pro-
grams, Primer3 plus (Rozen and Skaletsky) and Net primer (PREMIER Biosoft, Palo Alto, CA,
USA), based on the Reference RNA sequences available in NCBI (Table 1). The cDNA was
diluted from 1 in 4 to 1in 1000 and pooled from 10 samples to generate 5 standards which
were used to establish a standard curve for testing primer combinations for quantitative real
time PCR. Only those assays which gave a single sharp peak by melt curve analysis and
achieved an amplification efficiency of 0.9–1.1 and an R2 value� 0.98 were used for quantita-
tion of gene expression.
The reactions were performed in duplicate on a Fluidigm Biomark HD instrument (San
Francisco, CA, USA) using the following protocol. The reaction started with a pre-amplifica-
tion step consisting of a 95˚C hold for 10 min, followed by 12 cycles of 95˚C for 15 s and 60˚C
for 4 min each using 50 nM of each primer and 2.5 μl of cDNA in 10 μl. The amplified product
was then diluted 1 in 5 and added in 0.05 μl to the final reaction volume of 0.1 μl in a 48 x 48
plate which contained 500 nM of each primer per assay. The final amplification conditions
were a 60 s activation step at 95˚C, followed by 30 cycles of 96˚C denaturation for 5 s and 60˚C
annealing/extension for 20 s using SsoFast EvaGreen Supermix with Low ROX (Biorad, Her-
cules, Ca, USA) which contained a fluorescent intercalating agent for measuring amplification.
The expression values for each gene were determined as the mean of the ratio of 2-Δ Ct for the
target gene to the mean of RPL32 and PPIA because this gene combination was determined to
be the most stable across all samples out of RPL32, PPIA, ACTB and GAPDH with a value of
0.056 using the Normfinder program.
Statistical analyses
ANOVA and post-hoc statistical calculations using Tukey’s test were performed using Graph-
Pad Prism version 6.00 (GraphPad Software Inc., La Jolla, CA, USA) following log transforma-
tion where appropriate to normalise the raw data distribution. Pearson’s correlations across all
target genes and samples were performed on the data in Partek Genomics Suite (St Louis, MI,
USA). Hierarchical clustering by gene only was also performed on the data using the Euclidian
algorithm for dissimilarity with average linkage in Partek to generate a heatmap of relative
gene expression. Prior to clustering, the raw data were first normalised by adjusting the mean
expression across all samples for each gene to zero and the standard deviation to one.
Results and discussion
Morphometric analyses of non-stromal component of the ovarian cortex
The non-stromal area of the cortex includes ovigerous cords at early stages (stages I and II)
and follicles at later stages (stages III to V) (Fig 1). Its total volume increased significantly and
progressively with ovarian development but plateaued at stage IV (Fig 2A). However the pro-
portion of non-stroma in the cortex (volume density) declined significantly and progressively
throughout gestation (Fig 2B), largely due to a cessation at stage III as indicated by the plateau-
ing in its volume, and the continued growth of stroma after stage III [13].
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Table 1. List of genes and primers used for qRT-PCR.
Gene name Gene Symbol GenBank Accession No. Primers (5’-3’) Size (bp)
Aldehyde dehydrogenase 1 family, member A1 ALDH1A1 NM_174239.2 F: GCGGAAACACAGTGGTTGTC 150
R: GAGAAGAAATGGCTGCCCCT
Anti Mullerian Hormone AMH NM_173890.1 F: ACACCGGCAAGCTCCTCAT 67
R: CACCATGTTTGGGACGTGG
Cyclin D2 CCND2 NM_001076372.1 F: GGTGGATCTCCTGGCAAAGA 98
R: ACGGTACTGCTGCAGGCTATTC
Catenin (cadherin-associated protein), beta 1, 88kDa CTNNB1 NM_001076141 F: GAATTGACAAAACTGCTGAATGATG 102
R: GATGGCGTGTCTCGAAGCTT
Cytochrome P450 family 19 subfamily A, member 1 CYP19A1 NM_174305.1 F: ATGCTTTTGGAAGTGCTG 143
R: TTAGCGCTCGAGGCAC
Deleted in azoospermia-like DAZL NM_001081725.1 F: ACGTTTTGCCCAGTGAATGC 98
R: TACCACCGTCTGTATGCTTCTG
Desmoglein 2 DSG2 NM_001192172.2 F: AAGACCCTCGCTGAAGTTTG 84
R: TGCTTCTCTTGCGGGTTTTG
Estrogen receptor 1 ESR1 NM_001001443.1 F: GTCCACCTTTTGGAATGTGC 124
R: ATTTTCCCTGGTTCCTGTCC
Estrogen receptor 2 ESR2 NM_174051.3 F: TCGACTTCGGAAGTGCTATGAG 136
R: ACCGTTCCTCTTGGTTTTGC
Forkhead box L2 FOXL2 NM_001031750.1 F: AGAATAGCATCCGCCACAAC 127
R: CCCTTCTCGAACATGTCCTC
Follicle stimulating hormone receptor (FSHR) FSHR NM_174061.1 F: GACCCTGATGCCTTCCAGA 74
R: TGGCAAGTGCTTAATACCTGTGTT
Glyceraldehyde 3-phosphate dehydrogenase GAPDH NM_001034034.2 F: ACCACTTTGGCATCGTGGAG 76
R: GGGCCATCCACAGTCTTCTG
GATA binding protein 4 GATA4 NM_001192877.1 F: CAGGAGGCAAAAATGCTAGG 82
R: ATCACCCGTCGTCTTTCTTC
Inhibin, beta A INHBA NM_174363.2 F: ATCATCACGTTCGCGGAATC 144
R: ACTTTGCTCCGGGTCCTGTT
Keratin 19 KRT19 NM_001015600.3 F: AAGCTTTGCGCATGAGTGTG 97
R: TCAATCTGCATCTCCAGGTCAG
Leucine-rich repeat containing G protein-coupled receptor 5 LGR5 NM_001277226 F: TTGGGAGATCTGCTTTTCAACA 64
R: TGTGAGGCGCCATTCAAA
Nuclear receptor subfamily 5, group A, member 1 NR5A1 NM_174403.2 F: CAGACCTTCATCTCCATCGTG 147
R: CTTGCCATGCTGAATCTGAC
POU class 5 homeobox 1 OCT4 NM_174580.2 F: AGGCTTTGCAGCTCAGTTTC 79
R: TTGTTGTCAGCTTCCTCCAC
Ribosomal protein L19 RPL19 NM_001040516.1 F: GATCCGGAAGCTGATCAAAG 113
R: TACCCATATGCCTGCCTTTC
DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 VASA NM_001007819.1 F: ATGAAGCTGATCGCATGCTG 91
R: TGACGCTGTTCCTTTGATGG
Wingless-type MMTV integration site family, member 2B WNT2B NM_001099363 F: CGGACTGACCTGGTCTACTTTG 67
R: AGGGAACCTGCAGCCTTGT
F is forward and R is the reverse primer sequence.
https://doi.org/10.1371/journal.pone.0214130.t001
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Expression of Ki67 was used to estimate the percentage of proliferating cells at different
developmental stages. The proliferation index of the non-stromal area was highest at stages I
and II, declining substantially at stage III and remaining very low thereafter (Fig 2C). Further-
more, we calculated the numerical density of proliferating cells and all cells in the non-stromal
compartment. The numerical density of proliferating cells also significantly declined at stage
III and then remained low (Fig 2D). The observed high proliferation in the early stages of ovar-
ian development relates mainly to the germ cells (identified based on their morphology),
which show high mitotic activity after settling in the genital ridge and differentiation into
oogonia [26, 27]. The decline in proliferation at stage III was, however, accompanied by an
increase of the total volume of non-stroma and further small percentage increases in stages IV
and V. These were presumably due to increases in the volumes of germ cells from oogonia to
oocytes and at the very latter stages activation of follicles.
The highest number of ovarian germ cells is reached around day 90 in the bovine [28] and
182 days in human gestation [29]. The oogonia start to enter meiosis between weeks 10–11 in
human [29] and arrest in prophase I until puberty. However in the human fetal ovary, mitotic
oogonia occur simultaneously to meiotic oocytes until five months of gestation [29, 30], which
is the time point after stage II in our study when the proliferation drops drastically. This is the
time when the first primordial follicles are formed, between days 90–140 in the bovine [31]
and days 126–133 in the human [32]. However, the numerical density of proliferating cells did
Fig 2. Morphometric analyses of the non-stromal component of the ovarian cortex during bovine fetal ovarian development. Data are presented as
means ± SEM. Samples were grouped into 5 stages of ovarian development based on their histological morphology: ovigerous cord formation (n = 7,
stage I), ovigerous cord breakdown (n = 4, stage II), follicle formation (n = 3, stage III), ovarian surface epithelium (OSE) formation (n = 8, stage IV)
and tunica albuginea formation (n = 5, stage V). One-way ANOVA with post hoc Tuckey’s test were used to analyse the data. � P< 0.05, �� P< 0.01,
��� P< 0.001, ���� P< 0.0001. Volume density is the percentage of cortex that is the non-stromal compartment.
https://doi.org/10.1371/journal.pone.0214130.g002
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slightly increase from stage III to stage IV but not significantly. This is consistent with the acti-
vation of primordial follicles toward differentiation into primary follicles, which occurs in the
human between 238–266 days [33] and in the bovine between 140–210 days of gestation [31],
corresponding to stage III and IV in our study. The subsequent differentiation of the primary
follicles to secondary follicles is accompanied by granulosa cell proliferation to form the multi-
ple layers of granulosa cells in more mature follicles. The first secondary follicles have been
observed in the bovine fetal ovary after day 210 of gestation [31], which corresponds with stage
IV in our study. The numerical density of all the non-stromal cells appeared relatively stable
throughout ovarian development (Fig 2E).
Germ cell markers
The pluripotency marker OCT4 was highly expressed in early ovarian development and then
declined rapidly by 120 days of gestation at stage II (Fig 2A and S1A Fig). This is expected as
germ cells first undergo mitosis and then differentiate and enter meiosis I after colonising the
developing ovary. DAZL and VASA levels were very low at 58 and 66 days, with higher but var-
iable levels during the rest of gestation (Fig 3B and 3D and S1B–S1D Fig). As we observed pre-
viously in early gestation in particular [1] the developmental stage of ovaries can differ from
one animal to another at the same age. This variability might be caused by environmental
effects such as nutrition during gestation [34]. We therefore devised a classification system of
developmental stages I to V for the morphometric analysis instead of using gestational age.
However, for the RNA analyses the ovaries were not collected for histological classification
and so we have analysed those data by age of the fetus as determined by the crown-rump
length [24], which could contribute to some variability.
In species with long gestations and large ovaries, like the bovine, different portions of the
ovary can be at different developmental stages, especially since follicle formation commences
Fig 3. Germ and stem cell-specific genes in fetal ovarian development. Expression levels of genes for each animal are plotted against gestational age
in days (n = 16 or 17).
https://doi.org/10.1371/journal.pone.0214130.g003
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at the medullary-cortical interface and progresses over time in the direction of the surface.
Thus it is not unusual to have follicles near the medulla that have not only formed but have
commenced growing whilst at the same time ovigerous cords are still present near the surface
of the ovary (Fig 3K of [1]). Consequently, although individual germ cells sequentially express
OCT4, DAZL and then VASA [1], this does not necessarily occur with RNA analyses of whole
ovaries as the isolated RNA from whole ovaries reflects the total of all the developmental stages
of germ cells at any one time in each ovary.
Stem cell markers
Whilst LGR5 and ALDH1A1 are stem cell markers, their expression could indicate develop-
ment of either germ cells or somatic stem cells that exist in the ovary [15]. The stem cell marker
LGR5 declined throughout gestation to low levels in the third trimester (Fig 2B–2D and S1B–
S1D Fig). A recent study in human fetal ovaries reported an initial decline in LGR5 expression
levels from 8–11 weeks to 14–16 weeks, but then no further change towards 17–21 weeks [35].
Furthermore, treatment with BMP-4 of cultured fetal cells (~ 14 weeks) increased the expres-
sion of LGR5. In the mouse, lgr5 expression first occurs at E13.5 in cells on the surface and sub-
surface. The subsurface expression declines towards postnatal day 1 and is diminished by
postnatal day 7. The lgr5-positive cells in the subsurface express foxl2, a granulosa cell marker,
and the lgr5-positive cells on the surface express cytokeratin 8, a surface epithelial marker [36].
lgr5-positive cells are also involved in the rapid remodelling of the surface epithelial layer after
ovulation, suggesting that they have stem cell properties [36]. On the other hand, Rastetter
et al. [17] found that lgr5 is expressed in somatic cells, which neither express foxl2 nor nr2f2
(coup-tfII), and that lgr5 expression increases after sex determination in the fetal mouse ovary
until birth.
The expression of ALDH1A1, another stem cell marker, is barely detectable prior to day 79
but increased significantly and linearly thereafter (Fig 2E and S1E Fig). ALDH1A1, encodes
retinaldehyde dehydrogenase, and is involved in the last step of the synthesis of retinoic acid,
which is crucial for entry of germ cells into meiosis. This would explain the observed increase
in the bovine as the entry of oogonia into meiosis occurs around 80 to 130 days of gestation
[37]. In contrast, a study in the human fetal ovary analysing the mRNA levels of ALDH1A1 at
8–9 weeks (undifferentiated primordial germ cells), 14–16 weeks (meiotic entry) and 17–20
weeks (primordial follicle formation), reported a trend of declining expression [12]. The signif-
icance of ALDH1A1 expression in the bovine ovary is yet to be determined.
GREL cell markers
KRT19 has been shown to be expressed in GREL cells [1]. Later in development when the sur-
face epithelium has formed it is more highly expressed in the ovarian surface epithelial cells
[1]. KRT19 expression was highest at mid gestation (Fig 4A and S2A Fig). Cytokeratin 19 has
been previously detected in the undifferentiated gonadal blastemal, in the somatic cells of ovi-
gerous cords and early follicle stages in the mice [38] and in the rat [39] as well as in the oviger-
ous cords and primordial, primary and preovulatory follicles in human [40]. DSG2 is a
desmosomal protein also expressed in GREL cells and later in the ovarian surface epithelial
cells [1]. It was more highly expressed in early gestation and then declined steadily across ges-
tation (Fig 4B and S2B Fig). This expression pattern can be explained by the differentiation of
GREL cells into either surface epithelial cells or granulosa cells with the latter not expressing
desmosomes [41].
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Granulosa cell markers
The genes analysed in this section were chosen based on knowledge of either direct expres-
sion in fetal ovaries or in some cases inferred from expression observed in adult ovarian gran-
ulosa cells, such as CYP19A1. Analysing the expression of genes specific for granulosa cells
revealed three patterns (Fig 4 and S3 Fig). Firstly, genes which increased throughout gestation
and these include: AMH (Fig 5B and S3B Fig), FSHR (Fig 5C and S3C Fig), ESR1 (Fig 5E and
S3E Fig) and INHBA (Fig 5G and S3G Fig). AMH and FSHR have low expression in early and
mid-gestation and then a rapid increase towards the end of gestation, whereas the expression
of ESR1 and INHBA increased steadily across gestation. The increase in AMH as well as FSHR
is consistent with follicle activation and growth, which commences around day 180 of gesta-
tion in the bovine [42]. AMH is expressed by granulosa cells from preantral and small antral
follicles [43] in women. FSHR is expressed in the granulosa cells of primary and secondary
follicles with greater expression at antral stages in the bovine fetus [42]. Similar to our find-
ings in this study, INHBA increases in second trimester human ovaries [44]. In rodents, inhba
is expressed at low levels in the fetal ovary [45, 46], which might be due to follicle formation
occurring mostly after birth. There is no detectable INHBA expression in ovine fetal ovaries
throughout gestation [47]. However, the activin/inhibin βA subunit has been immunoloca-
lised to clusters of maturing oocytes in the fetal human ovary (18 weeks) prior to primordial
follicle formation, suggesting a role of activin A in the proliferation and survival of germ cells
at this stage [44]. Activin-βA mRNA is expressed in the goat from 36 dpc until adulthood and
has been considered to be a candidate co-factor for the action of FOXL2 on CYP19A1 [48].
Treatment of fetal human ovary transplants with activin A increased proliferation of oogonia
[44], and in neonatal mice the number of primordial follicles [49]. The corresponding recep-
tors; ActRIIA, ActRIIB and ALK4 (ActRIB) are expressed by germ cells and the latter two
additionally in stromal cells or other somatic cells amongst germ cell nests. The signalling tar-
gets of activin, Smad 2 and 3, have been localised to the nuclei of stromal cells and other
somatic cells between germ cells nests and also to pre-granulosa cells of primordial follicles in
human fetal ovaries between 14 and 20 weeks [50]. The expression of INHBA is increased in
fetal human ovary transplants treated with prostaglandin E2, which in vivo is synthesised by
germ cells [51]. Activins not only affect germ cell proliferation and survival, but are also
involved in the later stages of follicle differentiation, granulosa cell proliferation and oocyte
maturation [reviewed in [52, 53]].
Fig 4. Genes specific for GREL cells in fetal ovarian development. Expression levels of genes for each animal are
plotted against gestational age in days (n = 16 or 17).
https://doi.org/10.1371/journal.pone.0214130.g004
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Genes whose expression declined with gestational age included: CYP19A1 (Fig 5D and S3D
Fig), ESR2 (Fig 5F and S3F Fig), GATA4 (Fig 5I and S3I Fig) and the cell cycle gene CCND2
(Fig 5L and S3L Fig). Previous studies in cattle focusing on the expression of P450arom
(encoded by CYP19A1) and the two oestrogen receptors, ERα (ESR1) and ERβ (ESR2),
throughout gestation, found no decline in the expression of P450arom and ERβ. The results
were determined by in situ hybridisation and immunolocalisation [54, 55], neither of which is
as accurate as the quantitative RT-PCR used in the current study. Both mRNAs and proteins
were expressed by surface epithelial cells, pre-granulosa cells, granulosa cells and cells in the
Fig 5. Granulosa cell-specific genes in fetal ovarian development. Expression levels of genes for each animal are plotted against gestational age in
days (n = 16 or 17).
https://doi.org/10.1371/journal.pone.0214130.g005
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medulla, which are likely stromal cells [54, 55]. On the other hand, it has been reported that
oestradiol is produced early in ovarian development and declines when follicle growth occurs
later in gestation [31, 56], which could explain the high expression levels we observed in the
first trimester and the following observed decline in CYP19A1 and ESR2 throughout gestation.
In the goat, CYP19A1 and ESR2 expression has been detected from 36 dpc and ESR1 from 40
dpc until adulthood [48, 57]. P450arom is localised to somatic cells, which express FOXL2, in
the medullar region, whereas ERβ is also localised to germ cells [48]. In mice, ESR1 is mainly
expressed in interstitial (stromal) cells, whereas ESR2 is expressed in granulosa cells [58]. So,
the observed increase of ESR1 could be due to the expansion of the stromal compartment [13]
throughout ovarian development. We previously found that a high cell proliferation rate
occurs in stromal and non-stromal compartments early in ovarian development which then
declines towards mid- and late gestation [13], which would also explain the higher expression
levels of CCND2 observed early in gestation.
GATA-4 plays an important role during formation of the genital ridge and sex determina-
tion [59, 60]. Down-stream targets of GATA-4 are AMH [60, 61], SF1 (alias NR5A1), STAR
(steroidogenic acute regulatory protein), CYP19A1 [62, 63], INHA and INHBB [64] and
FOXL2 [65, 66]. It is constantly expressed in the bipotential gonad and after sex differentiation
in the ovary in fetal mice [67] and pigs [68]. In the postnatal mice, GATA-4 is found in the
granulosa and thecal cells of growing follicles and stromal cells, but not in luteal cells [67], in
contrast to the human adult ovary [69]. In human fetal ovaries, GATA4 is expressed in stromal
and pre-granulosa cells and later in granulosa cells with the highest expression occurring early
in development (~ 14 weeks) [70]–similar to our findings. Downregulation or loss of GATA-4
caused interruptions in folliculogenesis and recruitment of granulosa and thecal cells resulting
in lower numbers of primary follicles and activated follicles, and increased follicular atresia in
the existing follicles in adult mouse ovaries [59, 71]. GATA-4 appears to have an anti-apoptotic
effect on granulosa cells [70]. A more recent study in the developing mouse ovary suggests that
cells expressing gata4 are precursor cells of granulosa cells and that there are two populations;
one which additionally expresses p27, and one which is not expressing p27 and which is there-
fore highly proliferative [72]. The latter gives rise to the granulosa cells, which will form the so-
called cortical follicles from E18.5 to postnatal day 5, whereas the other population is involved
in the formation of the medullar follicles between E12.5 and E14.5 [17, 72].
FOXL2 (Fig 5A and S3A Fig), NR5A1 (Fig 5H and S3H Fig), WNT2B (Fig 5J and S3J Fig)
and CTNNB1 (Fig 5K and S3K Fig) are constitutively expressed throughout gestation. FOXL2
has been described as a female-specific marker from sex differentiation until adulthood [73,
74] and has been shown to be expressed early in bovine ovarian development in the GREL
cells which are enclosed together with the germ cells in the ovigerous cords, and in the granu-
losa cells later in development after follicle formation and growth occur [1]. In the human fetal
ovary, FOXL2 expression increases from 9 weeks to 18 weeks, when the first follicles are
formed [32]. The protein localises to the somatic cells streams in the ovarian stroma and the
somatic cells intermingled with germ cells, which will become pre-granulosa cells, as well as
pre-granulosa cells of primordial follicles. In goats, FOXL2 directly activates CYP19A1 by
binding to its promotor 2 [48] but in the current study no correlation between FOXL2 and
CYP19A1 was observed, suggesting that there could be differences between species in the regu-
lation of CYP19A1. NR5A1 has been shown to be expressed in the fetal bovine ovary in the
cells of the ovigerous cords and on the ovarian surface and later in development in the granu-
losa cells of growing follicles [1]. In the adult bovine ovary, NR5A1 (alias SF-1) is expressed by
granulosa and thecal cells [75]. In contrast to the bovine fetal ovary, NR5A1 is expressed in the
genital ridge of mice and rats until sex determination and then declines in the female until late
in gestation in the mice (E18.5) [76] or until after birth in the rat [77] when primordial follicle
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formation occurs. In the human fetal ovary, persistent NR5A1 expression has been shown
from the point of genital ridge formation up to week 15 of gestation [78] while expression later
than this is unclear. Little is known about the expression of WNT2B in the ovary. In the imma-
ture rat, WNT2B has been localised to the ovarian surface epithelium by in situ hybridisation
and has also been shown to be expressed in ovarian cancer cell lines [79]. Previously, Hatziro-
dos et al. [80] found in the bovine adult ovary that WNT2B is downregulated in the theca
interna of large (9–12 mm) compared to small (3–5 mm) healthy follicles, whereas the Wnt
inhibitor FRZB was upregulated.
Relationships between cell markers
Pearson correlation analyses (Tables 2 and 3) of genes expressed in germ and stem cells show a
very strong positive correlation between DAZL and VASA, which both are reported to induce
meiotic progression in germ cells [81]. OCT4 and LGR5 show both a negative correlation with
ALDH1A1 but a strong positive correlation with the GREL cell marker DSG2. ALDH1A1 was
negatively correlated with DSG2. There were also correlations between germ cell markers and
granulosa cell markers. OCT4 positively correlated with CYP19A1 and CCDN2, and negatively
with ESR1 and INHBA. DAZL showed a positive correlation with CCDN2 and VASA but was
negatively correlated with NR5A1. The stem cell marker LGR5 correlated negatively with
AMH, FSHR and INHBA but positively with DSG2. The other stem cell-specific marker,
ALDH1A1, appears to be strongly correlated with many granulosa cell-specific genes; posi-
tively with AMH, FSHR, ESR1 and INHBA, and negatively with CYP19A1, ESR2, GATA4 and
CCDN2. This is interesting as retinoic acid signalling appears to be essential for induction of
meiosis of germ cells but not for granulosa cell specification, at least in mice [82]. On the other
Table 2. Pearson’s correlation coefficients between markers for germ and stem cells and all genes examined and gestational age. The intensity of the background col-
our indicates the strength of the significance of the correlation. Blue is a negative correlation and red is a positive correlation. (aP< 0.05, bP< 0.01, cP< 0.01; n = 17).
Germ and stem cell markers
OCT4 DAZL VASA LGR5 ALDH1A1
Gestational age -0.620b -0.242 -0.022 -0.479 0.897d
Germ and stem cell markers OCT4 0.055 -0.162 0.375 -0.560a
DAZL 0.055 0.858c 0.284 -0.388
VASA -0.162 0.858c 0.191 -0.267
LGR5 0.375 0.284 0.191 -0.603a
ALDH1A1 -0.560a -0.388 -0.267 -0.603a
GREL cell markers KRT19 -0.197 0.003 0.368 0.394 -0.042
DSG2 0.779c 0.429 0.131 0.714b -0.789c
Granulosa cell markers FOXL2 -0.160 -0.368 -0.196 -0.297 -0.137
AMH -0.319 -0.332 -0.367 -0.506a 0.737c
FSHR -0.314 -0.215 -0.093 -0.499a 0.702b
CYP19A1 0.651b -0.155 -0.360 0.188 -0.645b
ESR1 -0.695b -0.14 0.171 -0.476 0.729c
ESR2 0.378 0.008 -0.137 0.351 -0.712b
INHBA -0.486a -0.375 -0.292 -0.573a 0.795c
NR5A1 0.315 -0.381 -0.487a 0.053 -0.380
GATA4 0.474 0.346 0.178 0.432 -0.701c
WNT2B 0.169 0.319 0.415 -0.322 -0.212
CTNNB1 -0.039 -0.138 0.011 -0.204 0.011
CCND2 0.633b 0.597a 0.301 0.098 -0.512a
https://doi.org/10.1371/journal.pone.0214130.t002
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hand, DSG2 was positively correlated with CYP19A1, ESR2, GATA4 and CCDN2, and nega-
tively with AMH, FSHR, ESR1 and INHBA and additionally negatively with ALDH1A1.
Surprisingly, no correlation existed between KRT19 and DSG2. Furthermore, KRT19 was
only correlated to CCDN2. Correlation analysis of the genes within the group of granulosa
cell-specific markers, revealed a positive correlation between FOXL2 and NR5A1, between
AMH, FSHR and INHBA, between FSHR and ESR2, and between WNT2B and CCDN2.
CYP19A1 correlated positively with ESR2, NR5A1 and GATA4, but negatively with ESR1 and
INHBA. As expected, ESR1 was positively correlated with INHBA, but negatively with ESR2,
GATA4 and CCDN2. ESR2 showed a positive correlation with GATA4, whereas INHBA was
negatively correlated with GATA4. Additionally, GATA4 was positively correlated with
CCDN2. Interestingly, CTNNB1 showed no correlation with any of the germ, stem, GREL or
granulosa cell markers.
The multitude of both negative and positive correlations, therefore, in expression of genes
in germ and somatic cells, and the correlations amongst genes expressed within a cell lineage,
suggest a degree of co-regulation or coordination of behaviours of different cells. Since many
of these genes either increase or decrease during gestation, the relationships between these
genes may reflect their physiological role in the transition of ovigerous cords to follicles, oogo-
nia to oocytes or GREL cells to granulosa cells.
Gene expression and ovarian development. The early cortex is characterised by forma-
tion and growth of the ovigerous cords which occurs by replication of GREL and germ cells. It
is characterised by high proliferation indices (Fig 2) and high expression of CCND2 (Fig 5).
Table 3. Pearson’s correlation coefficients between markers for GREL and granulosa cells and all genes examined and gestational age. The intensity of the back-





KRT19 DSG2 FOXL2 AMH FSHR CYP19A1 ESR1 ESR2 INHBA NR5A1 GATA4 WNT2B CTNNB1 CCND2




DAZL 0.003 0.429 -0.368 -0.332 -0.215 -0.155 -0.140 0.008 -0.375 -0.381 0.346 0.319 -0.138 0.597a
VASA 0.368 0.131 -0.196 -0.367 -0.093 -0.360 0.171 -0.137 -0.292 -0.487a 0.178 0.415 0.011 0.301
OCT4 -0.197 0.779c -0.16 -0.319 -0.314 0.651b -0.695b 0.378 -0.486a 0.315 0.474 0.169 -0.039 0.633b
LGR5 0.394 0.714b -0.297 -0.506a -0.499a 0.188 -0.476 0.351 -0.573a 0.053 0.432 -0.322 -0.204 0.098
ALDH1A1 -0.042 -0.789c -0.137 0.737c 0.702b -0.645b 0.729c -0.712b 0.795c -0.38 -0.701b -0.212 0.011 -0.512a
GREL cell
markers
KRT19 -0.123 -0.208 -0.323 -0.018 -0.34 0.333 -0.146 -0.107 -0.343 -0.076 -0.204 0.171 -0.525a
DSG2 -0.123 -0.277 -0.517a -0.507a 0.587a -0.820c 0.549a -0.673b 0.27 0.705b 0.011 -0.100 0.647b
Granulosa cell
markers
FOXL2 -0.208 -0.277 -0.019 -0.248 0.24 0.11 0.306 -0.101 0.598a -0.137 0.418 -0.062 -0.092
AMH -0.323 -0.517a -0.019 0.624b -0.368 0.317 -0.481 0.766c -0.011 -0.563a -0.305 -0.130 -0.277
FSHR -0.018 -0.507a -0.248 0.624b -0.472 0.408 -0.548a 0.520a -0.211 -0.259 -0.057 0.447 -0.314
CYP19A1 -0.34 0.587a 0.24 -0.368 -0.472 -0.832c 0.853c -0.549a 0.581a 0.632b 0.111 -0.085 0.439
ESR1 0.333 -0.820c 0.11 0.317 0.408 -0.832c -0.733 0.550a -0.410 -0.754c 0.089 0.121 -0.531a
ESR2 -0.146 0.549a 0.306 -0.481 -0.548a 0.853c -0.733c -0.721b 0.626b 0.748c 0.152 -0.122 0.297
INHBA -0.107 -0.673b -0.101 0.766c 0.520a -0.549a 0.550b -0.721b -0.339 -0.699b -0.360 0.120 -0.424
NR5A1 -0.343 0.270 0.598a -0.011 -0.211 0.581a -0.410 0.626b -0.339 0.240 0.118 0.036 0.068
GATA4 -0.076 0.705b -0.137 -0.563a -0.259 0.632b -0.754c 0.748c -0.699b 0.240 0.238 0.223 0.512a
WNT2B -0.204 0.011 0.418 -0.305 -0.057 0.111 0.089 0.152 -0.360 0.118 0.238 0.185 0.555a
CTNNB1 0.171 -0.100 -0.062 -0.130 0.447 -0.085 0.121 -0.122 0.120 0.036 0.223 0.185 -0.052
CCND2 -0.525a 0.647b -0.092 -0.277 -0.314 0.439 -0.531a 0.297 -0.424 0.068 0.512a 0.555a -0.052
https://doi.org/10.1371/journal.pone.0214130.t003
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The germ cells are less mature and there is high expression of OCT4 and DAZL. GREL cells are
present at that stage and they have extensive cell junctions and express DSG2 which is elevated
at these early stages (Fig 4). CYP19 and ESR2 are also highly expressed at these early stages sug-
gesting that oestradiol might have a role then. Subsequently the cords begin to break into
smaller clusters of cells (stage II) and ESR1 and ALDH1 are upregulated. The change in ESR1
probably reflects maturation of oogonia into oocytes. As development continues and follicles
are being formed (stage III), cell replication declines and CYP19A1, ESR2 and OCT4 are down
regulated. This, in conjunction with continued expansion of stroma [13], may have led to a
decline in the proportion of the non-stromal compartments in the cortex. The changes in
OCT4 signal maturation of the germ cells. At later stages follicle activation commences and
expression of genes in growing follicles, FSHR, AMH and INHBA, is increased. KRT19 is
expressed in the surface epithelium [1] and its expression is increased as the surface epithelium
is formed (stage IV).
Conclusions
The expression of many genes increased across gestation matched by a concomitant decline
in others, with many being positively or negatively correlated, even when potentially not
expressed in the same cell type. These relationships between genes may reflect their roles in the
transition of ovigerous cords to follicles, oogonia to oocytes, or GREL cells to granulosa cells.
Further work is now underway to identify genes that act as regulators and those that are
regulated.
Supporting information
S1 Fig. Expression of germ and stem cell markers. Measurement of gene expression of germ
and stem cell markers in fetal ovaries by q-PCR graphed by trimester (1st, 2nd and 3rd trimes-
ters have n = 5, n = 7 and n = 5 animals, respectively). Mean ± SEM are shown and statistical
differences between trimesters are shown as ��, or ����, indicating P< 0.01 or P< 0.0001,
respectively.
(TIF)
S2 Fig. Expression GREL cell markers. Measurement of gene expression of GREL cell mark-
ers in fetal ovaries by q-PCR graphed by trimester (1st, 2nd and 3rd trimesters have n = 5,
n = 7 and n = 5 animals, respectively). Mean ± SEM are shown and statistical differences
between trimesters are shown as ���, indicating P< 0.001, respectively.
(TIF)
S3 Fig. Expression of granulosa cell markers. Measurement of gene expression of granulosa
cell markers in fetal ovaries by q-PCR graphed by trimester (1st, 2nd and 3rd trimesters have
n = 5, n = 7 and n = 5 animals, respectively). Mean ± SEM are shown and statistical differences
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S1 Fig. Germ and stem cell marker expression. Measurement of gene expression of germ 
and stem cell markers in fetal ovaries by q-PCR graphed by trimester (1st, 2nd and 3rd 
trimesters have n = 5, n = 7 and n = 5 animals, respectively). Mean ± SEM are shown and 




S2 Fig. GREL cell marker expression. Measurement of gene expression of GREL cell 
markers in fetal ovaries by q-PCR graphed by trimester (1st, 2nd and 3rd trimesters have n = 
5, n = 7 and n = 5 animals, respectively). Mean ± SEM are shown and statistical differences 
between trimesters are shown as ***, indicating P < 0.001, respectively. 
 
 
S3 Fig. Granulosa cell marker expression. Measurement of gene expression of granulosa 
cell markers in fetal ovaries by q-PCR graphed by trimester (1st, 2nd and 3rd trimesters have 
n = 5, n = 7 and n = 5 animals, respectively). Mean ± SEM are shown and statistical 
differences between trimesters are shown as *, **, ***, or ****, indicating P < 0.05, P < 
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Summary (200 words) 
 
When first formed the ovary has an established epithelium only at its base or hilum. Later, an 
epithelium is established around the rest of the ovary. To examine this further we conducted 
scanning electron microscopy of the surface of bovine fetal ovaries and 
immunohistochemistry of ovarian cross-sections. From the earliest time point, the cells on the 
surface of the base or hilum of the ovary were cuboidal. On the remainder of the ovary, the 
surface was more irregular. By mid-development, the surface was covered completely with 
either a stratified or simple epithelium of cuboidal cells. Clefts were observed in the surface 
and appeared to form due to the expansion of stroma surrounding each open ovigerous cord, 
elevating the areas surrounding each cord, whilst leaving the opening of the cord to form the 
base of each cleft. The continued expansion of the surrounding stroma below the surface 
appeared not only to close the ovigerous cords from the surface but to compress the clefts into 
the shape of a groove. Later, most of the ovarian surface was covered with a simple cuboidal 
epithelium. The changes to the ovarian surface during fetal development coincide with the 










The mature ovary is covered by a predominantly single layer of flat to cuboidal epithelial 
cells. This surface epithelium is rich in keratins 7, 8, 18 and 19, and has intercellular 
desmosomes and incomplete tight junctions (Auersperg et al. 2001; Zhu et al. 2004). The sub-
epithelial basal lamina is underlain by the stromal fibrous tunica albuginea (Hummitzsch et al. 
2013; Zhu et al. 2004). Interestingly, the surface epithelium in the mature ovary is extremely 
dynamic. Continued expansion and contraction of the surface occurs as follicles and corpora 
lutea grow and regress beneath it. Additionally, cell death and the repair of the tunica and 
surface epithelium at the point of rupture of the follicle wall occurs during the event of 
ovulation (Murdoch 1994; Nicosia et al. 1991). It is assumed that stem cells in the remaining 
surface epithelium proliferate and differentiate, to restore the surface damaged at ovulation. 
Until recently, little was known about the surface epithelial stem cells (Flesken-Nikitin et al. 
2013; Ng et al. 2014; Rastetter et al. 2014) with the first study to identify possible 
stem/progenitor cells in mice (Szotek et al. 2008). The ovarian surface epithelium is also 
potentially a major contributor to the incidence of ovarian cancers. Ovarian epithelial 
carcinomas represent around 90% of ovarian malignant neoplasms (Torre et al. 2018). 
However, there is good evidence to suggest that at least the high grade serous ovarian 
carcinomas and not derived from the ovarian surface epithelium but could arise from the 
secretory cells of the oviduct (Kroeger and Drapkin 2017; Labidi-Galy et al. 2017).  
The ovarian surface epithelium is also dynamic during fetal development. Earlier 
literature identified that the surface epithelium originates from the mesoderm-derived 
epithelial layer, which lines the intra-embryonic coelom and the area on the ventral surface of 
the mesonephros where the gonad is subsequently formed (Byskov 1986; Frӧjdman and 
Pelliniemi 1995). The mesonephric surface is covered by a simple epithelium, except where 
gonadal thickening occurs (Kenngott et al. 2013). This thickening is due to proliferation of the 
surface cells which we have termed as gonadal ridge epithelial-like (GREL) cells 
(Hummitzsch et al. 2013). We observed that when the bovine fetal ovary is first formed, it is 
not covered by an established surface epithelium underlain by a basal lamina at the interface 
with stroma except at the base or hilum of the ovary (Hummitzsch et al. 2015; Hummitzsch et 
al. 2013; Rodgers and Hummitzsch 2014). The base or hilum of the ovary is in fact a 
protrusion of the mesonephros and it is covered by an established surface epithelium with a 
sub-epithelial basal lamina and epithelial-stromal interface. The remaining part of the ovary is 
composed of primordial germ cells interspersed in a cluster of GREL cells, which arise from 
the mesonephric surface epithelium through proliferation in a process that is also associated 
with degradation of the sub-epithelial basal lamina. Subsequently, the stroma from the 
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mesonephros, with its leading edge basal lamina, penetrates into the ovarian primordium 
towards its surface; branching as it does so. This branching process gives rise to alternating 
areas of stroma and GREL cells/primordial germ cells, known as ovigerous cords. Eventually 
the stroma expands to just below the GREL cells on the surface of the ovary and spreads 
laterally, closing off the ovigerous cords from the surface and trapping GREL cells on the 
surface (Hummitzsch et al. 2013). These GREL cells on the surface eventually develop an 
epithelial phenotype rich in cell junctions, as identified by immunostaining for plakophilin-2 
and desmoglein-2, and with a sub-epithelial basal lamina (Hummitzsch et al. 2013). The cells 
of the surface epithelium of the adult mouse ovary are also not uniform in their phenotype and 
gene expression (Flesken-Nikitin et al. 2013; Ng et al. 2014). Thus, the different 
developmental pathways for ovarian surface epithelial cells could be important in causing the 
heterogeneity of ovarian surface epithelial cells. 
 Since the surface epithelium of the ovary has heterogeneous cellular origins, 
undergoes continual death and renewal in adult life, and could be important in ovarian cancer, 
we examined the surface of the developing ovary using scanning electron microscopy (SEM). 
To interpret the features that we observed with SEM, we identified cytokeratin 19 (CK19) in 
epithelial cells and laminin 111 in basal laminas using immunohistochemistry on ovarian 
cross sections. We also performed morphometric analysis of the proportions of cells on the 
surface that had different shapes.  
 
 
Materials and Methods 
 
Bovine Ovaries 
Pairs of bovine fetal ovaries from different developmental stages were collected from 
pregnant Bos taurus cows processed at an abattoir (Midfield Meat International, 
Warrnambool, Victoria, Australia). To estimate the gestational age, the crown-rump length 
(CRL) was measured (Russe 1983). One ovary from each pair was fixed with 2.5% 
glutaraldehyde (ProSciTech, Thuringowa, Queensland, Australia) in 0.1 M phosphate buffer 
solution (PBS; Merck Pty Ltd, Victoria, Australia) for subsequent SEM (n = 11 were used for 
SEM), whereas the corresponding ovary was embedded in O.C.T. compound (ProSciTech, 
Thuringowa, Queensland, Australia) and stored in dry ice for subsequent histology and 
immunohistochemistry. All samples were then transported to the laboratory. DNA was 
extracted from tail samples from fetuses with CRL < 10 cm to determine the fetal sex using 
PCR of the SRY gene, as previously described (Hummitzsch et al. 2013). The samples were 
grouped into three developmental stages; early stage (SEM n = 3, IHC n = 2, <100 days of 
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gestation), mid stage (SEM n = 5, IHC n = 8, 100-170 days of gestation) and late stage (SEM 
n = 3, IHC n = 4, >170 days of gestation). Furthermore, the age of each fetus was estimated 
from the CRL [y = –0.0103x2 + 3.4332x + 36.08; where y is the age in days and x is the CRL 
in cm, determined using Russe’s method (1983)]. 
 
Histology  
O.C.T. embedded blocks were cut using a Leica CM3050S Cryostat (Leica Biosystems, 
Victoria, Australia) into serial sections of 8 µm thickness. The sections were then mounted on 
Superfrost glass slides (HD Scientific Supplies, Wetherill Park, NSW, Australia), transported 




An indirect immunofluorescence method was used for dual localization of CK19 and laminin 
111. The primary antibodies used were mouse anti-human CK19 (0.25 µg/ml; Boehringer 
Ingelheim GmbH, Ingelheim am Rhein, Germany) to identify epithelial cells in combination 
with rabbit anti-mouse laminin 111, (L9393, from the basement membrane of an EHS mouse 
tumour, 5 µg/ml; Sigma Chemical Co, St Louis, MO, USA) to localize the basal lamina. The 
secondary antibodies were Biotin-(SP)-conjugated AffiniPure donkey anti-mouse IgG (1:100; 
#711 066 152) and donkey anti-rabbit IgG conjugated to Cy3 (1:100; #715 166 151) followed 
by dichlorotriazinylamino fluorescein (DTAF)-conjugated streptavidin (1:100; #016 010 
084). All the secondary antibodies and conjugated streptavidin were from Jackson 
ImmunoResearch Laboratories Inc (West Grove, PA, USA). The cell nuclei were 
counterstained with a 4’,6’-diamidino-2-phenylindole dihydrochloride (DAPI) solution 
(Molecular Probes, Fisher Scientific, Hampton, NH, USA). The bovine adult ovary was used 
as a positive control. Nonimmune mouse and rabbit sera (Sigma-Aldrich, St. Louis, MO, 
USA) were used as negative controls. All sections were photographed with an Olympus BX51 
microscope with an epifluorescence attachment and a Spot RT digital camera (Diagnostic 
Instruments, Meyer Instrument, Houston, TX, USA). 
 
Morphometric Analyses 
Morphometric analyses were conducted on the largest cross-section from each ovary, 
determined by hematoxylin-eosin staining for every 10th section. To analyse the ovarian 
surface, mid and late stage samples were used, and the surface was identified based on the 
positive CK19 and laminin 111 staining. Using ImageJ software (Schindelin et al. 2012), the 
ovarian epithelial perimeter was determined from the combined images taken from the 
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ovarian surface as a CK19 positive area at x20 magnification. The proportions of the 
perimeter of the surface covered by multi- or single- layered cuboidal cells, or squamous 
cells, or that which was denuded were measured. No columnar-shaped cells were observed. 
 
Scanning Electron Microscopy 
The fixed bovine fetal ovaries were washed 3 times with 0.1 M PBS pH 7.25 (Merck Pty Ltd, 
Victoria, Australia). The samples were then transported to Adelaide Microscopy and 
postfixed with 2% osmium tetroxide in PBS for 1 hour. After washing twice for 5 mins with 
PBS containing 4% sucrose, the samples were then dehydrated in a graded series of ethanol (2 
x 10 min each in 70, 90, and 100%). The samples were incubated in 1:1 100% 
ethanol:hexamethyldisilazane (HMDS) for 10 mins, then 2 x 10 mins in 100% HMDS, air 
dried and mounted on aluminium stubs with sticky tabs. A thin layer of dabs of paint was 
applied around the samples and dried. The stubs were then placed under vacuum in a 208 
High Resolution Sputter Coater (Cressington Scientific Instruments, Watford, UK). After 
choosing the correct positions, the stubs were metallized with platinum using high vacuum 
systems and then stored in SEM storage boxes until examination. The processed samples were 
examined with a Philips XL30 SEM (North Billerica, MA, USA) operated at 10 kV. 
 
Statistical Analyses 
All statistical analyses were carried out using Microsoft Office Excel 2010 and GraphPad 
Prism Version 7.00 for Windows (GraphPad Software Inc., La Jolla, CA, USA). The 





Immunohistochemical Changes  
The early ovarian primordium developed on the ventral side of the mesonephros. As observed 
previously (Hummitzsch et al. 2013) the mesonephros was covered by a simple single-layered 
surface epithelium which stained strongly for CK19 (Fig. 1). The same surface epithelium 
was observed at the base or hilum of the developing ovarian primordium (Figs. 1A and B). 
These simple surface epithelial cells of the mesonephros and the hilum of the ovary were 
underlain by a basal lamina, identified by localizing laminin 111 (Fig. 1B). The rest of the 
ovarian surface, not at the base or hilum of the ovary, was not covered by a surface epithelium 
underlain by a basal lamina. Instead GREL cells, which also expressed lower levels of CK19 
and formed the main body of the ovarian primordium, formed the outmost layer of cells on 
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this part of the ovary (Fig. 1C). They appeared to be relatively tightly connected to each other 
(Fig. 1C). Laminin 111 fibres of basal lamina fragments were observed inside the developing 
ovary, where the mesonephric stroma had penetrated. At the end of the first trimester, the 
stroma had expanded towards the ovarian surface (Fig. 1D). This resulted in the formation of 
ovigerous cords, which contained both germ and GREL cells. The ovigerous cords were 
separated from the stromal compartments by a basal lamina. The GREL cells on the surface 
stained more strongly for CK19 than the GREL cells deeper in the ovary.  
In the second trimester, the stroma had penetrated further towards the ovarian surface 
and had commenced expanding laterally below the surface (Fig. 2A). A basal lamina formed 
below some layers of GREL cells on the surface (Fig. 2B) and continued to separate the 
stroma from the ovigerous cords. GREL cells on the surface began to stain more strongly for 
CK19. The staining across the surface was uneven (Fig. 2A). The surface appeared to be 
physically uneven and was sporadically punctuated with deep clefts containing strongly 
CK19-positive GREL cells on the surface of the clefts (Fig. 2C). At this stage, some of the 
ovigerous cords were still open towards the surface (Figs 2A, D and E) and, in some 
instances, the openings were below the level of the surrounding surface, suggesting that the 
clefts might be formed at the openings of the ovigerous cords by expansion of the stroma 
below the surface and around the cleft. Numerous GREL cells at the opening of the ovigerous 
cords were staining more strongly for CK19 (Figs 2E and D).  
At the medullary end of the ovigerous cords, the expansion of the stroma resulted in 
the breakdown of the ovigerous cords, firstly into smaller cords and then into primordial 
follicles (Figs 2E and F). Some of these follicles were activated and had begun to differentiate 
into primary follicles. The stroma became denser, especially below the surface (Fig. 2F). At 
the beginning of the mid-stage, the cells on the surface formed multiple layers (Figs. 2A, B, D 
and E). However, at the end of the second trimester, more areas of the surface had become 
single-layered (Figs 2F, G and H). The surface cells in the single layers had either flattened 
(Fig. 2G) or cuboidal shapes (Fig. 2H).  
 At the late stage of ovarian development, the surface of the ovary was still very 
irregular with clefts and grooves (Fig. 3A). The surface cells were tightly packed but some 
denuded areas were observed (Fig. 3B). Areas of multi-layered surface epithelium were also 
found, especially in the clefts (Fig. 3C), but the majority of the surface at this stage appeared 
to be single-layered (Fig. 3D). 
 
Morphometric Changes  
We analysed the proportions of cuboidal (single- or multi-layered) and flattened squamous 
cells in the ovarian surface throughout mid and late development (Table 1). There was no 
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significant difference between the proportions of the single-layered cuboidal cells between the 
two developmental stages examined (Fig. 4A); with this cell type making up approximately 
85 % of the ovarian surface cover. Multilayered cuboidal cells covered around 10% of the 
surface during mid and late development (Fig. 4B). The percentage of flat squamous cells per 
surface epithelial perimeter was higher at the late stage, with approximately 7%, compared 
with the mid stage with around 2.5% (Fig. 4C). We rarely observed areas of the ovary which 
were not covered by an epithelium (very small areas in 2 of the 14 ovaries examined). We 
assumed these denuded areas were probably artefacts (Fig. 3B) resulting from the sample 
processing and excluded them from the analyses. 
 
Ultrastructural Changes  
SEM of the ovarian primordium revealed a very uneven surface with clefts and grooves (Fig. 
5A). The cells on the surface were either squamous with an extracellular matrix between the 
cells (Fig. 5B), or they were round in shape (Fig. 5C, D). Microvilli (Fig. 5E) and isolated 
cilia (Fig. 5F) were visible on the surface of the cells. Infrequently, germ cells which were 
larger than the surface cells and had a round shape with smooth appearance, were observed on 
the surface (Fig. 5G). 
 The surface of the ovary appeared even more irregular at mid-stage than at earlier 
stages. SEM showed clefts and grooves (Fig. 6). The surface cells appear more rounded in 
shape in areas that were less uneven (Fig. 6B). The stroma was visible in areas where the 
surface had been denuded during processing (Fig. 6B). In areas further away from the hilum, 
flat deep clefts covered the surface (Fig. 6C). The cells between the clefts appeared flat and 
the cell borders were indistinct (Fig. 6C)and gaps between the surface cells were filled with 
an extracellular matrix (Fig. 6D). 
 At the late stages, the ovary still had an uneven surface (Fig. 7A). There appeared to 
be two types of cell shape: rounded cells (Figs 7B and C) and more spindle-shaped cells (Figs 
7B and C). Some shallow clefts were observed on the surface (Fig. 7D). The surface cells had 
microvilli (Fig. 7E), but there were also areas where the surface of the cells was covered by 





This study identified detailed changes occurring on the surface of the ovary throughout 
gestation by using SEM of the ovarian surface and immunohistochemistry of ovarian cross 
sections. Immunostaining for CK19 identified the formation of epithelial cells. CK19 is a 
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member of a large family of epithelial keratins, which form cytoskeletal intermediate 
filaments (Turner and Milliken 2000) and CK19 is generally expressed in simple epithelia 
(Ordonez 2013), as occurs on the ovarian surface. CK19 has been observed at low levels in 
GREL cells in the early stages of ovarian development and at high levels in surface epithelial 
cells later in development of bovine ovaries (Hummitzsch et al. 2013), in adult human ovaries 
(Auersperg and Maines-Bandiera 2000; Matei et al. 2002; Ramayya et al. 2010) and in 
neonatal and adult ovine ovaries (Logan et al. 2002). Polyclonal antiserum to laminin 111 was 
used to visualize the basal laminas in the developing ovary. Basal laminas, when newly 
formed during fetal development, are often rich in laminins, which are less rigid than later in 
development when they become cross-linked to type IV collagens via nidogens (Miner et al. 
2004). The reduced rigidity of laminin-rich basal laminas enables early basal lamina to 
expand easily during growth. Of the laminin chains, α1, β1 and γ1 are also common in fetal 
basal laminas (Miner et al. 2004). In the fetal ovary, basal laminas occur at the interface of 
ovigerous cords and surrounding stroma. They also develop beneath the surface epithelium at 
the interface with stroma. Previously, we identified a number of other components of basal 
lamina in fetal ovaries, including collagen type IV α1, collagen XVIII, perlecan and nidogens 
1 and 2, and observed the sub-epithelial basal lamina by transmission electron microscopy 
(Hummitzsch et al. 2013). The immunohistochemistry of ovarian cross-sections that we 
undertook was valuable in identifying and interpreting the SEM changes in surface topology 
that occurred during development of the ovary. 
As observed here and previously, when the bovine fetal ovary is first formed it is not 
covered by an established surface epithelium underlain by a basal lamina at an interface with 
stroma, as observed in adult ovaries, except at the base or hilum of the ovary (Hummitzsch et 
al. 2015; Hummitzsch et al. 2013; Rodgers and Hummitzsch 2014). The base or hilum of the 
ovary is a protrusion of the mesonephros. That part of the ovary is covered by an established 
classic surface epithelium with a sub-epithelial basal lamina and epithelial-stromal interface 
and is derived directly from the mesonephros. The remaining major apical part of the ovary is 
composed of a cluster of GREL cells, which arise from the mesonephric surface epithelium 
through proliferation in a process that is also associated with degradation of the sub-epithelial 
basal lamina on the surface of the mesonephros. It is this non hilum apical part of the ovary 
that undergoes many changes during fetal development and as reported here.  
In the current study, in the early stages of ovarian development, GREL cells on the 
non-hilum surface formed the outmost layer of cells. They formed a compact layer. In an 
earlier study of bovine fetal ovaries, we showed by electron microscopy that the GREL cells 
of the outermost layer were connected to each other by adherens junctions (Hummitzsch et al. 
2013). At the mid-stage of ovarian development, germ cells had migrated into the ovary and 
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started proliferating. At the same time, the penetrating stroma, also originating from the 
mesonephros, started to spread laterally below the ovarian surface. At this point, some germ 
cells were then trapped on the surface (Hummitzsch et al. 2013). Germ cells were therefore 
observed by SEM on the ovarian surface, as had also been observed previously in bovine 
(Hummitzsch et al. 2013), human (Motta and Makabe 1986) and murine ovaries (Kerr et al. 
2006). The penetrating stroma did not reach and spread out onto the surface of the ovary but 
rather spread laterally below and it could also be speculated that this because the GREL cells 
on the surface had formed a barrier as a compact layer of cells connected by adherens 
junctions.  
Clefts and grooves were present on the surface of the ovary, as observed here by SEM 
and previously in the human developing ovary (Motta and Makabe 1982). The clefts and 
grooves are probably the same structures, but one is more rounded and the other more 
elongated. We prefer to use the terms ‘cleft’, defined as a hollow area or indentation, and 
‘groove’, defined as a long, narrow cut or depression, as these descriptors do not readily 
imply assumptions about how they are formed. Some other terms, such as ‘invagination’, 
‘folds’, ‘furrows’ or ‘sulci’, have previously been used but they imply some mechanism as to 
how these structures are formed that may not be correct. We observed that the clefts and 
grooves developed at the opening of the ovigerous cords to the surface of the ovary. We 
interpret that clefts first develop, not by invagination of the surface, but rather by stroma, 
which surrounds the open cords, expanding and thus lifting the surface around each open cord 
and thus forming a cleft as stylized in Fig 8. The areas surrounding the clefts then appeared as 
ridges or papillae under SEM, and as also observed in the developing human ovary (Motta 
and Makabe 1982). This description is supported by the localization of stroma around the 
cords and the known substantial expansion that the stroma undergoes during early fetal 
development of the ovary (Hartanti et al. 2018). 
During development, the GREL cells on the surface of the ovary began to 
epithelialize, as seen by the increased intensity of staining for CK19. This occurred once the 
stroma had penetrated to below the surface and there was then a sub-epithelial basal lamina 
and epithelial-stromal interface. At the top of the ovigerous cords open to the surface where 
clefts formed, the GREL cells inside the clefts and grooves also epithelialized with increased 
staining for CK19. However, these cells were not in a single layer, as the GREL cells on the 
wall of the clefts near their opening to the surface also epithelialized. Eventually the clefts 
appeared to be compressed from their sides as the surrounding stroma expanded, turning them 
into fissure-shaped grooves, lined with epithelial cells that stained strongly for CK19. 
Eventually, some of these clusters of epithelial cells appeared to be internalized, as the stroma 
expanded laterally below the surface leaving a single layer of epithelial cells on the surface 
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underlain by stroma and some islets of epithelial cells surrounded by stroma, situated below 
the surface. The ultimate fate of these structures is unknown.  
The shape of epithelial cells (squamous, cuboidal or columnar) and type of epithelium 
(simple or stratified) is of interest. Variation of cell shapes has been reported in adult ovarian 
surfaces of humans (Blaustein 1984; Gillett et al. 1991) and other mammals (Motta and Van 
Blerkom 1980). It has been suggested that this variation is due to a result of mechanical 
deformation of normal cells during ovulation. It is observed that, during ovulation, mouse 
ovarian surface epithelial cells undergo active proliferation (Singavarapu et al. 2010), which 
is also likely to alter the cell shape. We observed that the GREL cells covering the ovarian 
surface differentiated into a simple surface epithelium (Hummitzsch et al. 2013), with most of 
the surface covered by single layers of cuboidal (80%) or squamous (5%) cells. In the current 
study, only two ovaries out of the fourteen examined by immunohistochemistry were missing 
small proportions (< 3%) of surface epithelium and this is regarded as an artefact. In some 
cross-sections this was confirmed, as surface cells were observed to be detaching. It has been 
reported that denuding of the surface epithelium of the human ovary is due to tissue handling 
(Gillett 1991; Kruk et al. 1990). Cells on the surface were also observed to have an ECM 
deposited continuously around each cell and between each other. The cells had microvilli, 
cilia and blebs on their antral sides. At this stage, we are not sure if the blebs are real or 
artefacts, as they were not observed consistently. 
In summary, the surface topology of the ovary is largely governed by cellular 
activities beneath the surface. In adults, the surface is continually altered by expansion and 
contraction of the follicles and corpora lutea, and cell death and the repair of the tunica and 
surface epithelium occurs at the point of rupture of the follicle wall during ovulation. In the 
developing fetal ovary, many of the changes in surface topology also appear to arise by 
rearrangement of cells below the surface. The penetration of stroma into the ovarian 
primordium and the lateral expansion of stroma beneath the surface contribute to the 
formation of an established surface epithelium with a sub-epithelial basal lamina and an 
epithelial-stromal interface. The early formation of clefts on the ovarian surface appears due 
to the expansion of stroma surrounding each open ovigerous cord, elevating the areas 
surrounding each cord, whilst leaving the opening of the cord to form the base of each cleft. 
Then the continued expansion of the surrounding stroma below the surface not only closes the 
ovigerous cords from the surface but appears to compress the clefts into the shape of a groove 
on the surface. In some cases this separates the epithelial cells on the walls of the clefts and 
grooves from the surface entirely to produce a structure similar to an inclusion cyst. Clearly 
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Figure 1. Fluorescence micrographs of the ovary and mesonephros during early stages of 
development [cytokeratin 19 (CK19) in green; laminin 111 in red]. (A) The fetal ovary (top 
left) developed on the ventral surface of the mesonephros (bottom right). (B) The hilum area 
of the developing ovary and the mesonephros were covered by single-layered surface 
epithelium, strongly positive for CK19 and underlain by a basal lamina (laminin 111 positive, 
arrows). (C) The remaining ovary/apex surface at this stage of development was not covered 
by a surface epithelial layer underlain by a basal lamina, rather it is covered by somatic GREL 
cells, which also expressed CK19 and fragments of basal lamina observed throughout the 
ovary (arrows). (D) Penetration of mesonephric stroma into the developing ovary resulted in 
the formation of ovigerous cords (unfilled triangle), which contain germ and GREL cells, 
separated from the stroma (asterisk) by a basal lamina (arrows). The GREL cells at this later 
stage and closer to the surface strongly expressed CK19. Nuclei were counterstained with 
DAPI (blue). (A) - (C) 53 days and (D) 76 days of gestation. Scale bars: (A), (C) and (D) 100 






Figure 2. Fluorescence micrographs of the ovary during mid stages of development (CK19 is 
green; laminin 111 is red). (A) Stroma has penetrated further towards the surface and then 
spread laterally below layers of GREL cells on the surface. The staining of CK19 showed a 
gradient – strong in GREL cells on the surface and in GREL cells clustering at the opening to 
the ovarian surface of the ovigerous cords. The weakest staining was in GREL cells deeper in 
the cords in the ovary. Basal lamina (laminin 111 positive) separated the ovigerous cords 
(unfilled triangle) and stromal compartments (asterisk). The ovigerous cords were still open at 
the surface (dotted-line arrow) in some areas and strongly positive GREL cells were observed 
clustered at the openings. (B) A basal lamina formed below the surface cells (double arrow) 
and started to close the ovigerous cords (unfilled triangle) from outside the ovary. The surface 
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of the developing ovary was very uneven; (C) deep clefts (filled triangle) and (D) shallow 
clefts in areas of ovigerous cords being open to the surface (dotted-line arrow) were visible 
and again strongly CK19 positive, clustered at the opening. (E) The stroma expanded and 
laminin 111 fibres (red) were visible in the stromal compartments (asterisk). The expansion 
caused the breakdown of ovigerous cords (unfilled triangle) into smaller cords and finally into 
the smaller primordial follicles (block arrow) closer to the medulla. GREL cells differentiated 
into pre-granulosa cells of primordial follicles and weakly stained for CK19. Additionally, 
fewer ovigerous cords were still open to the surface (dotted-line arrow). (F) Later in 
development, all ovigerous cords were broken down into follicles (block arrow) and a proper 
surface epithelium was separated from the stroma below by a basal lamina. The surface 
epithelium changed from multi-layered to single-layered, with areas of (G) flattened cells or 
(H) cuboidal cells. Nuclei were counterstained in DAPI (blue). (A) 124 days, (B) and (C) 107 
days, (D) 146 days, (E) 144 days, (F) 180 days, (G) and (H) 135 days of gestation. Scale bars: 











Figure 3. Fluorescence micrographs of the ovarian surface during late stages of development. 
(A) The surface of the late stage ovary remained uneven, showing folds and deep clefts. The 
surface epithelial cells stained strongly for CK19 (green). Below the surface epithelium, the 
stroma was now denser (red, stained for laminin 111) and had formed the tunica albuginea. 
(B) The surface epithelial cells were tightly connected with each other and easily shed as 
layer. (C) Even the fully developed ovary had areas with multi-layered surface epithelium, but 
most of the surface cover was (D) single layered. Nuclei were counterstained in blue. (A) 214 








Figure 4. Morphometric analyses of the ovarian surface epithelial cells during bovine fetal 
development. Data are presented as mean ± s.e.m. Samples were grouped into two stages of 
ovarian development: mid (n = 4, 100-170 days of gestation) and late (n = 4, >170 days of 
gestation) stages. (A) The proportion of the area of the ovarian surface occupied by multilayer 
cuboidal epithelial cells, (B) The proportion of the area of the ovarian surface occupied by 
single-layered cuboidal epithelial cells and (C) The proportion of the area of the ovarian 
surface occupied by squamous epithelial cells. One-way ANOVA with post hoc Tuckey’s 





Figure 5. Scanning electron micrographs of the ovarian surface during early stages of 
development. (A) The surface of the developing ovary appeared uneven and furrowed. It was 
covered by areas of flattened cells (B), whose intercellular gaps were filled with extracellular 
matrix material (dotted arrow), and rounded cells (C) close to each other (D). The surface 
cells had microvilli (E, arrow) and single cilia (F, unfilled arrow). Sporadically, germ cells 
were visible on the surface (G, asterisk). (A), (C) and (G) 76 days, (B) and (D) 53 days, (E) 
and (F) 66 days of gestation. Scale bars: (A) 50 m, (B) and (C) 10 m, (D) 20 m, (E) and 





Figure 6. Scanning electron micrographs of the ovarian surface during mid stages of 
development. (A) The surface of the mid-stage ovary appeared more uneven than in the early 
stages, with tissue strands and furrows. (B) Most of the ovary was covered by rounded cells 
and, sporadically, denuded areas were visible (unfilled square). (C) Flat and deep clefts 
(asterisk) populated the surface. (D) Extracellular matrix material filled the gaps between cells 
(dotted line). (A) 144 days, (B) 107 days, (C) 124 days and (D) 101 days of gestation. Scale 





Figure 7. Scanning electron micrographs of ovarian surface during late stages of 
development. (A) There were fewer clefts/furrows covering the surface at the late stages. (B) 
The surface cells appeared to have different shapes, with areas with rounded cells (a) and 
more spindle-shaped cells (b). Denuded areas were sporadically visible (unfilled square). (C) 
Different cell shapes at higher magnification. (D) Shallow clefts were found in some areas. 
(E) Microvilli were visible on the surface of cells. (F) In some areas, the surface cells were 
covered by blebs (block arrow). (A) and (F) 214 days, (B) - (E) 243 days of gestation. Scale 





Figure 8. Schematic diagram showing the formation of clefts and grooves on the surface of 
the ovary. This diagram was assembled from the current data and that published previously 
(Hummitzsch et al. 2013). (A) GREL cells form the outermost layers of cells on the non-
hilum surface of the ovary. Germ cells have migrated into the ovary and started proliferating. 
Penetrating stroma (arrows) originating from the mesonephros has penetrated the ovary and 
branched as it did so. This branching process gave rise to alternating areas of stroma and 
GREL cells/primordial germ cells, with the later known as ovigerous cords (*). (B) The 
penetrating stroma did not reach the surface of the ovary, rather, to just below it. It began to 
spread laterally below the surface, except where the ovigerous cords are open to the surface at 
this stage. The expansion of stroma surrounding open ovigerous cords (arrows) raised the 
surface surrounding the openings of ovigerous cords and thus created clefts, each with an 
opening of a cord at its base. (C) The continued expansion of the stroma leads to a single 
layer of GREL cells on the surface between the clefts. These cells have epithelized. GREL 
cells on the sides and bottom of the clefts are epithelized. (D) Continued expansion of the 
stroma compresses the clefts into the shapes of grooves. (E) Eventually the grooves become 
separated from the surface by the laterally spreading of stroma. This produces a structure 
similar to an inclusion cyst. What happens to these subsequently is not known but they are 


























1 101 2.85 2.25 0.52 0.07 
2 107 3.48 2.76 0.54 0.17 
3 144 5.34 4.08 1.01 0.25 
4 160 4.86 3.86 0.29 0.71 
5 180 5.07 3.89 0.40 0.78 
6 205 4.22 3.58 0.40 0.24 
7 214 3.81 3.26 0.46 0.09 
8 243 7.72 6.57 0.67 0.48 
 






General discussion and  





This thesis consists of four interconnected studies examining the development of the 
bovine fetal ovary and its potential links with reproductive disorders. The first study in this 
thesis identified the changes in stromal behaviour during bovine fetal ovary development. 
The second study connected the ovarian development with PCOS, one of the reproductive 
disorders in which the stroma in the adult ovary is grossly fibrous and extensive. The third 
study analysed the portrait of changes in GREL cells, granulosa cells and oogonium/oocytes 
during bovine fetal ovarian development. The last study described the changes to the ovarian 
surface during bovine fetal development, linking them with the remodelling of the stroma and 
ovigerous cords.  
The important role of stroma during fetal ovarian development has been shown 
recently. It is believed that the stroma has critical roles in the formation of ovigerous cords, 
follicles, surface epithelium and tunica albuginea (Hummitzsch, et al. 2013). Early in the 
development of the ovary, the stroma from the mesonephros penetrates the developing ovary. 
It branches as it does so. The stroma continues to penetrate the ovary primordium towards the 
ovarian surface, grouping the primordial germ cells and some GREL cells into ovigerous 
cords. Once the stroma reaches to just below the surface of the ovary, it spreads laterally, 
causing the ovigerous cords to become smaller and eventually become follicles (Sarraj and 
Drummond 2012, Smith, et al. 2014). GREL cells on the ovarian surface then differentiate 
into surface epithelium and the stroma beneath the surface changes its phenotype into tunica 
albuginea (Hummitzsch, et al. 2013).  
Morphometric analyses were used to analyse the developmental changes in the ovary. 
Since there is variation in the developmental stage between ovaries of the same age in cattle 
(Hummitzsch, et al. 2013), we grouped our bovine fetal ovaries into five different stages: 
Stage I, ovigerous cord formation; Stage II, ovigerous cord breakdown; Stage III, follicle 
formation; Stage IV, ovarian surface epithelium formation and Stage V, tunica albuginea 
formation. Using cortical stroma of bovine fetal ovaries, we were able to analyse the 
developing ovary morphometrically and demonstrate that the ovarian stroma expands 
throughout gestation and the expansion is at its greatest during early development, due to cell 
proliferation.  
The movement of ovarian stroma during fetal development is believed to be regulated 
by many genes, such as fibrillin 1-3 (FBN1-3), TGFB1-3, decorin (DCN), and versican 
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(VCAN) (Hummitzsch, et al. 2013, Prodoehl, et al. 2009). To correlate the histological 
changes in the stroma with gene expression, we analysed 18 genes that are known to be 
correlated with the extracellular matrix, such as asporin (ASPN), biglycan (BGN), lumican 
(LUM), fibromodulin (FMOD), fibronectin (FN) and osteoglycin (OGN). These genes were 
highly expressed later in gestation and their expression levels correlated with each other, 
confirming our observation about stromal expansion during fetal ovarian development.  
Abnormal stromal growth has been linked to reproductive disorders, such as PCOS 
(Abbott, et al. 2006, Li and Huang 2008). Working together with our international 
collaborators, we were able to show that most of the PCOS candidate genes studied in recent 
GWAS papers were expressed during fetal ovarian development. The expression levels of 
these genes can be categorised into 3 groups: early, late and constant expression. Our 
outcomes also suggested the possibility of TGFβ regulation in the expression of some of the 
PCOS candidate genes. TGFβ has been known to stimulate stromal expansion and collagen 
deposition. This study highlighted the possibility of predisposition to the development of the 
PCOS phenotype in adulthood arising during fetal development. 
Using the cortical non-stromal area, consisting of germ cells, GREL cells and 
granulosa cells, and the same classification stages, we conducted a morphometric analysis 
and were able to describe how the volume of the non-stromal areas progressively increased 
during ovarian development, then levelled off during the formation of the surface epithelium. 
Additionally, the proportion of non-stromal areas in the ovarian cortex decreased throughout 
gestation. This could be due to an interruption in the growth of the non-stroma cells and the 
continued growth of stroma. Our study showed that the proliferation index in the non-stromal 
area was very high initially and then declined substantially at the time follicles formed, which 
is stage III of development. Thereafter, it remained low. This is consistent with the 
proliferation of oogonia, which occurs until 5 months of gestation in the human fetal ovary, 
the time when the primordial follicles begin to form at 90-140 days (Yang and Fortune 2008) 
and 126-133 days (Duffin, et al. 2009) of gestation in cattle and humans, respectively. The 
numerical density of the non-stromal cells was relatively constant throughout ovarian 
development. 
In early ovarian development, proliferation of GREL cells is observed at the genital 
ridge at the ventral side of mesonephros (Hummitzsch, et al. 2013). At this stage, a true 
classical surface epithelium can only be seen at the base of the ovarian primordium, which is 
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really a protruding mesonephros. After the stroma reaches to just below the ovarian surface, 
the GREL cells on the surface differentiate into a classical surface epithelium, covering the 
rest of the fetal ovary (Hummitzsch, et al. 2013). In adult life, the ovarian surface consists of 
two different shapes of cells: cuboidal and squamous cells. It is believed that these two cell 
types have a critical role during the post-ovulation repair of ovarian surface (Flesken-Nikitin, 
et al. 2013, Ng, et al. 2014). We carefully examined the ovarian surface using SEM 
throughout fetal development and divided the samples into three groups: the early, mid and 
late stages of development. The early stage ovary has a group of cuboidal cells near the base 
of the ovary, whereas the rest of the ovarian surface has an irregular surface with 
invaginations. This is consistent with our previous finding that in early development, the 
developing ovary is not covered by a classical epithelium, except at the ovarian base. The rest 
of the ovarian surface consists of GREL cells and germ cells (Hummitzsch, et al. 2013). The 
mid stage ovarian surface consists of cuboidal cells near the base of the ovary, with 
involutions occurring across the rest of the ovarian surface. At this stage, the stroma has 
penetrated the developing ovary towards the ovarian surface and has enclosed some GREL 
cells and oogonia into ovigerous cords, which are open to the surface. Some GREL cells at 
the ovarian surface have commenced differentiating into a surface epithelium (Hummitzsch, 
et al. 2013). It has been suggested that the stroma has an important role in the formation of 
the ovarian surface epithelium. We believe that the involutions represent the open ovigerous 
cords and the protrusions around the involutions represent the areas where the stroma has 
penetrated to just below the ovarian surface, as shown in our immunohistochemistry of 
ovarian cross sections. At a late stage, the ovarian surface consisted of two types of cells: 
cuboidal cells and squamous cells. Involutions were still observed in this stage, however, they 
were wider and the invaginations deeper than the mid stage ovarian surface, as shown by our 
immunohistochemistry.  
The ovarian surface epithelium consists of two different shapes of cell: cuboidal and 
squamous cells. In the human fetal ovary, the surface epithelium is observed to be changed 
from a flat to a cuboidal simple epithelium at around 10-20 weeks of gestation (Motta, et al. 
1997). Our immunohistochemistry results showed that mid and late stage ovaries consist of 
multi and single layered cuboidal cells, as well as single layered squamous cells. Although 
we did not find any significant differences between mid and late stage ovaries, we observed 
that late stage ovaries had more areas with squamous cells when compared with mid stage 
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ovaries. This could be due to the different stages of the follicles in the cortex of the late stage 
ovary and might be related to preparation for the ovulation process in the adult ovary.  
Collectively, this thesis provides further evidence of the importance of stromal changes 
during fetal ovarian development. Additionally, this thesis substantiates a linkage between 
PCOS-candidate genes and ovarian development and this could improve our understanding of 
the origin(s) of PCOS. The outcomes of this thesis provide a foundation for promising future 
research directions, highlighting that understanding fetal ovary development is imperative. 
 
6.2.      Future Directions 
This thesis offers outcomes that can be used to inform future studies related to ovarian 
development. It is clearly shown that the stroma has a critical role in the development of the 
ovary. Investigating the function and mechanism of stromal related genes during fetal ovarian 
development is imperative, given the growing evidence about the important of stroma in the 
formation of ovigerous cords, follicles, surface epithelium and tunica albuginea.  
Analysing the PCOS candidate genes during fetal ovarian development is also 
important. We have shown that some PCOS candidate genes were highly expressed during 
early ovarian development, the time when the stromal development is observed to be at its 
greatest. One of these genes is HMGA2, which was recently shown to affect leanness in pigs 
(Chung, et al. 2018), suggesting that HMGA2 might be related to the proliferation of pre-
adipocytes cells. One of PCOS’ complications is obesity, reported in 61 to 76% of patients 
with PCOS in the United States and Australia (Fauser, et al. 2012). Future research should 
examine the role and regulation of this gene further in the fetal ovary.  
Recently, THADA has been shown to be an important cause of obesity. A knockout 
THADA study in Drosophila found that THADA knockout mutants were characterised by 
obesity and reduced thermogenesis, as well as a higher lipid storage in fat body compared to 
wild type (Moraru, et al. 2017). It will be interesting to study this gene analysing its role and 
regulation in the fetal ovary, as well as in the adult PCOS ovary and fat cells.  
Recent studies have linked PCOS with inflammation. Women with PCOS have higher 
levels of inflammatory cytokines (IL6, IL18, and TNF alpha) and Th1 subsets (Al-Musawy, 
et al. 2018, Qin, et al. 2016). TOX has been shown to play a critical role in the development 
of the immune system (Aliahmad, et al. 2010, Aliahmad and Kaye 2008, Aliahmad, et al. 
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2012). We also observed that TOX3 was highly expressed at the time the ovarian stroma 
penetrates the developing ovary, suggesting that TOX3 might be related to stromal behaviour 
during ovarian development. It would be interesting to study the role and regulation of TOX3 
further, especially in the ovarian stroma where immune cells reside.  
The adult ovarian surface changes its morphology and this is thought to be related to 
the ovulation process. Our observations on the fetal ovarian surface suggest a role of stroma 
in the formation of the ovarian surface epithelium. The fetal ovarian surface epithelium is 
believed to originate from the mesonephric epithelium at the base of the ovary and from 
GREL cells for the rest of the ovarian surface. Future study should target the relationship 
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This present thesis highlights the critical role of stroma during fetal ovarian 
development, especially in the formation of ovarian surface epithelium as well as the fetal 
predisposition of PCOS. However, there are many aspects that still need to be investigated, 
such as the factors that regulate the differentiation of GREL cells into surface epithelial cells 
and its relationship with stromal penetration. The discovery of advance technology in genetic 
and molecular biology provides the possibility of revealing the complex process of gene 
expression and regulation during fetal ovarian development. The ultimate goals would be to 
determine and understand the underlying mechanism of fetal ovarian development to 
understand the pathogenesis of reproductive disorders, such as PCOS, leading to the 
discovery of screening and prevention methods. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
